{
    "attrs": [
      {
        "attr_id": "_NCT|NCT", 
        "branch": "NCT", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "NCT", 
        "trunk": "_NCT", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_PMID|PMID", 
        "branch": "PMID", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "PMID", 
        "trunk": "_PMID", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_Trial_Name|Trial_Name", 
        "branch": "Trial_Name", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Trial_Name", 
        "trunk": "_Trial_Name", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_AUTHORS|AUTHORS", 
        "branch": "Authors", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Authors", 
        "trunk": "_Authors", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_YEAR|YEAR", 
        "branch": "Year", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Year", 
        "trunk": "_Year", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_INCLUDED IN MA|INCLUDED IN MA", 
        "branch": "Included in MA", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Included in MA", 
        "trunk": "_Included in MA", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_FULL PUB OR ABSTRACT|FULL PUB OR ABSTRACT", 
        "branch": "Full Pub or Abstract", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Full Pub or Abstract", 
        "trunk": "_Full Pub or Abstract", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_PHASE|PHASE", 
        "branch": "Phase", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Phase", 
        "trunk": "_Phase", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_ORIGINAL/FOLLOW UP|ORIGINAL/FOLLOW UP", 
        "branch": "Original/Follow Up", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Original/Follow Up", 
        "trunk": "_Original/Follow Up", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_NUMBER OF ARMS INCLUDED|NUMBER OF ARMS INCLUDED", 
        "branch": "Number of Arms Included", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Number of Arms Included", 
        "trunk": "_Number of Arms Included", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_Treatment_Arms|Treatment_Arms", 
        "branch": "Treatment_Arms", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Treatment_Arms", 
        "trunk": "_Treatment_Arms", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_Control_Arm|Control_Arm", 
        "branch": "Control_Arm", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Control_Arm", 
        "trunk": "_Control_Arm", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_Class_of_Agent_in_Treatment_Arm_1|Class_of_Agent_in_Treatment_Arm_1", 
        "branch": "Class_of_Agent_in_Treatment_Arm_1", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Class_of_Agent_in_Treatment_Arm_1", 
        "trunk": "_Class_of_Agent_in_Treatment_Arm_1", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_TREATMENT ARM 1 REGIMEN|TREATMENT ARM 1 REGIMEN", 
        "branch": "Treatment Arm 1 Regimen", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Treatment Arm 1 Regimen", 
        "trunk": "_Treatment Arm 1 Regimen", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_TOTAL PARTICIPANTS - N|TOTAL PARTICIPANTS - N", 
        "branch": "Total Participants - N", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Total Participants - N", 
        "trunk": "_Total Participants - N", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_TREATMENT ARM - N|TREATMENT ARM - N", 
        "branch": "Treatment Arm - N", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Treatment Arm - N", 
        "trunk": "_Treatment Arm - N", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_Control_Arm - N|Control_Arm - N", 
        "branch": "Control_Arm - N", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Control_Arm - N", 
        "trunk": "_Control_Arm - N", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_MEDIAN FOLLOW-UP DURATION (MO)|MEDIAN FOLLOW-UP DURATION (MO)", 
        "branch": "Median Follow-Up Duration (mo)", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Median Follow-Up Duration (mo)", 
        "trunk": "_Median Follow-Up Duration (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN ON-TREATMENT DURATION (MO)|TREATMENT", 
        "branch": "Treatment", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Median On-Treatment Duration (mo) | Treatment", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 2, 
        "trunk": "Median On-Treatment Duration (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN ON-TREATMENT DURATION (MO)|CONTROL", 
        "branch": "Control", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Median On-Treatment Duration (mo) | Control", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 2, 
        "trunk": "Median On-Treatment Duration (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_QUALITY OF LIFE REPORTED|QUALITY OF LIFE REPORTED", 
        "branch": "Quality of Life reported", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Quality of Life reported", 
        "trunk": "_Quality of Life reported", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_QUALITY OF LIFE SCALE|QUALITY OF LIFE SCALE", 
        "branch": "Quality of Life Scale", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Quality of Life Scale", 
        "trunk": "_Quality of Life Scale", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REPORTING BY PROGNOSTIC GROUPS - Y/N|SYNCHRONOUS", 
        "branch": "Synchronous", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Reporting by prognostic groups - Y/N | Synchronous", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 4, 
        "trunk": "Reporting by prognostic groups - Y/N", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REPORTING BY PROGNOSTIC GROUPS - Y/N|METACHRONOUS", 
        "branch": "Metachronous", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Reporting by prognostic groups - Y/N | Metachronous", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 4, 
        "trunk": "Reporting by prognostic groups - Y/N", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REPORTING BY PROGNOSTIC GROUPS - Y/N|HIGH VOLUME", 
        "branch": "High volume", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Reporting by prognostic groups - Y/N | High volume", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 4, 
        "trunk": "Reporting by prognostic groups - Y/N", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REPORTING BY PROGNOSTIC GROUPS - Y/N|LOW VOLUME", 
        "branch": "Low volume", 
        "cate": "TRIAL CHARACTERISTICS", 
        "name": "Reporting by prognostic groups - Y/N | Low volume", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 4, 
        "trunk": "Reporting by prognostic groups - Y/N", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MODE OF METASTASES - N (%)|SYNCHRONOUS|CONTROL", 
        "branch": "Synchronous", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Mode of metastases - N (%) | Synchronous | Control", 
        "sub_branches": [
          {
            "attr_id": "MODE OF METASTASES - N (%)|SYNCHRONOUS|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 18, 
            "name": " Mode of metastases - N (%) | Synchronous | Treatment", 
            "sub_category": true, 
            "sub_parent": "Synchronous", 
            "trunk": "Mode of metastases - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "MODE OF METASTASES - N (%)|SYNCHRONOUS|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 18, 
            "name": " Mode of metastases - N (%) | Synchronous | Control", 
            "sub_category": true, 
            "sub_parent": "Synchronous", 
            "trunk": "Mode of metastases - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "Mode of metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MODE OF METASTASES - N (%)|SYNCHRONOUS|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 18, 
        "name": " Mode of metastases - N (%) | Synchronous | Treatment", 
        "sub_category": true, 
        "sub_parent": "Synchronous", 
        "trunk": "Mode of metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MODE OF METASTASES - N (%)|SYNCHRONOUS|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 18, 
        "name": " Mode of metastases - N (%) | Synchronous | Control", 
        "sub_category": true, 
        "sub_parent": "Synchronous", 
        "trunk": "Mode of metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MODE OF METASTASES - N (%)|METACHRONOUS|CONTROL", 
        "branch": "Metachronous", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Mode of metastases - N (%) | Metachronous | Control", 
        "sub_branches": [
          {
            "attr_id": "MODE OF METASTASES - N (%)|METACHRONOUS|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 18, 
            "name": " Mode of metastases - N (%) | Metachronous | Treatment", 
            "sub_category": true, 
            "sub_parent": "Metachronous", 
            "trunk": "Mode of metastases - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "MODE OF METASTASES - N (%)|METACHRONOUS|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 18, 
            "name": " Mode of metastases - N (%) | Metachronous | Control", 
            "sub_category": true, 
            "sub_parent": "Metachronous", 
            "trunk": "Mode of metastases - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "Mode of metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MODE OF METASTASES - N (%)|METACHRONOUS|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 18, 
        "name": " Mode of metastases - N (%) | Metachronous | Treatment", 
        "sub_category": true, 
        "sub_parent": "Metachronous", 
        "trunk": "Mode of metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MODE OF METASTASES - N (%)|METACHRONOUS|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 18, 
        "name": " Mode of metastases - N (%) | Metachronous | Control", 
        "sub_category": true, 
        "sub_parent": "Metachronous", 
        "trunk": "Mode of metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "VOLUME OF DISEASE - N (%)|HIGH|CONTROL", 
        "branch": "High", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Volume of disease - N (%) | High | Control", 
        "sub_branches": [
          {
            "attr_id": "VOLUME OF DISEASE - N (%)|HIGH|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 19, 
            "name": " Volume of disease - N (%) | High | Treatment", 
            "sub_category": true, 
            "sub_parent": "High", 
            "trunk": "Volume of disease - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "VOLUME OF DISEASE - N (%)|HIGH|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 19, 
            "name": " Volume of disease - N (%) | High | Control", 
            "sub_category": true, 
            "sub_parent": "High", 
            "trunk": "Volume of disease - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "Volume of disease - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "VOLUME OF DISEASE - N (%)|HIGH|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 19, 
        "name": " Volume of disease - N (%) | High | Treatment", 
        "sub_category": true, 
        "sub_parent": "High", 
        "trunk": "Volume of disease - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "VOLUME OF DISEASE - N (%)|HIGH|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 19, 
        "name": " Volume of disease - N (%) | High | Control", 
        "sub_category": true, 
        "sub_parent": "High", 
        "trunk": "Volume of disease - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "VOLUME OF DISEASE - N (%)|LOW|CONTROL", 
        "branch": "Low", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Volume of disease - N (%) | Low | Control", 
        "sub_branches": [
          {
            "attr_id": "VOLUME OF DISEASE - N (%)|LOW|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 19, 
            "name": " Volume of disease - N (%) | Low | Treatment", 
            "sub_category": true, 
            "sub_parent": "Low", 
            "trunk": "Volume of disease - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "VOLUME OF DISEASE - N (%)|LOW|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 19, 
            "name": " Volume of disease - N (%) | Low | Control", 
            "sub_category": true, 
            "sub_parent": "Low", 
            "trunk": "Volume of disease - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "Volume of disease - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "VOLUME OF DISEASE - N (%)|LOW|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 19, 
        "name": " Volume of disease - N (%) | Low | Treatment", 
        "sub_category": true, 
        "sub_parent": "Low", 
        "trunk": "Volume of disease - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "VOLUME OF DISEASE - N (%)|LOW|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 19, 
        "name": " Volume of disease - N (%) | Low | Control", 
        "sub_category": true, 
        "sub_parent": "Low", 
        "trunk": "Volume of disease - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "DOCETAXEL ADMINISTRATION - N (%)|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": "Docetaxel administration - N (%) | Treatment", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 2, 
        "trunk": "Docetaxel administration - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "DOCETAXEL ADMINISTRATION - N (%)|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": "Docetaxel administration - N (%) | Control", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 2, 
        "trunk": "Docetaxel administration - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN AGE (YEARS)|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": "Median Age (years) | Treatment", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 2, 
        "trunk": "Median Age (years)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN AGE (YEARS)|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": "Median Age (years) | Control", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 2, 
        "trunk": "Median Age (years)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|WHITE|CONTROL", 
        "branch": "White", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Race - N (%) | White | Control", 
        "sub_branches": [
          {
            "attr_id": "RACE - N (%)|WHITE|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | White | Treatment", 
            "sub_category": true, 
            "sub_parent": "White", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "RACE - N (%)|WHITE|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | White | Control", 
            "sub_category": true, 
            "sub_parent": "White", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 7, 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|WHITE|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | White | Treatment", 
        "sub_category": true, 
        "sub_parent": "White", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|WHITE|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | White | Control", 
        "sub_category": true, 
        "sub_parent": "White", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|BLACK OR AFRICAN AMERICAN|CONTROL", 
        "branch": "Black or African American", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Race - N (%) | Black or African American | Control", 
        "sub_branches": [
          {
            "attr_id": "RACE - N (%)|BLACK OR AFRICAN AMERICAN|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Black or African American | Treatment", 
            "sub_category": true, 
            "sub_parent": "Black or African American", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "RACE - N (%)|BLACK OR AFRICAN AMERICAN|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Black or African American | Control", 
            "sub_category": true, 
            "sub_parent": "Black or African American", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 7, 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|BLACK OR AFRICAN AMERICAN|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Black or African American | Treatment", 
        "sub_category": true, 
        "sub_parent": "Black or African American", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|BLACK OR AFRICAN AMERICAN|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Black or African American | Control", 
        "sub_category": true, 
        "sub_parent": "Black or African American", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|ASIAN|CONTROL", 
        "branch": "Asian", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Race - N (%) | Asian | Control", 
        "sub_branches": [
          {
            "attr_id": "RACE - N (%)|ASIAN|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Asian | Treatment", 
            "sub_category": true, 
            "sub_parent": "Asian", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "RACE - N (%)|ASIAN|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Asian | Control", 
            "sub_category": true, 
            "sub_parent": "Asian", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 7, 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|ASIAN|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Asian | Treatment", 
        "sub_category": true, 
        "sub_parent": "Asian", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|ASIAN|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Asian | Control", 
        "sub_category": true, 
        "sub_parent": "Asian", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|NAT. HAWAIIAN OR PAC. ISLANDER|CONTROL", 
        "branch": "Nat. Hawaiian or Pac. Islander", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control", 
        "sub_branches": [
          {
            "attr_id": "RACE - N (%)|NAT. HAWAIIAN OR PAC. ISLANDER|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment", 
            "sub_category": true, 
            "sub_parent": "Nat. Hawaiian or Pac. Islander", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "RACE - N (%)|NAT. HAWAIIAN OR PAC. ISLANDER|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control", 
            "sub_category": true, 
            "sub_parent": "Nat. Hawaiian or Pac. Islander", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 7, 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|NAT. HAWAIIAN OR PAC. ISLANDER|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment", 
        "sub_category": true, 
        "sub_parent": "Nat. Hawaiian or Pac. Islander", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|NAT. HAWAIIAN OR PAC. ISLANDER|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control", 
        "sub_category": true, 
        "sub_parent": "Nat. Hawaiian or Pac. Islander", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|AMER. INDIAN OR ALASKA NAT.|CONTROL", 
        "branch": "Amer. Indian or Alaska Nat.", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Race - N (%) | Amer. Indian or Alaska Nat. | Control", 
        "sub_branches": [
          {
            "attr_id": "RACE - N (%)|AMER. INDIAN OR ALASKA NAT.|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment", 
            "sub_category": true, 
            "sub_parent": "Amer. Indian or Alaska Nat.", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "RACE - N (%)|AMER. INDIAN OR ALASKA NAT.|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Amer. Indian or Alaska Nat. | Control", 
            "sub_category": true, 
            "sub_parent": "Amer. Indian or Alaska Nat.", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 7, 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|AMER. INDIAN OR ALASKA NAT.|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment", 
        "sub_category": true, 
        "sub_parent": "Amer. Indian or Alaska Nat.", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|AMER. INDIAN OR ALASKA NAT.|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Amer. Indian or Alaska Nat. | Control", 
        "sub_category": true, 
        "sub_parent": "Amer. Indian or Alaska Nat.", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|OTHER|CONTROL", 
        "branch": "Other", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Race - N (%) | Other | Control", 
        "sub_branches": [
          {
            "attr_id": "RACE - N (%)|OTHER|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Other | Treatment", 
            "sub_category": true, 
            "sub_parent": "Other", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "RACE - N (%)|OTHER|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Other | Control", 
            "sub_category": true, 
            "sub_parent": "Other", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 7, 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|OTHER|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Other | Treatment", 
        "sub_category": true, 
        "sub_parent": "Other", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|OTHER|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Other | Control", 
        "sub_category": true, 
        "sub_parent": "Other", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|UNKNOWN|CONTROL", 
        "branch": "Unknown", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Race - N (%) | Unknown | Control", 
        "sub_branches": [
          {
            "attr_id": "RACE - N (%)|UNKNOWN|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Unknown | Treatment", 
            "sub_category": true, 
            "sub_parent": "Unknown", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "RACE - N (%)|UNKNOWN|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 22, 
            "name": " Race - N (%) | Unknown | Control", 
            "sub_category": true, 
            "sub_parent": "Unknown", 
            "trunk": "Race - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 7, 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|UNKNOWN|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Unknown | Treatment", 
        "sub_category": true, 
        "sub_parent": "Unknown", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "RACE - N (%)|UNKNOWN|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 22, 
        "name": " Race - N (%) | Unknown | Control", 
        "sub_category": true, 
        "sub_parent": "Unknown", 
        "trunk": "Race - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|NORTH AMERICA|CONTROL", 
        "branch": "North America", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Region - N (%) | North America | Control", 
        "sub_branches": [
          {
            "attr_id": "REGION - N (%)|NORTH AMERICA|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | North America | Treatment", 
            "sub_category": true, 
            "sub_parent": "North America", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "REGION - N (%)|NORTH AMERICA|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | North America | Control", 
            "sub_category": true, 
            "sub_parent": "North America", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 6, 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|NORTH AMERICA|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | North America | Treatment", 
        "sub_category": true, 
        "sub_parent": "North America", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|NORTH AMERICA|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | North America | Control", 
        "sub_category": true, 
        "sub_parent": "North America", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|SOUTH AMERICA|CONTROL", 
        "branch": "South America", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Region - N (%) | South America | Control", 
        "sub_branches": [
          {
            "attr_id": "REGION - N (%)|SOUTH AMERICA|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | South America | Treatment", 
            "sub_category": true, 
            "sub_parent": "South America", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "REGION - N (%)|SOUTH AMERICA|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | South America | Control", 
            "sub_category": true, 
            "sub_parent": "South America", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 6, 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|SOUTH AMERICA|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | South America | Treatment", 
        "sub_category": true, 
        "sub_parent": "South America", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|SOUTH AMERICA|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | South America | Control", 
        "sub_category": true, 
        "sub_parent": "South America", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|EUROPE|CONTROL", 
        "branch": "Europe", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Region - N (%) | Europe | Control", 
        "sub_branches": [
          {
            "attr_id": "REGION - N (%)|EUROPE|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | Europe | Treatment", 
            "sub_category": true, 
            "sub_parent": "Europe", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "REGION - N (%)|EUROPE|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | Europe | Control", 
            "sub_category": true, 
            "sub_parent": "Europe", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 6, 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|EUROPE|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | Europe | Treatment", 
        "sub_category": true, 
        "sub_parent": "Europe", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|EUROPE|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | Europe | Control", 
        "sub_category": true, 
        "sub_parent": "Europe", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|AFRICA|CONTROL", 
        "branch": "Africa", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Region - N (%) | Africa | Control", 
        "sub_branches": [
          {
            "attr_id": "REGION - N (%)|AFRICA|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | Africa | Treatment", 
            "sub_category": true, 
            "sub_parent": "Africa", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "REGION - N (%)|AFRICA|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | Africa | Control", 
            "sub_category": true, 
            "sub_parent": "Africa", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 6, 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|AFRICA|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | Africa | Treatment", 
        "sub_category": true, 
        "sub_parent": "Africa", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|AFRICA|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | Africa | Control", 
        "sub_category": true, 
        "sub_parent": "Africa", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|ASIA|CONTROL", 
        "branch": "Asia", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Region - N (%) | Asia | Control", 
        "sub_branches": [
          {
            "attr_id": "REGION - N (%)|ASIA|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | Asia | Treatment", 
            "sub_category": true, 
            "sub_parent": "Asia", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "REGION - N (%)|ASIA|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | Asia | Control", 
            "sub_category": true, 
            "sub_parent": "Asia", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 6, 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|ASIA|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | Asia | Treatment", 
        "sub_category": true, 
        "sub_parent": "Asia", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|ASIA|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | Asia | Control", 
        "sub_category": true, 
        "sub_parent": "Asia", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|OCEANIA|CONTROL", 
        "branch": "Oceania", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Region - N (%) | Oceania | Control", 
        "sub_branches": [
          {
            "attr_id": "REGION - N (%)|OCEANIA|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | Oceania | Treatment", 
            "sub_category": true, 
            "sub_parent": "Oceania", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "REGION - N (%)|OCEANIA|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 23, 
            "name": " Region - N (%) | Oceania | Control", 
            "sub_category": true, 
            "sub_parent": "Oceania", 
            "trunk": "Region - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 6, 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|OCEANIA|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | Oceania | Treatment", 
        "sub_category": true, 
        "sub_parent": "Oceania", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "REGION - N (%)|OCEANIA|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 23, 
        "name": " Region - N (%) | Oceania | Control", 
        "sub_category": true, 
        "sub_parent": "Oceania", 
        "trunk": "Region - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PS - N (%)|0|CONTROL", 
        "branch": "0", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " PS - N (%) | 0 | Control", 
        "sub_branches": [
          {
            "attr_id": "PS - N (%)|0|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 24, 
            "name": " PS - N (%) | 0 | Treatment", 
            "sub_category": true, 
            "sub_parent": "0", 
            "trunk": "PS - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "PS - N (%)|0|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 24, 
            "name": " PS - N (%) | 0 | Control", 
            "sub_category": true, 
            "sub_parent": "0", 
            "trunk": "PS - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "PS - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PS - N (%)|0|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 24, 
        "name": " PS - N (%) | 0 | Treatment", 
        "sub_category": true, 
        "sub_parent": "0", 
        "trunk": "PS - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PS - N (%)|0|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 24, 
        "name": " PS - N (%) | 0 | Control", 
        "sub_category": true, 
        "sub_parent": "0", 
        "trunk": "PS - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PS - N (%)|1-2|CONTROL", 
        "branch": "1-2", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " PS - N (%) | 1-2 | Control", 
        "sub_branches": [
          {
            "attr_id": "PS - N (%)|1-2|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 24, 
            "name": " PS - N (%) | 1-2 | Treatment", 
            "sub_category": true, 
            "sub_parent": "1-2", 
            "trunk": "PS - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "PS - N (%)|1-2|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 24, 
            "name": " PS - N (%) | 1-2 | Control", 
            "sub_category": true, 
            "sub_parent": "1-2", 
            "trunk": "PS - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "PS - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PS - N (%)|1-2|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 24, 
        "name": " PS - N (%) | 1-2 | Treatment", 
        "sub_category": true, 
        "sub_parent": "1-2", 
        "trunk": "PS - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PS - N (%)|1-2|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 24, 
        "name": " PS - N (%) | 1-2 | Control", 
        "sub_category": true, 
        "sub_parent": "1-2", 
        "trunk": "PS - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "GLEASON SCORE - N (%)|\u2264 7|CONTROL", 
        "branch": "\u2264 7", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Gleason score - N (%) | \u2264 7 | Control", 
        "sub_branches": [
          {
            "attr_id": "GLEASON SCORE - N (%)|\u2264 7|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 25, 
            "name": " Gleason score - N (%) | \u2264 7 | Treatment", 
            "sub_category": true, 
            "sub_parent": "\u2264 7", 
            "trunk": "Gleason score - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "GLEASON SCORE - N (%)|\u2264 7|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 25, 
            "name": " Gleason score - N (%) | \u2264 7 | Control", 
            "sub_category": true, 
            "sub_parent": "\u2264 7", 
            "trunk": "Gleason score - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "Gleason score - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "GLEASON SCORE - N (%)|\u2264 7|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 25, 
        "name": " Gleason score - N (%) | \u2264 7 | Treatment", 
        "sub_category": true, 
        "sub_parent": "\u2264 7", 
        "trunk": "Gleason score - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "GLEASON SCORE - N (%)|\u2264 7|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 25, 
        "name": " Gleason score - N (%) | \u2264 7 | Control", 
        "sub_category": true, 
        "sub_parent": "\u2264 7", 
        "trunk": "Gleason score - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "GLEASON SCORE - N (%)|\u2265 8|CONTROL", 
        "branch": "\u2265 8", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Gleason score - N (%) | \u2265 8 | Control", 
        "sub_branches": [
          {
            "attr_id": "GLEASON SCORE - N (%)|\u2265 8|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 25, 
            "name": " Gleason score - N (%) | \u2265 8 | Treatment", 
            "sub_category": true, 
            "sub_parent": "\u2265 8", 
            "trunk": "Gleason score - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "GLEASON SCORE - N (%)|\u2265 8|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 25, 
            "name": " Gleason score - N (%) | \u2265 8 | Control", 
            "sub_category": true, 
            "sub_parent": "\u2265 8", 
            "trunk": "Gleason score - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "Gleason score - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "GLEASON SCORE - N (%)|\u2265 8|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 25, 
        "name": " Gleason score - N (%) | \u2265 8 | Treatment", 
        "sub_category": true, 
        "sub_parent": "\u2265 8", 
        "trunk": "Gleason score - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "GLEASON SCORE - N (%)|\u2265 8|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 25, 
        "name": " Gleason score - N (%) | \u2265 8 | Control", 
        "sub_category": true, 
        "sub_parent": "\u2265 8", 
        "trunk": "Gleason score - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|LIVER|CONTROL", 
        "branch": "Liver", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Metastases - N (%) | Liver | Control", 
        "sub_branches": [
          {
            "attr_id": "METASTASES - N (%)|LIVER|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 26, 
            "name": " Metastases - N (%) | Liver | Treatment", 
            "sub_category": true, 
            "sub_parent": "Liver", 
            "trunk": "Metastases - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "METASTASES - N (%)|LIVER|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 26, 
            "name": " Metastases - N (%) | Liver | Control", 
            "sub_category": true, 
            "sub_parent": "Liver", 
            "trunk": "Metastases - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 4, 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|LIVER|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 26, 
        "name": " Metastases - N (%) | Liver | Treatment", 
        "sub_category": true, 
        "sub_parent": "Liver", 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|LIVER|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 26, 
        "name": " Metastases - N (%) | Liver | Control", 
        "sub_category": true, 
        "sub_parent": "Liver", 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|LUNGS|CONTROL", 
        "branch": "Lungs", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Metastases - N (%) | Lungs | Control", 
        "sub_branches": [
          {
            "attr_id": "METASTASES - N (%)|LUNGS|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 26, 
            "name": " Metastases - N (%) | Lungs | Treatment", 
            "sub_category": true, 
            "sub_parent": "Lungs", 
            "trunk": "Metastases - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "METASTASES - N (%)|LUNGS|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 26, 
            "name": " Metastases - N (%) | Lungs | Control", 
            "sub_category": true, 
            "sub_parent": "Lungs", 
            "trunk": "Metastases - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 4, 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|LUNGS|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 26, 
        "name": " Metastases - N (%) | Lungs | Treatment", 
        "sub_category": true, 
        "sub_parent": "Lungs", 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|LUNGS|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 26, 
        "name": " Metastases - N (%) | Lungs | Control", 
        "sub_category": true, 
        "sub_parent": "Lungs", 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|BONE|CONTROL", 
        "branch": "Bone", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Metastases - N (%) | Bone | Control", 
        "sub_branches": [
          {
            "attr_id": "METASTASES - N (%)|BONE|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 26, 
            "name": " Metastases - N (%) | Bone | Treatment", 
            "sub_category": true, 
            "sub_parent": "Bone", 
            "trunk": "Metastases - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "METASTASES - N (%)|BONE|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 26, 
            "name": " Metastases - N (%) | Bone | Control", 
            "sub_category": true, 
            "sub_parent": "Bone", 
            "trunk": "Metastases - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 4, 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|BONE|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 26, 
        "name": " Metastases - N (%) | Bone | Treatment", 
        "sub_category": true, 
        "sub_parent": "Bone", 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|BONE|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 26, 
        "name": " Metastases - N (%) | Bone | Control", 
        "sub_category": true, 
        "sub_parent": "Bone", 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|NODAL|CONTROL", 
        "branch": "Nodal", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Metastases - N (%) | Nodal | Control", 
        "sub_branches": [
          {
            "attr_id": "METASTASES - N (%)|NODAL|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 26, 
            "name": " Metastases - N (%) | Nodal | Treatment", 
            "sub_category": true, 
            "sub_parent": "Nodal", 
            "trunk": "Metastases - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "METASTASES - N (%)|NODAL|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 26, 
            "name": " Metastases - N (%) | Nodal | Control", 
            "sub_category": true, 
            "sub_parent": "Nodal", 
            "trunk": "Metastases - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 4, 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|NODAL|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 26, 
        "name": " Metastases - N (%) | Nodal | Treatment", 
        "sub_category": true, 
        "sub_parent": "Nodal", 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "METASTASES - N (%)|NODAL|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 26, 
        "name": " Metastases - N (%) | Nodal | Control", 
        "sub_category": true, 
        "sub_parent": "Nodal", 
        "trunk": "Metastases - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|PROSTATECTOMY|CONTROL", 
        "branch": "Prostatectomy", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Previous local therapy - N (%) | Prostatectomy | Control", 
        "sub_branches": [
          {
            "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|PROSTATECTOMY|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 27, 
            "name": " Previous local therapy - N (%) | Prostatectomy | Treatment", 
            "sub_category": true, 
            "sub_parent": "Prostatectomy", 
            "trunk": "Previous local therapy - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|PROSTATECTOMY|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 27, 
            "name": " Previous local therapy - N (%) | Prostatectomy | Control", 
            "sub_category": true, 
            "sub_parent": "Prostatectomy", 
            "trunk": "Previous local therapy - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 3, 
        "trunk": "Previous local therapy - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|PROSTATECTOMY|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 27, 
        "name": " Previous local therapy - N (%) | Prostatectomy | Treatment", 
        "sub_category": true, 
        "sub_parent": "Prostatectomy", 
        "trunk": "Previous local therapy - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|PROSTATECTOMY|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 27, 
        "name": " Previous local therapy - N (%) | Prostatectomy | Control", 
        "sub_category": true, 
        "sub_parent": "Prostatectomy", 
        "trunk": "Previous local therapy - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|ORCHIECTOMY|CONTROL", 
        "branch": "Orchiectomy", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Previous local therapy - N (%) | Orchiectomy | Control", 
        "sub_branches": [
          {
            "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|ORCHIECTOMY|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 27, 
            "name": " Previous local therapy - N (%) | Orchiectomy | Treatment", 
            "sub_category": true, 
            "sub_parent": "Orchiectomy", 
            "trunk": "Previous local therapy - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|ORCHIECTOMY|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 27, 
            "name": " Previous local therapy - N (%) | Orchiectomy | Control", 
            "sub_category": true, 
            "sub_parent": "Orchiectomy", 
            "trunk": "Previous local therapy - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 3, 
        "trunk": "Previous local therapy - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|ORCHIECTOMY|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 27, 
        "name": " Previous local therapy - N (%) | Orchiectomy | Treatment", 
        "sub_category": true, 
        "sub_parent": "Orchiectomy", 
        "trunk": "Previous local therapy - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|ORCHIECTOMY|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 27, 
        "name": " Previous local therapy - N (%) | Orchiectomy | Control", 
        "sub_category": true, 
        "sub_parent": "Orchiectomy", 
        "trunk": "Previous local therapy - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|RADIOTHERAPY|CONTROL", 
        "branch": "Radiotherapy", 
        "cate": "POPULATION CHARACTERISTICS", 
        "name": " Previous local therapy - N (%) | Radiotherapy | Control", 
        "sub_branches": [
          {
            "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|RADIOTHERAPY|TREATMENT", 
            "branch": "Treatment", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 27, 
            "name": " Previous local therapy - N (%) | Radiotherapy | Treatment", 
            "sub_category": true, 
            "sub_parent": "Radiotherapy", 
            "trunk": "Previous local therapy - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|RADIOTHERAPY|CONTROL", 
            "branch": "Control", 
            "cate": "POPULATION CHARACTERISTICS", 
            "index_attr": 27, 
            "name": " Previous local therapy - N (%) | Radiotherapy | Control", 
            "sub_category": true, 
            "sub_parent": "Radiotherapy", 
            "trunk": "Previous local therapy - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 3, 
        "trunk": "Previous local therapy - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|RADIOTHERAPY|TREATMENT", 
        "branch": "Treatment", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 27, 
        "name": " Previous local therapy - N (%) | Radiotherapy | Treatment", 
        "sub_category": true, 
        "sub_parent": "Radiotherapy", 
        "trunk": "Previous local therapy - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PREVIOUS LOCAL THERAPY - N (%)|RADIOTHERAPY|CONTROL", 
        "branch": "Control", 
        "cate": "POPULATION CHARACTERISTICS", 
        "index_attr": 27, 
        "name": " Previous local therapy - N (%) | Radiotherapy | Control", 
        "sub_category": true, 
        "sub_parent": "Radiotherapy", 
        "trunk": "Previous local therapy - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_PRIMARY ENDPOINT(S)|PRIMARY ENDPOINT(S)", 
        "branch": "Primary Endpoint(s)", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": "Primary Endpoint(s)", 
        "trunk": "_Primary Endpoint(s)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_SECONDARY ENDPOINT(S)|SECONDARY ENDPOINT(S)", 
        "branch": "Secondary Endpoint(s)", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": "Secondary Endpoint(s)", 
        "trunk": "_Secondary Endpoint(s)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ORR - N (%)|TREATMENT|PD", 
        "branch": "Treatment", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": " ORR - N (%) | Treatment | PD", 
        "sub_branches": [
          {
            "attr_id": "ORR - N (%)|TREATMENT|OVERALL", 
            "branch": "Overall", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 30, 
            "name": " ORR - N (%) | Treatment | Overall", 
            "sub_category": true, 
            "sub_parent": "Treatment", 
            "trunk": "ORR - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "ORR - N (%)|TREATMENT|CR", 
            "branch": "CR", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 30, 
            "name": " ORR - N (%) | Treatment | CR", 
            "sub_category": true, 
            "sub_parent": "Treatment", 
            "trunk": "ORR - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "ORR - N (%)|TREATMENT|SD", 
            "branch": "SD", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 30, 
            "name": " ORR - N (%) | Treatment | SD", 
            "sub_category": true, 
            "sub_parent": "Treatment", 
            "trunk": "ORR - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "ORR - N (%)|TREATMENT|PD", 
            "branch": "PD", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 30, 
            "name": " ORR - N (%) | Treatment | PD", 
            "sub_category": true, 
            "sub_parent": "Treatment", 
            "trunk": "ORR - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 4, 
        "sub_length": 2, 
        "trunk": "ORR - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ORR - N (%)|TREATMENT|OVERALL", 
        "branch": "Overall", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 30, 
        "name": " ORR - N (%) | Treatment | Overall", 
        "sub_category": true, 
        "sub_parent": "Treatment", 
        "trunk": "ORR - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ORR - N (%)|TREATMENT|CR", 
        "branch": "CR", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 30, 
        "name": " ORR - N (%) | Treatment | CR", 
        "sub_category": true, 
        "sub_parent": "Treatment", 
        "trunk": "ORR - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ORR - N (%)|TREATMENT|SD", 
        "branch": "SD", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 30, 
        "name": " ORR - N (%) | Treatment | SD", 
        "sub_category": true, 
        "sub_parent": "Treatment", 
        "trunk": "ORR - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ORR - N (%)|TREATMENT|PD", 
        "branch": "PD", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 30, 
        "name": " ORR - N (%) | Treatment | PD", 
        "sub_category": true, 
        "sub_parent": "Treatment", 
        "trunk": "ORR - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ORR - N (%)|CONTROL|PD", 
        "branch": "Control", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": " ORR - N (%) | Control | PD", 
        "sub_branches": [
          {
            "attr_id": "ORR - N (%)|CONTROL|OVERALL", 
            "branch": "Overall", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 30, 
            "name": " ORR - N (%) | Control | Overall", 
            "sub_category": true, 
            "sub_parent": "Control", 
            "trunk": "ORR - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "ORR - N (%)|CONTROL|CR", 
            "branch": "CR", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 30, 
            "name": " ORR - N (%) | Control | CR", 
            "sub_category": true, 
            "sub_parent": "Control", 
            "trunk": "ORR - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "ORR - N (%)|CONTROL|SD", 
            "branch": "SD", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 30, 
            "name": " ORR - N (%) | Control | SD", 
            "sub_category": true, 
            "sub_parent": "Control", 
            "trunk": "ORR - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "ORR - N (%)|CONTROL|PD", 
            "branch": "PD", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 30, 
            "name": " ORR - N (%) | Control | PD", 
            "sub_category": true, 
            "sub_parent": "Control", 
            "trunk": "ORR - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 4, 
        "sub_length": 2, 
        "trunk": "ORR - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ORR - N (%)|CONTROL|OVERALL", 
        "branch": "Overall", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 30, 
        "name": " ORR - N (%) | Control | Overall", 
        "sub_category": true, 
        "sub_parent": "Control", 
        "trunk": "ORR - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ORR - N (%)|CONTROL|CR", 
        "branch": "CR", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 30, 
        "name": " ORR - N (%) | Control | CR", 
        "sub_category": true, 
        "sub_parent": "Control", 
        "trunk": "ORR - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ORR - N (%)|CONTROL|SD", 
        "branch": "SD", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 30, 
        "name": " ORR - N (%) | Control | SD", 
        "sub_category": true, 
        "sub_parent": "Control", 
        "trunk": "ORR - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ORR - N (%)|CONTROL|PD", 
        "branch": "PD", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 30, 
        "name": " ORR - N (%) | Control | PD", 
        "sub_category": true, 
        "sub_parent": "Control", 
        "trunk": "ORR - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ADVERSE EVENTS - N (%)|ALL-CAUSE GRADE 3 OR HIGHER|CONTROL", 
        "branch": "All-Cause Grade 3 or Higher", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control", 
        "sub_branches": [
          {
            "attr_id": "ADVERSE EVENTS - N (%)|ALL-CAUSE GRADE 3 OR HIGHER|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 31, 
            "name": " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment", 
            "sub_category": true, 
            "sub_parent": "All-Cause Grade 3 or Higher", 
            "trunk": "Adverse Events - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "ADVERSE EVENTS - N (%)|ALL-CAUSE GRADE 3 OR HIGHER|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 31, 
            "name": " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control", 
            "sub_category": true, 
            "sub_parent": "All-Cause Grade 3 or Higher", 
            "trunk": "Adverse Events - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 3, 
        "trunk": "Adverse Events - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ADVERSE EVENTS - N (%)|ALL-CAUSE GRADE 3 OR HIGHER|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 31, 
        "name": " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment", 
        "sub_category": true, 
        "sub_parent": "All-Cause Grade 3 or Higher", 
        "trunk": "Adverse Events - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ADVERSE EVENTS - N (%)|ALL-CAUSE GRADE 3 OR HIGHER|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 31, 
        "name": " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control", 
        "sub_category": true, 
        "sub_parent": "All-Cause Grade 3 or Higher", 
        "trunk": "Adverse Events - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ADVERSE EVENTS - N (%)|TREATMENT-RELATED GRADE 3 OR HIGHER|CONTROL", 
        "branch": "Treatment-related Grade 3 or Higher", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control", 
        "sub_branches": [
          {
            "attr_id": "ADVERSE EVENTS - N (%)|TREATMENT-RELATED GRADE 3 OR HIGHER|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 31, 
            "name": " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment", 
            "sub_category": true, 
            "sub_parent": "Treatment-related Grade 3 or Higher", 
            "trunk": "Adverse Events - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "ADVERSE EVENTS - N (%)|TREATMENT-RELATED GRADE 3 OR HIGHER|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 31, 
            "name": " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control", 
            "sub_category": true, 
            "sub_parent": "Treatment-related Grade 3 or Higher", 
            "trunk": "Adverse Events - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 3, 
        "trunk": "Adverse Events - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ADVERSE EVENTS - N (%)|TREATMENT-RELATED GRADE 3 OR HIGHER|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 31, 
        "name": " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment", 
        "sub_category": true, 
        "sub_parent": "Treatment-related Grade 3 or Higher", 
        "trunk": "Adverse Events - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ADVERSE EVENTS - N (%)|TREATMENT-RELATED GRADE 3 OR HIGHER|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 31, 
        "name": " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control", 
        "sub_category": true, 
        "sub_parent": "Treatment-related Grade 3 or Higher", 
        "trunk": "Adverse Events - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ADVERSE EVENTS - N (%)|TREATMENT-RELATED GRADE 5|CONTROL", 
        "branch": "Treatment-related Grade 5", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": " Adverse Events - N (%) | Treatment-related Grade 5 | Control", 
        "sub_branches": [
          {
            "attr_id": "ADVERSE EVENTS - N (%)|TREATMENT-RELATED GRADE 5|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 31, 
            "name": " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment", 
            "sub_category": true, 
            "sub_parent": "Treatment-related Grade 5", 
            "trunk": "Adverse Events - N (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "ADVERSE EVENTS - N (%)|TREATMENT-RELATED GRADE 5|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 31, 
            "name": " Adverse Events - N (%) | Treatment-related Grade 5 | Control", 
            "sub_category": true, 
            "sub_parent": "Treatment-related Grade 5", 
            "trunk": "Adverse Events - N (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 3, 
        "trunk": "Adverse Events - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ADVERSE EVENTS - N (%)|TREATMENT-RELATED GRADE 5|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 31, 
        "name": " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment", 
        "sub_category": true, 
        "sub_parent": "Treatment-related Grade 5", 
        "trunk": "Adverse Events - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "ADVERSE EVENTS - N (%)|TREATMENT-RELATED GRADE 5|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 31, 
        "name": " Adverse Events - N (%) | Treatment-related Grade 5 | Control", 
        "sub_category": true, 
        "sub_parent": "Treatment-related Grade 5", 
        "trunk": "Adverse Events - N (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "NO. OF DEATHS - N|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": "No. of Deaths - N | Treatment", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 2, 
        "trunk": "No. of Deaths - N", 
        "vtype": "text"
      }, 
      {
        "attr_id": "NO. OF DEATHS - N|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": "No. of Deaths - N | Control", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 2, 
        "trunk": "No. of Deaths - N", 
        "vtype": "text"
      }, 
      {
        "attr_id": "TTPSA (MO)|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": "TTPSA (mo) | Treatment", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 2, 
        "trunk": "TTPSA (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "TTPSA (MO)|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": "TTPSA (mo) | Control", 
        "sub_branches": [], 
        "sub_categories_length": 1, 
        "sub_length": 2, 
        "trunk": "TTPSA (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|OVERALL|CONTROL", 
        "branch": "Overall", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": " OS Rate (%) | Overall | Control", 
        "sub_branches": [
          {
            "attr_id": "OS RATE (%)|OVERALL|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 34, 
            "name": " OS Rate (%) | Overall | Treatment", 
            "sub_category": true, 
            "sub_parent": "Overall", 
            "trunk": "OS Rate (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "OS RATE (%)|OVERALL|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 34, 
            "name": " OS Rate (%) | Overall | Control", 
            "sub_category": true, 
            "sub_parent": "Overall", 
            "trunk": "OS Rate (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 1, 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|OVERALL|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 34, 
        "name": " OS Rate (%) | Overall | Treatment", 
        "sub_category": true, 
        "sub_parent": "Overall", 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|OVERALL|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 34, 
        "name": " OS Rate (%) | Overall | Control", 
        "sub_category": true, 
        "sub_parent": "Overall", 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN OS (MO)|OVERALL|CONTROL", 
        "branch": "Overall", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": " Median OS (mo) | Overall | Control", 
        "sub_branches": [
          {
            "attr_id": "MEDIAN OS (MO)|OVERALL|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 35, 
            "name": " Median OS (mo) | Overall | Treatment", 
            "sub_category": true, 
            "sub_parent": "Overall", 
            "trunk": "Median OS (mo)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "MEDIAN OS (MO)|OVERALL|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 35, 
            "name": " Median OS (mo) | Overall | Control", 
            "sub_category": true, 
            "sub_parent": "Overall", 
            "trunk": "Median OS (mo)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 1, 
        "trunk": "Median OS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN OS (MO)|OVERALL|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 35, 
        "name": " Median OS (mo) | Overall | Treatment", 
        "sub_category": true, 
        "sub_parent": "Overall", 
        "trunk": "Median OS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN OS (MO)|OVERALL|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 35, 
        "name": " Median OS (mo) | Overall | Control", 
        "sub_category": true, 
        "sub_parent": "Overall", 
        "trunk": "Median OS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PFS RATE (%)|OVERALL|CONTROL", 
        "branch": "Overall", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": " PFS Rate (%) | Overall | Control", 
        "sub_branches": [
          {
            "attr_id": "PFS RATE (%)|OVERALL|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 36, 
            "name": " PFS Rate (%) | Overall | Treatment", 
            "sub_category": true, 
            "sub_parent": "Overall", 
            "trunk": "PFS Rate (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "PFS RATE (%)|OVERALL|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 36, 
            "name": " PFS Rate (%) | Overall | Control", 
            "sub_category": true, 
            "sub_parent": "Overall", 
            "trunk": "PFS Rate (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 1, 
        "trunk": "PFS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PFS RATE (%)|OVERALL|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 36, 
        "name": " PFS Rate (%) | Overall | Treatment", 
        "sub_category": true, 
        "sub_parent": "Overall", 
        "trunk": "PFS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "PFS RATE (%)|OVERALL|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 36, 
        "name": " PFS Rate (%) | Overall | Control", 
        "sub_category": true, 
        "sub_parent": "Overall", 
        "trunk": "PFS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN PFS (MO)|OVERALL|CONTROL", 
        "branch": "Overall", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "name": " Median PFS (mo) | Overall | Control", 
        "sub_branches": [
          {
            "attr_id": "MEDIAN PFS (MO)|OVERALL|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 37, 
            "name": " Median PFS (mo) | Overall | Treatment", 
            "sub_category": true, 
            "sub_parent": "Overall", 
            "trunk": "Median PFS (mo)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "MEDIAN PFS (MO)|OVERALL|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS FOR OVERALL POPULATION", 
            "index_attr": 37, 
            "name": " Median PFS (mo) | Overall | Control", 
            "sub_category": true, 
            "sub_parent": "Overall", 
            "trunk": "Median PFS (mo)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 1, 
        "trunk": "Median PFS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN PFS (MO)|OVERALL|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 37, 
        "name": " Median PFS (mo) | Overall | Treatment", 
        "sub_category": true, 
        "sub_parent": "Overall", 
        "trunk": "Median PFS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN PFS (MO)|OVERALL|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS FOR OVERALL POPULATION", 
        "index_attr": 37, 
        "name": " Median PFS (mo) | Overall | Control", 
        "sub_category": true, 
        "sub_parent": "Overall", 
        "trunk": "Median PFS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|SYNCHRONOUS|CONTROL", 
        "branch": "Synchronous", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "name": " OS Rate (%) | Synchronous | Control", 
        "sub_branches": [
          {
            "attr_id": "OS RATE (%)|SYNCHRONOUS|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 38, 
            "name": " OS Rate (%) | Synchronous | Treatment", 
            "sub_category": true, 
            "sub_parent": "Synchronous", 
            "trunk": "OS Rate (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "OS RATE (%)|SYNCHRONOUS|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 38, 
            "name": " OS Rate (%) | Synchronous | Control", 
            "sub_category": true, 
            "sub_parent": "Synchronous", 
            "trunk": "OS Rate (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 4, 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|SYNCHRONOUS|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 38, 
        "name": " OS Rate (%) | Synchronous | Treatment", 
        "sub_category": true, 
        "sub_parent": "Synchronous", 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|SYNCHRONOUS|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 38, 
        "name": " OS Rate (%) | Synchronous | Control", 
        "sub_category": true, 
        "sub_parent": "Synchronous", 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|METACHRONOUS|CONTROL", 
        "branch": "Metachronous", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "name": " OS Rate (%) | Metachronous | Control", 
        "sub_branches": [
          {
            "attr_id": "OS RATE (%)|METACHRONOUS|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 38, 
            "name": " OS Rate (%) | Metachronous | Treatment", 
            "sub_category": true, 
            "sub_parent": "Metachronous", 
            "trunk": "OS Rate (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "OS RATE (%)|METACHRONOUS|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 38, 
            "name": " OS Rate (%) | Metachronous | Control", 
            "sub_category": true, 
            "sub_parent": "Metachronous", 
            "trunk": "OS Rate (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 4, 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|METACHRONOUS|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 38, 
        "name": " OS Rate (%) | Metachronous | Treatment", 
        "sub_category": true, 
        "sub_parent": "Metachronous", 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|METACHRONOUS|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 38, 
        "name": " OS Rate (%) | Metachronous | Control", 
        "sub_category": true, 
        "sub_parent": "Metachronous", 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|HIGH VOLUME|CONTROL", 
        "branch": "High volume", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "name": " OS Rate (%) | High volume | Control", 
        "sub_branches": [
          {
            "attr_id": "OS RATE (%)|HIGH VOLUME|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 38, 
            "name": " OS Rate (%) | High volume | Treatment", 
            "sub_category": true, 
            "sub_parent": "High volume", 
            "trunk": "OS Rate (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "OS RATE (%)|HIGH VOLUME|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 38, 
            "name": " OS Rate (%) | High volume | Control", 
            "sub_category": true, 
            "sub_parent": "High volume", 
            "trunk": "OS Rate (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 4, 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|HIGH VOLUME|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 38, 
        "name": " OS Rate (%) | High volume | Treatment", 
        "sub_category": true, 
        "sub_parent": "High volume", 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|HIGH VOLUME|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 38, 
        "name": " OS Rate (%) | High volume | Control", 
        "sub_category": true, 
        "sub_parent": "High volume", 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|LOW VOLUME|CONTROL", 
        "branch": "Low volume", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "name": " OS Rate (%) | Low volume | Control", 
        "sub_branches": [
          {
            "attr_id": "OS RATE (%)|LOW VOLUME|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 38, 
            "name": " OS Rate (%) | Low volume | Treatment", 
            "sub_category": true, 
            "sub_parent": "Low volume", 
            "trunk": "OS Rate (%)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "OS RATE (%)|LOW VOLUME|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 38, 
            "name": " OS Rate (%) | Low volume | Control", 
            "sub_category": true, 
            "sub_parent": "Low volume", 
            "trunk": "OS Rate (%)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 4, 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|LOW VOLUME|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 38, 
        "name": " OS Rate (%) | Low volume | Treatment", 
        "sub_category": true, 
        "sub_parent": "Low volume", 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "OS RATE (%)|LOW VOLUME|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 38, 
        "name": " OS Rate (%) | Low volume | Control", 
        "sub_category": true, 
        "sub_parent": "Low volume", 
        "trunk": "OS Rate (%)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN OS (MO)|HIGH VOLUME|CONTROL", 
        "branch": "High volume", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "name": " Median OS (mo) | High volume | Control", 
        "sub_branches": [
          {
            "attr_id": "MEDIAN OS (MO)|HIGH VOLUME|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 39, 
            "name": " Median OS (mo) | High volume | Treatment", 
            "sub_category": true, 
            "sub_parent": "High volume", 
            "trunk": "Median OS (mo)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "MEDIAN OS (MO)|HIGH VOLUME|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 39, 
            "name": " Median OS (mo) | High volume | Control", 
            "sub_category": true, 
            "sub_parent": "High volume", 
            "trunk": "Median OS (mo)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "Median OS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN OS (MO)|HIGH VOLUME|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 39, 
        "name": " Median OS (mo) | High volume | Treatment", 
        "sub_category": true, 
        "sub_parent": "High volume", 
        "trunk": "Median OS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN OS (MO)|HIGH VOLUME|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 39, 
        "name": " Median OS (mo) | High volume | Control", 
        "sub_category": true, 
        "sub_parent": "High volume", 
        "trunk": "Median OS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN OS (MO)|LOW VOLUME|CONTROL", 
        "branch": "Low volume", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "name": " Median OS (mo) | Low volume | Control", 
        "sub_branches": [
          {
            "attr_id": "MEDIAN OS (MO)|LOW VOLUME|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 39, 
            "name": " Median OS (mo) | Low volume | Treatment", 
            "sub_category": true, 
            "sub_parent": "Low volume", 
            "trunk": "Median OS (mo)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "MEDIAN OS (MO)|LOW VOLUME|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 39, 
            "name": " Median OS (mo) | Low volume | Control", 
            "sub_category": true, 
            "sub_parent": "Low volume", 
            "trunk": "Median OS (mo)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "Median OS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN OS (MO)|LOW VOLUME|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 39, 
        "name": " Median OS (mo) | Low volume | Treatment", 
        "sub_category": true, 
        "sub_parent": "Low volume", 
        "trunk": "Median OS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN OS (MO)|LOW VOLUME|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 39, 
        "name": " Median OS (mo) | Low volume | Control", 
        "sub_category": true, 
        "sub_parent": "Low volume", 
        "trunk": "Median OS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN PFS (MO)|HIGH VOLUME|CONTROL", 
        "branch": "High volume", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "name": " Median PFS (mo) | High volume | Control", 
        "sub_branches": [
          {
            "attr_id": "MEDIAN PFS (MO)|HIGH VOLUME|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 40, 
            "name": " Median PFS (mo) | High volume | Treatment", 
            "sub_category": true, 
            "sub_parent": "High volume", 
            "trunk": "Median PFS (mo)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "MEDIAN PFS (MO)|HIGH VOLUME|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 40, 
            "name": " Median PFS (mo) | High volume | Control", 
            "sub_category": true, 
            "sub_parent": "High volume", 
            "trunk": "Median PFS (mo)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "Median PFS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN PFS (MO)|HIGH VOLUME|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 40, 
        "name": " Median PFS (mo) | High volume | Treatment", 
        "sub_category": true, 
        "sub_parent": "High volume", 
        "trunk": "Median PFS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN PFS (MO)|HIGH VOLUME|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 40, 
        "name": " Median PFS (mo) | High volume | Control", 
        "sub_category": true, 
        "sub_parent": "High volume", 
        "trunk": "Median PFS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN PFS (MO)|LOW VOLUME|CONTROL", 
        "branch": "Low volume", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "name": " Median PFS (mo) | Low volume | Control", 
        "sub_branches": [
          {
            "attr_id": "MEDIAN PFS (MO)|LOW VOLUME|TREATMENT", 
            "branch": "Treatment", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 40, 
            "name": " Median PFS (mo) | Low volume | Treatment", 
            "sub_category": true, 
            "sub_parent": "Low volume", 
            "trunk": "Median PFS (mo)", 
            "vtype": "text"
          }, 
          {
            "attr_id": "MEDIAN PFS (MO)|LOW VOLUME|CONTROL", 
            "branch": "Control", 
            "cate": "RESULTS BY PROGNOSTIC GROUPS", 
            "index_attr": 40, 
            "name": " Median PFS (mo) | Low volume | Control", 
            "sub_category": true, 
            "sub_parent": "Low volume", 
            "trunk": "Median PFS (mo)", 
            "vtype": "text"
          }
        ], 
        "sub_categories_length": 2, 
        "sub_length": 2, 
        "trunk": "Median PFS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN PFS (MO)|LOW VOLUME|TREATMENT", 
        "branch": "Treatment", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 40, 
        "name": " Median PFS (mo) | Low volume | Treatment", 
        "sub_category": true, 
        "sub_parent": "Low volume", 
        "trunk": "Median PFS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "MEDIAN PFS (MO)|LOW VOLUME|CONTROL", 
        "branch": "Control", 
        "cate": "RESULTS BY PROGNOSTIC GROUPS", 
        "index_attr": 40, 
        "name": " Median PFS (mo) | Low volume | Control", 
        "sub_category": true, 
        "sub_parent": "Low volume", 
        "trunk": "Median PFS (mo)", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_ADD-ON TREATMENT|ADD-ON TREATMENT", 
        "branch": "Add-on Treatment", 
        "cate": "_SYS", 
        "name": "Add-on Treatment", 
        "trunk": "_Add-on Treatment", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_TREATMENT CLASS|TREATMENT CLASS", 
        "branch": "Treatment Class", 
        "cate": "_SYS", 
        "name": "Treatment Class", 
        "trunk": "_Treatment Class", 
        "vtype": "text"
      }, 
      {
        "attr_id": "_TYPE OF THERAPY|TYPE OF THERAPY", 
        "branch": "Type of Therapy", 
        "cate": "_SYS", 
        "name": "Type of Therapy", 
        "trunk": "_Type of Therapy", 
        "vtype": "text"
      }
    ], 
    "cfg": {
      "cols": {
        "default": [
          "Authors", 
          "Trial_Name", 
          "Treatment Arm 1", 
          "Control_Arm"
        ], 
        "fixed": [
          "Authors"
        ]
      }, 
      "filters": [
        {
          "attr": "Type of Therapy", 
          "display_name": "Type of Therapy", 
          "type": "radio", 
          "value": 0, 
          "values": [
            {
              "default": true, 
              "display_name": "All", 
              "sql_cond": "{$col} is not NULL", 
              "value": 0
            }, 
            {
              "default": false, 
              "display_name": "Triplet", 
              "sql_cond": "{$col} like '%Triplet%'", 
              "value": 1
            }, 
            {
              "default": false, 
              "display_name": "ARPI-doublet", 
              "sql_cond": "{$col} like '%ARPI-doublet%'", 
              "value": 2
            }, 
            {
              "default": false, 
              "display_name": "Chemo-doublet", 
              "sql_cond": "{$col} like '%Chemo-doublet%'", 
              "value": 3
            }
          ]
        }, 
        {
          "attr": "Add-on Treatment", 
          "display_name": "Add-on Treatment", 
          "type": "radio", 
          "value": 0, 
          "values": [
            {
              "default": true, 
              "display_name": "All", 
              "sql_cond": "{$col} is not NULL", 
              "value": 0
            }, 
            {
              "default": false, 
              "display_name": "Darolutamide + Docetaxel", 
              "sql_cond": "{$col} like '%Darolutamide + Docetaxel%'", 
              "value": 1
            }, 
            {
              "default": false, 
              "display_name": "Abiraterone acetate + Docetaxel", 
              "sql_cond": "{$col} like '%Abiraterone acetate + Docetaxel%'", 
              "value": 2
            }, 
            {
              "default": false, 
              "display_name": "Apalutamide", 
              "sql_cond": "{$col} like '%Apalutamide%'", 
              "value": 3
            }, 
            {
              "default": false, 
              "display_name": "Enzalutamide", 
              "sql_cond": "{$col} like '%Enzalutamide%'", 
              "value": 4
            }, 
            {
              "default": false, 
              "display_name": "Abiraterone acetate", 
              "sql_cond": "{$col} like '%Abiraterone acetate%'", 
              "value": 5
            }, 
            {
              "default": false, 
              "display_name": "Docetaxel", 
              "sql_cond": "{$col} like '%Docetaxel%'", 
              "value": 6
            }, 
            {
              "default": false, 
              "display_name": "TAK", 
              "sql_cond": "{$col} like '%TAK%'", 
              "value": 7
            }
          ]
        }, 
        {
          "attr": "Treatment Class", 
          "display_name": "Treatment Class", 
          "type": "radio", 
          "value": 0, 
          "values": [
            {
              "default": true, 
              "display_name": "All", 
              "sql_cond": "{$col} is not NULL", 
              "value": 0
            }, 
            {
              "default": false, 
              "display_name": "ARPI", 
              "sql_cond": "{$col} like '%ARPI%'", 
              "value": 1
            }, 
            {
              "default": false, 
              "display_name": "Chemotherapy", 
              "sql_cond": "{$col} like '%Chemotherapy%'", 
              "value": 2
            }
          ]
        }, 
        {
          "attr": "Original/Follow Up", 
          "display_name": "Trial Version", 
          "type": "radio", 
          "value": 0, 
          "values": [
            {
              "default": true, 
              "display_name": "All", 
              "sql_cond": "{$col} is not NULL", 
              "value": 0
            }, 
            {
              "default": false, 
              "display_name": "Original", 
              "sql_cond": "{$col} like '%Original%'", 
              "value": 1
            }, 
            {
              "default": false, 
              "display_name": "Follow up", 
              "sql_cond": "{$col} like '%Follow up%'", 
              "value": 2
            }
          ]
        }
      ]
    }, 
    "itable": {
      "abbr": "SN8GKJCT", 
      "certainty": {
        "cie": "4", 
        "importance": "1", 
        "imprecision": "1", 
        "inconsistency": "1", 
        "indirectness": "1", 
        "publication_bias": "0", 
        "risk_of_bias": "1"
      }, 
      "coe": {}, 
      "data": {
        "10.1016/j.annonc.2020.08.871": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "501 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": "8 (2)", 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 244.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "STAMPEDE", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "501 (100)", 
                "17B78092E8E1": "243 (48.5)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": null, 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": null, 
                "25835DAF88D0": 67, 
                "2600019AA423": "Abstract", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 1003, 
                "2FB5E711ED4D": "0 (0)", 
                "30367DD2D73C": null, 
                "355467E6F99D": null, 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": 70.8, 
                "4BCC29FD82C5": 502.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": "196 (39.0)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": null, 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": "21 (4)", 
                "638859C30428": null, 
                "66260E0A7574": 67.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": null, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "502 (100)", 
                "6FCD847B7D4E": "448 (89)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": null, 
                "870828CC9464": "0 (0)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "502 (100)", 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": 79.2, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": null, 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT00268476", 
                "AB1128C53AB2": "10.1016/j.annonc.2020.08.871", 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": "256 (51)", 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": 73.3, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "206 (41.1)", 
                "CB8A3369E369": "434 (87)", 
                "CB90E5B8EF95": "No", 
                "CE95DBF09499": null, 
                "CECABA14750C": 501, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": "21 (4)", 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 329.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": 45.6, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": "7 (1)", 
                "EB421A7B8403": null, 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": null, 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": null, 
                "F665784BFCA0": 40.8, 
                "F91E38093E93": "Abiraterone acetate", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": null, 
                "FD62EFD5662E": "AAP+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "10.1093/annonc/mdz394.046": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": null, 
                "011F14149E53": null, 
                "0348CAC2849A": null, 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": null, 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": null, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "ENZAMET", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": null, 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": null, 
                "1C1F3983C02E": null, 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": null, 
                "25835DAF88D0": null, 
                "2600019AA423": "Abstract", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": null, 
                "2F4A705D3F9D": 1125, 
                "2FB5E711ED4D": null, 
                "30367DD2D73C": null, 
                "355467E6F99D": null, 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 562.0, 
                "4C28828475CE": null, 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": null, 
                "5E38B4BCDEBD": null, 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": null, 
                "6740730B2D70": null, 
                "684320C8F19F": null, 
                "6858E301D236": null, 
                "6EDA470D3DED": null, 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Enzalutamide 160mg OD; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": null, 
                "870828CC9464": null, 
                "8A4762F6156F": null, 
                "8C9D45766DFA": null, 
                "8E23DACFB0A8": null, 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": null, 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": "Yes", 
                "AAA2600F90CA": "NCT02446405", 
                "AB1128C53AB2": "10.1093/annonc/mdz394.046", 
                "AC649E8D1F86": null, 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": null, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": null, 
                "CE95DBF09499": null, 
                "CECABA14750C": 563, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": null, 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": null, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": null, 
                "E0B67B296150": null, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": null, 
                "EBEC64CC1B96": null, 
                "F0D411DE4F55": "EORTC QLQ-C 30, PR25", 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": null, 
                "F665784BFCA0": null, 
                "F91E38093E93": "Enzalutamide", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "NSAA+ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": null, 
                "FD62EFD5662E": "E+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "10.1200/jco.2020.38.6_suppl.87": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": null, 
                "011F14149E53": null, 
                "0348CAC2849A": null, 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": null, 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": null, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "TITAN", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": null, 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": null, 
                "1C1F3983C02E": null, 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": null, 
                "25835DAF88D0": 69, 
                "2600019AA423": "Abstract", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "63 (high risk) and 85 (low risk) at 2 y", 
                "2D4C089B0DFA": "No", 
                "2F4A705D3F9D": 1052, 
                "2FB5E711ED4D": null, 
                "30367DD2D73C": null, 
                "355467E6F99D": null, 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 527.0, 
                "4C28828475CE": "No", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": null, 
                "5E38B4BCDEBD": "OS, rPFS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 68.0, 
                "6740730B2D70": null, 
                "684320C8F19F": null, 
                "6858E301D236": null, 
                "6EDA470D3DED": null, 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Apalutamide 240 OD; standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "Time to cytotoxic chemotherapy; Time to pain progression", 
                "870828CC9464": null, 
                "8A4762F6156F": null, 
                "8C9D45766DFA": null, 
                "8E23DACFB0A8": null, 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": null, 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT02489318", 
                "AB1128C53AB2": "10.1200/jco.2020.38.6_suppl.87", 
                "AC649E8D1F86": null, 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": "21.8 (low risk); 19.5 (high risk)", 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": null, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": "No", 
                "CE95DBF09499": null, 
                "CECABA14750C": 525, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": null, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": null, 
                "E0B67B296150": 52.2, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": "20.3 (low risk); 14.7 (high risk)", 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": null, 
                "EBEC64CC1B96": "55 (10.4)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": null, 
                "F665784BFCA0": null, 
                "F91E38093E93": "Apalutamide", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": "76 (high risk) and 90 (low risk) at 2 y", 
                "FC992E7A5D74": "58 (11)", 
                "FD62EFD5662E": "APA+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "10.1200/jco.2021.39.6_suppl.11": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": null, 
                "011F14149E53": "~87 (16.6)", 
                "0348CAC2849A": null, 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "~87 (16.6)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": null, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "TITAN", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": null, 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": null, 
                "1C1F3983C02E": null, 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": null, 
                "25835DAF88D0": 69, 
                "2600019AA423": "Abstract", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "52 at 4 y", 
                "2D4C089B0DFA": "No", 
                "2F4A705D3F9D": 1052, 
                "2FB5E711ED4D": null, 
                "30367DD2D73C": null, 
                "355467E6F99D": null, 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 527.0, 
                "4C28828475CE": "No", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": null, 
                "5E38B4BCDEBD": "OS, rPFS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 68.0, 
                "6740730B2D70": null, 
                "684320C8F19F": null, 
                "6858E301D236": null, 
                "6EDA470D3DED": "~87 (16.5)", 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Apalutamide 240 OD; standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "Time to cytotoxic chemotherapy; Time to pain progression", 
                "870828CC9464": null, 
                "8A4762F6156F": null, 
                "8C9D45766DFA": null, 
                "8E23DACFB0A8": null, 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": null, 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": "Yes", 
                "AAA2600F90CA": "NCT02489318", 
                "AB1128C53AB2": "10.1200/jco.2021.39.6_suppl.11", 
                "AC649E8D1F86": null, 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": 39.3, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": 44, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": "No", 
                "CE95DBF09499": null, 
                "CECABA14750C": 525, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": null, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "~87 (16.5)", 
                "E0B67B296150": 52.2, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": 20.2, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": null, 
                "EBEC64CC1B96": "55 (10.4)", 
                "F0D411DE4F55": "FACT-P", 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": null, 
                "F665784BFCA0": null, 
                "F91E38093E93": "Apalutamide", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": "65 at 4 y", 
                "FC992E7A5D74": "58 (11)", 
                "FD62EFD5662E": "APA+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "23306100": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "192 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": "3 (2)", 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 88.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "GETUG-AFU15", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "128 (67)", 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "Chemo-doublet", 
                "1A752545DC79": "113 (59)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": "108 (56)", 
                "22286C840BFC": null, 
                "25183756ACC6": null, 
                "25835DAF88D0": 63, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "62.9 at 3 y", 
                "2D4C089B0DFA": "No", 
                "2F4A705D3F9D": 385, 
                "2FB5E711ED4D": "62 (32)", 
                "30367DD2D73C": null, 
                "355467E6F99D": "103 (55)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "100 (52)", 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": 22.9, 
                "4BCC29FD82C5": 193.0, 
                "4C28828475CE": "No", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "78 (41)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": "22 (11)", 
                "638859C30428": null, 
                "66260E0A7574": 64.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": null, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "193 (100)", 
                "6FCD847B7D4E": "156 (81)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
                "7AB539ED4DCA": "Chemotherapy", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "cPFS; bPFS", 
                "870828CC9464": "46 (24)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "144 (75)", 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": 58.9, 
                "9698F4F8CA22": "34 (18.3)", 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "84 (45)", 
                "9C83E46F40DD": "Original", 
                "9E2C8F8E78F1": "0 (0)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": "Yes", 
                "AAA2600F90CA": "NCT00104715", 
                "AB1128C53AB2": 23306100, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": 20, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": 50, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": "155 (81)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 192, 
                "D497B247EF62": "Chemotherapy", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": "22 (11)", 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 88.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": 54.2, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": 15.4, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": "9 (5)", 
                "EB421A7B8403": "4 (2.1)", 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "0 (0)", 
                "F0D411DE4F55": "EORTC QLQ-C 30", 
                "F1C4BA3F6E42": "179 (91.5)", 
                "F596E2C6ED57": null, 
                "F665784BFCA0": 12.9, 
                "F91E38093E93": "Docetaxel", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": "64.2 at 3 y", 
                "FC992E7A5D74": "192 (100)", 
                "FD62EFD5662E": "D+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "26244877": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "397 (100)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "0 (0)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 101.0, 
                "116B243F7C0C": "6 (1.5)", 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "CHAARTED", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "289 (72.8)", 
                "17B78092E8E1": "263 (66.2)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "Chemo-doublet", 
                "1A752545DC79": "243 (61.8)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": "277 (69.8)", 
                "25835DAF88D0": 64, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 790, 
                "2FB5E711ED4D": "108 (27.2)", 
                "30367DD2D73C": "272 (69.2)", 
                "355467E6F99D": "241 (60.7)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": "33 (8.4)", 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": 33.0, 
                "4BCC29FD82C5": 393.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": 32.2, 
                "567F7C6DB3C0": "143 (36.4)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "104 (26)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": null, 
                "638859C30428": "20 (5.1)", 
                "66260E0A7574": 63.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": 49.2, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "0 (0)", 
                "6FCD847B7D4E": null, 
                "7149F82D389F": "37 (9.4)", 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
                "7AB539ED4DCA": "Chemotherapy", 
                "7B0EFF1CA297": "121 (30.8)", 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": "73 (18.6)", 
                "8685EAA9D758": null, 
                "86DFC7127724": "PSA level; Time to castration-resistant prostate cancer; Time to clinical progression", 
                "870828CC9464": "106 (27.0)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "286 (72.8)", 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": 57.6, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": "39 (9.8)", 
                "9BCB3087C50B": "117 (30)", 
                "9C83E46F40DD": "Original", 
                "9E2C8F8E78F1": "0 (0)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT00309985", 
                "AB1128C53AB2": 26244877, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": "10 (2.5)", 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": "250 (63.6)", 
                "B457B682A558": "27 (6.8)", 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": 28.9, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "134 (33.8)", 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": "81 (20.4)", 
                "CECABA14750C": 397, 
                "D497B247EF62": "Chemotherapy", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": "4 (1.0)", 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 136.0, 
                "DAB906673934": "344 (86.6)", 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "393 (100)", 
                "E0B67B296150": 44.0, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": "1 (1)", 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "0 (0)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "120 (30.2)", 
                "F665784BFCA0": 19.8, 
                "F91E38093E93": "Docetaxel", 
                "F9640855F41B": "330 (84.0)", 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": "397 (100)", 
                "FD62EFD5662E": "D+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "26610858": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "192 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 115.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "GETUG-AFU15", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "128 (67)", 
                "17B78092E8E1": "92 (48)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "Chemo-doublet", 
                "1A752545DC79": "113 (59)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": "181 (99)", 
                "25835DAF88D0": 63, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 385, 
                "2FB5E711ED4D": "62 (32)", 
                "30367DD2D73C": "176 (96)", 
                "355467E6F99D": "103 (55)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": 22.9, 
                "4BCC29FD82C5": 193.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": 35.1, 
                "567F7C6DB3C0": "102 (53)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": 83.4, 
                "5C07F729B9AA": "78 (41)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 64.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": 39.8, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "193 (100)", 
                "6FCD847B7D4E": "95 (49)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
                "7AB539ED4DCA": "Chemotherapy", 
                "7B0EFF1CA297": "7(4)", 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "bPFS ; rPFS", 
                "870828CC9464": "46 (24)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "144 (75)", 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": 62.1, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "84 (45)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT00104715", 
                "AB1128C53AB2": 26610858, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": 62.1, 
                "B3DA3CABD8E6": "91 (47)", 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": 83.9, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "100 (52)", 
                "CB8A3369E369": "82 (43)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 192, 
                "D497B247EF62": "Chemotherapy", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 127.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": 48.6, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": 48.6, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "0 (0)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "2(1)", 
                "F665784BFCA0": 12.9, 
                "F91E38093E93": "Docetaxel", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": "192 (100)", 
                "FD62EFD5662E": "D+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "26719232": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": "2 (0)", 
                "0741F8ABDAF7": "592 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": "15 (1)", 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 175.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "STAMPEDE", 
                "1622BC83AB7E": "5 (0)", 
                "16CE6FB34321": "366 (62)", 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "Chemo-doublet", 
                "1A752545DC79": "810 (68)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": "220 (19)", 
                "22286C840BFC": null, 
                "25183756ACC6": null, 
                "25835DAF88D0": 65, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": "No", 
                "2F4A705D3F9D": 2962, 
                "2FB5E711ED4D": "227 (38)", 
                "30367DD2D73C": null, 
                "355467E6F99D": "436 (74)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "102 (17)", 
                "3E1E7201B7D5": "844 (71)", 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 1184.0, 
                "4C28828475CE": "No", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": 33.3, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": 33.1, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "282 (24)", 
                "5E38B4BCDEBD": "OS, FFS", 
                "60C7E1905D85": "13 (2)", 
                "638859C30428": null, 
                "66260E0A7574": 65.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": 49.7, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "1184 (100)", 
                "6FCD847B7D4E": "634 (54)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
                "7AB539ED4DCA": "Chemotherapy", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": null, 
                "870828CC9464": "230 (39)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "362 (61)", 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": "399 (32)", 
                "95066A6595E3": 81.0, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "110 (19)", 
                "9C83E46F40DD": "Original", 
                "9E2C8F8E78F1": "4(0.7)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT00268476", 
                "AB1128C53AB2": 26719232, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": 11, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": "424 (72)", 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": 43, 
                "B8FE4F52434E": "288 (52)", 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": "307 (52)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 592, 
                "D497B247EF62": "Chemotherapy", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": "33 (3)", 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 415.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": 14.7, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": 71.0, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": 24, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": "6 (1)", 
                "EB421A7B8403": "5(0.4)", 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "0 (0)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": null, 
                "F665784BFCA0": null, 
                "F91E38093E93": "Docetaxel", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": "593 (100)", 
                "FD62EFD5662E": "D+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "28578607": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": null, 
                "011F14149E53": null, 
                "0348CAC2849A": null, 
                "050FC810D9C0": "71 (12)", 
                "0741F8ABDAF7": null, 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": "30 (5)", 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 169.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "LATITUDE", 
                "1622BC83AB7E": "73 (12)", 
                "16CE6FB34321": "597 (100)", 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "586 (97)", 
                "1C1F3983C02E": null, 
                "1F2FA6ACB251": "287 (48)", 
                "22286C840BFC": null, 
                "25183756ACC6": null, 
                "25835DAF88D0": 68, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "49 at 3 y", 
                "2D4C089B0DFA": "No", 
                "2F4A705D3F9D": 1199, 
                "2FB5E711ED4D": "0 (0)", 
                "30367DD2D73C": null, 
                "355467E6F99D": "584 (98)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "283 (47)", 
                "3E1E7201B7D5": "26 (4)", 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": 33.0, 
                "4BCC29FD82C5": 602.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "1 (0.2)", 
                "5E38B4BCDEBD": "OS, rPFS", 
                "60C7E1905D85": "73 (12)", 
                "638859C30428": null, 
                "66260E0A7574": 67.0, 
                "6740730B2D70": null, 
                "684320C8F19F": null, 
                "6858E301D236": null, 
                "6EDA470D3DED": null, 
                "6FCD847B7D4E": "585 (98)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "Time to pain progression; Time to initiation of chemotherapy; Subsequent therapy for prostate cancer;  PSA progression; Symptomatic skeletal-related events", 
                "870828CC9464": "0 (0)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "602 (100)", 
                "8E23DACFB0A8": null, 
                "92BE5A7F545E": "287 (48)", 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "4 (0.7)", 
                "9C83E46F40DD": "Original", 
                "9E2C8F8E78F1": "24 (4)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT01715285", 
                "AB1128C53AB2": 28578607, 
                "AC649E8D1F86": null, 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": 24, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": "19 (3)", 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": 30.4, 
                "B8FE4F52434E": "374(63)", 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": "580 (97)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 597, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": 33.2, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": "72 (12)", 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 237.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": null, 
                "E0B67B296150": 34.7, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": 7.4, 
                "E27A08B27405": null, 
                "E30780128AA5": 14, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": "32 (5)", 
                "EB421A7B8403": "28 (5)", 
                "EBC598BE38BB": null, 
                "EBEC64CC1B96": "187 (40)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": null, 
                "F665784BFCA0": 14.8, 
                "F91E38093E93": "Abiraterone acetate", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": "66 at 3 y", 
                "FC992E7A5D74": "106 (34)", 
                "FD62EFD5662E": "AAP+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "28578639": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": "5 (1)", 
                "0741F8ABDAF7": "960 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": "8 (1)", 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 184.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "STAMPEDE", 
                "1622BC83AB7E": "3 (<1)", 
                "16CE6FB34321": "500 (52.1)", 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "721 (75)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": "150 (16)", 
                "22286C840BFC": null, 
                "25183756ACC6": "745 (78)", 
                "25835DAF88D0": 67, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "76 at 3 y", 
                "2D4C089B0DFA": "No", 
                "2F4A705D3F9D": 1917, 
                "2FB5E711ED4D": "460 (47.9)", 
                "30367DD2D73C": "744 (78)", 
                "355467E6F99D": "715 (74)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "142 (15)", 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 957.0, 
                "4C28828475CE": "No", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": 33.3, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": 33.1, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "223 (23)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": "21 (2)", 
                "638859C30428": null, 
                "66260E0A7574": 67.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": 49.7, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "957 (100)", 
                "6FCD847B7D4E": "434 (45)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": "213 (22)", 
                "7CC71BD77655": "90.3 at 3 y", 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "FFS", 
                "870828CC9464": "455 (47.5)", 
                "8A4762F6156F": "56.6 at 3 y", 
                "8C9D45766DFA": "502 (52.5)", 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": "315 (33)", 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "221 (23)", 
                "9C83E46F40DD": "Original", 
                "9E2C8F8E78F1": "3 (0.3)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT00268476", 
                "AB1128C53AB2": 28578639, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": 33.2, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": "70.0 at 3 y", 
                "B66DC32F5166": null, 
                "B79629FB310C": 40, 
                "B8FE4F52434E": "443 (47)", 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": "448 (47)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 960, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": "21 (2)", 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 262.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": 14.7, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": null, 
                "E17312D8DE93": "92.6 at 3 y", 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": "7 (1)", 
                "EB421A7B8403": "9 (0.9)", 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": null, 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "215 (22)", 
                "F665784BFCA0": null, 
                "F91E38093E93": "Abiraterone acetate", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": "83 at 3 y", 
                "FC992E7A5D74": null, 
                "FD62EFD5662E": "AAP+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "29326030": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": null, 
                "011F14149E53": null, 
                "0348CAC2849A": null, 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": null, 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": null, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "LATITUDE", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": null, 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": null, 
                "1C1F3983C02E": null, 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": null, 
                "25835DAF88D0": null, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": null, 
                "2F4A705D3F9D": 1199, 
                "2FB5E711ED4D": null, 
                "30367DD2D73C": null, 
                "355467E6F99D": null, 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 602.0, 
                "4C28828475CE": null, 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": null, 
                "5E38B4BCDEBD": "OS, rPFS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": null, 
                "6740730B2D70": null, 
                "684320C8F19F": null, 
                "6858E301D236": null, 
                "6EDA470D3DED": null, 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": null, 
                "870828CC9464": null, 
                "8A4762F6156F": null, 
                "8C9D45766DFA": null, 
                "8E23DACFB0A8": null, 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": null, 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": "Yes", 
                "AAA2600F90CA": "NCT01715285", 
                "AB1128C53AB2": 29326030, 
                "AC649E8D1F86": null, 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": "~30", 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": null, 
                "CE95DBF09499": null, 
                "CECABA14750C": 597, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": null, 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": null, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": null, 
                "E0B67B296150": null, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": null, 
                "EBEC64CC1B96": null, 
                "F0D411DE4F55": "FACT-P, EORTC QLQ-C 30, BPI-SF, BFI", 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": null, 
                "F665784BFCA0": null, 
                "F91E38093E93": "Abiraterone acetate", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": null, 
                "FD62EFD5662E": "AAP+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "29384722": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "397 (100)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "0 (0)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 188.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "CHAARTED", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "289 (72.8)", 
                "17B78092E8E1": "263 (66.2)", 
                "18921A8A3057": 42.5, 
                "1957FE4BDCED": "Chemo-doublet", 
                "1A752545DC79": "243 (61.8)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": null, 
                "22286C840BFC": 35.2, 
                "25183756ACC6": "277 (69.8)", 
                "25835DAF88D0": 64, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 790, 
                "2FB5E711ED4D": "108 (27.2)", 
                "30367DD2D73C": "272 (69.2)", 
                "355467E6F99D": "241 (60.7)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": 30.3, 
                "4BCC29FD82C5": 393.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": 34.4, 
                "567F7C6DB3C0": "143 (36.4)", 
                "5A1430A37320": 27.3, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "104 (26)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 63.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": 51.2, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "0 (0)", 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": 47.9, 
                "794014C65160": null, 
                "7A300805A69F": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
                "7AB539ED4DCA": "Chemotherapy", 
                "7B0EFF1CA297": "121 (30.8)", 
                "7CC71BD77655": null, 
                "80892D26074F": 63.5, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "Time to CRPC", 
                "870828CC9464": "106 (27.0)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "286 (72.8)", 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": 57.6, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "117 (30)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": 44.3, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT00309985", 
                "AB1128C53AB2": 29384722, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": "250 (63.6)", 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": 61.9, 
                "B79629FB310C": 53.7, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "134 (33.8)", 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 397, 
                "D497B247EF62": "Chemotherapy", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 211.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": 13.0, 
                "DF0ADDCB046E": "393 (100)", 
                "E0B67B296150": 47.2, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": 65.7, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "0 (0)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "120 (30.2)", 
                "F665784BFCA0": 19.8, 
                "F91E38093E93": "Docetaxel", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": "397 (100)", 
                "FD62EFD5662E": "D+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "29522362": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "397 (100)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "0 (0)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": null, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "CHAARTED", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": null, 
                "17B78092E8E1": "263 (66.2)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "Chemo-doublet", 
                "1A752545DC79": null, 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": "277 (69.8)", 
                "25835DAF88D0": 64, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": null, 
                "2F4A705D3F9D": 790, 
                "2FB5E711ED4D": null, 
                "30367DD2D73C": "272 (69.2)", 
                "355467E6F99D": null, 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": "33 (8.4)", 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 393.0, 
                "4C28828475CE": null, 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": "143 (36.5)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": null, 
                "5E38B4BCDEBD": "FACT-P", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 63.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": null, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "0 (0)", 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
                "7AB539ED4DCA": "Chemotherapy", 
                "7B0EFF1CA297": "120 (30.6)", 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": "73 (18.6)", 
                "8685EAA9D758": null, 
                "86DFC7127724": null, 
                "870828CC9464": null, 
                "8A4762F6156F": null, 
                "8C9D45766DFA": null, 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": null, 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": "Yes", 
                "AAA2600F90CA": "NCT00309985", 
                "AB1128C53AB2": 29522362, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": "249 (63.5)", 
                "B457B682A558": "27 (6.8)", 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": null, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "134 (33.8)", 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": null, 
                "CE95DBF09499": "81 (20.4)", 
                "CECABA14750C": 397, 
                "D497B247EF62": "Chemotherapy", 
                "D5E5F6396AFF": null, 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": null, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "393 (100)", 
                "E0B67B296150": null, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "0 (0)", 
                "F0D411DE4F55": "FACT-P, FACT-Taxane, FACIT-Fatigue", 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "120 (30.2)", 
                "F665784BFCA0": null, 
                "F91E38093E93": "Docetaxel", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": "397 (100)", 
                "FD62EFD5662E": "D+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "29529169": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "377 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 105.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "STAMPEDE", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "227 (60)", 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "153 (81)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": "300 (80)", 
                "25835DAF88D0": 65, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "76.7 at 4 y", 
                "2D4C089B0DFA": "No", 
                "2F4A705D3F9D": 566, 
                "2FB5E711ED4D": "150 (40)", 
                "30367DD2D73C": "149 (79)", 
                "355467E6F99D": "276 (75)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 189.0, 
                "4C28828475CE": "No", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "35 (19)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 65.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": null, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "189 (100)", 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": "40 (21)", 
                "7CC71BD77655": "91.9 at 4 y", 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "FFS", 
                "870828CC9464": "74 (39)", 
                "8A4762F6156F": "67.0 at 4 y", 
                "8C9D45766DFA": "115 (61)", 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": "86 (50)", 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "91 (25)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT00268476", 
                "AB1128C53AB2": 29529169, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": 78.2, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": "60.8 at 4 y", 
                "B66DC32F5166": null, 
                "B79629FB310C": 48, 
                "B8FE4F52434E": "180 (48)", 
                "BB93BE8888AA": "61.9 at 4 y", 
                "C7D275071E5D": null, 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 377, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 44.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": null, 
                "E17312D8DE93": "89.3 at 4 y", 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": 78.2, 
                "E7260BA72D00": null, 
                "E82A9CE41292": "72.6 at 4 y", 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "189 (100)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "77 (20)", 
                "F665784BFCA0": null, 
                "F91E38093E93": "Docetaxel", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "D+ADT", 
                "FBB1E4A88EE8": "72 at 4 y", 
                "FC992E7A5D74": "0 (0)", 
                "FD62EFD5662E": "AAP+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "30987939": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": null, 
                "011F14149E53": null, 
                "0348CAC2849A": null, 
                "050FC810D9C0": "71 (12)", 
                "0741F8ABDAF7": null, 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": "30 (5)", 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 275.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "LATITUDE", 
                "1622BC83AB7E": "73 (12)", 
                "16CE6FB34321": "597 (100)", 
                "17B78092E8E1": "487 (81.6)", 
                "18921A8A3057": 49.8, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "586 (97)", 
                "1C1F3983C02E": null, 
                "1F2FA6ACB251": "287 (48)", 
                "22286C840BFC": "38.2  at 4.3 y", 
                "25183756ACC6": null, 
                "25835DAF88D0": 67.3, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 1199, 
                "2FB5E711ED4D": "0 (0)", 
                "30367DD2D73C": null, 
                "355467E6F99D": "584 (98)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "283 (47)", 
                "3E1E7201B7D5": "26 (4)", 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": 53.3, 
                "4BCC29FD82C5": 602.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": 33.3, 
                "567F7C6DB3C0": "133 (22.1)", 
                "5A1430A37320": 33.1, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "16 (3)", 
                "5E38B4BCDEBD": "OS, rPFS", 
                "60C7E1905D85": "73 (12)", 
                "638859C30428": null, 
                "66260E0A7574": 66.8, 
                "6740730B2D70": null, 
                "684320C8F19F": 49.7, 
                "6858E301D236": null, 
                "6EDA470D3DED": null, 
                "6FCD847B7D4E": "585 (98)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": "50.5 at 4.3 y", 
                "794014C65160": null, 
                "7A300805A69F": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "Time to pain progression; Time to initiation of chemotherapy; Subsequent therapy for prostate cancer;  PSA progression; Symptomatic skeletal-related events", 
                "870828CC9464": "0 (0)", 
                "8A4762F6156F": "43.0 at 4.3 y", 
                "8C9D45766DFA": "602 (100)", 
                "8E23DACFB0A8": null, 
                "92BE5A7F545E": "309 (51)", 
                "95066A6595E3": 53.3, 
                "9698F4F8CA22": "11(2)", 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "13 (3)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": "3 (<1)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": 22.4, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT01715285", 
                "AB1128C53AB2": 30987939, 
                "AC649E8D1F86": null, 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": 25.8, 
                "B3DA3CABD8E6": "468 (77.7)", 
                "B457B682A558": "19 (3)", 
                "B525BFD9A067": "53.9 at 4.3 y", 
                "B66DC32F5166": "69.1 at 4.3 y", 
                "B79629FB310C": 51.8, 
                "B8FE4F52434E": "411 (69)", 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "110 (18.4)", 
                "CB8A3369E369": "580 (97)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 597, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": "72 (12)", 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 343.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": 14.7, 
                "DF0ADDCB046E": null, 
                "E0B67B296150": 36.5, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": 14.4, 
                "E7260BA72D00": "59.4 at 4.3 y", 
                "E82A9CE41292": null, 
                "E8EE12049B2E": "32 (5)", 
                "EB421A7B8403": "3 (0.5)", 
                "EBC598BE38BB": null, 
                "EBEC64CC1B96": "212 (35)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": "24(4)", 
                "F596E2C6ED57": null, 
                "F665784BFCA0": 30.1, 
                "F91E38093E93": "Abiraterone acetate", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": "144 (24)", 
                "FD62EFD5662E": "AAP+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "31150574": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": null, 
                "011F14149E53": "~87 (16.6)", 
                "0348CAC2849A": null, 
                "050FC810D9C0": "40 (7.6)", 
                "0741F8ABDAF7": "~87 (16.6)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 83.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "TITAN", 
                "1622BC83AB7E": "33 (6.3)", 
                "16CE6FB34321": "411 (78.3)", 
                "17B78092E8E1": "325 (61.9)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "358 (67.9)", 
                "1C1F3983C02E": null, 
                "1F2FA6ACB251": null, 
                "22286C840BFC": "71.0 at 1.9 y", 
                "25183756ACC6": "328 (62.5)", 
                "25835DAF88D0": 69, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "73.5 at 2 y", 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 1052, 
                "2FB5E711ED4D": "85 (16.2)", 
                "30367DD2D73C": "348 (66)", 
                "355467E6F99D": "351 (66.9)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": "52 (9.9)", 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 527.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": "192 (36.4)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "169 (32)", 
                "5E38B4BCDEBD": "OS, rPFS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 68.0, 
                "6740730B2D70": null, 
                "684320C8F19F": null, 
                "6858E301D236": null, 
                "6EDA470D3DED": "~87 (16.5)", 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": "78.8 at 1.9 y", 
                "794014C65160": null, 
                "7A300805A69F": "Apalutamide 240 OD; standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": "179 (34.0)", 
                "7CC71BD77655": "81.4 at 1.9 y", 
                "80892D26074F": null, 
                "8161C3F1D5BD": "40 (7.6)", 
                "8685EAA9D758": null, 
                "86DFC7127724": "Time to cytotoxic chemotherapy; Time to pain progression", 
                "870828CC9464": "59 (11.2)", 
                "8A4762F6156F": "77.1 at 1.9 y", 
                "8C9D45766DFA": "441 (83.7)", 
                "8E23DACFB0A8": null, 
                "92BE5A7F545E": "215 (40.8)", 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "174 (33.1)", 
                "9C83E46F40DD": "Original", 
                "9E2C8F8E78F1": "16 (3.0)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": 30.5, 
                "A599F8FF4C17": "Yes", 
                "AAA2600F90CA": "NCT02489318", 
                "AB1128C53AB2": 31150574, 
                "AC649E8D1F86": null, 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": 20.5, 
                "B3DA3CABD8E6": "335 (63.6)", 
                "B457B682A558": "68 (13)", 
                "B525BFD9A067": "82.7 at 1.9 y", 
                "B66DC32F5166": "93.0 at 1.9 y", 
                "B79629FB310C": 22.7, 
                "B8FE4F52434E": "221 (42.2)", 
                "BB93BE8888AA": "47.5 at 2 y", 
                "C7D275071E5D": "200 (38.1)", 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": "47 (9)", 
                "CECABA14750C": 525, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 117.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": 14.9, 
                "DF0ADDCB046E": "~87 (16.5)", 
                "E0B67B296150": 52.2, 
                "E17312D8DE93": "91.8 at 1.9 y", 
                "E2018F9EC89C": 12.9, 
                "E27A08B27405": null, 
                "E30780128AA5": 18.3, 
                "E7260BA72D00": "89.6 at 1.9 y", 
                "E82A9CE41292": "68.2 at 2 y", 
                "E8EE12049B2E": null, 
                "EB421A7B8403": "10 (1.9)", 
                "EBC598BE38BB": null, 
                "EBEC64CC1B96": "55 (10.4)", 
                "F0D411DE4F55": "FACT-P", 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "197 (37.5)", 
                "F665784BFCA0": 22.1, 
                "F91E38093E93": "Apalutamide", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": "82.4 at 2 y", 
                "FC992E7A5D74": "58 (11)", 
                "FD62EFD5662E": "APA+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "31157964": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "117 (20.8)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": "8 (1)", 
                "0741F8ABDAF7": "102 (18.1)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": "11 (2)", 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 102.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "ENZAMET", 
                "1622BC83AB7E": "5 (1)", 
                "16CE6FB34321": "325 (57.7)", 
                "17B78092E8E1": "291 (52)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "320 (57)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": "259 (46.1)", 
                "22286C840BFC": "67.3 at 2.8 y", 
                "25183756ACC6": "405 (71.9)", 
                "25835DAF88D0": 68.9, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "72 at 3 y", 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 1125, 
                "2FB5E711ED4D": "238 (42.3)", 
                "30367DD2D73C": "405 (72.1)", 
                "355467E6F99D": "335 (59.5)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "268 (47.6)", 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 562.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": "265 (47)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "164 (29.2)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": "55 (9.8)", 
                "638859C30428": null, 
                "66260E0A7574": 68.8, 
                "6740730B2D70": "344 (61.1)", 
                "684320C8F19F": null, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "93 (16.5)", 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": "72.5 at 2.8 y", 
                "794014C65160": null, 
                "7A300805A69F": "Enzalutamide 160mg OD; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": "157 (28)", 
                "7CC71BD77655": "79.1 at 2.8 y", 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "Time to PSA progression; rPFS", 
                "870828CC9464": "235 (41.8)", 
                "8A4762F6156F": "71.3 at 2.8 y", 
                "8C9D45766DFA": "327 (58.2)", 
                "8E23DACFB0A8": "340 (60.5)", 
                "92BE5A7F545E": "241 (43)", 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "152 (27)", 
                "9C83E46F40DD": "Original", 
                "9E2C8F8E78F1": "7 (1)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT02446405", 
                "AB1128C53AB2": 31157964, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": "297 (53)", 
                "B457B682A558": null, 
                "B525BFD9A067": "80.6 at 2.8 y", 
                "B66DC32F5166": "91.9 at 2.8 y", 
                "B79629FB310C": 34, 
                "B8FE4F52434E": "321 (57)", 
                "BB93BE8888AA": "41 at 3 y", 
                "C7D275071E5D": "272 (48)", 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 563, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": "48 (8.5)", 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 143.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "129 (22.9)", 
                "E0B67B296150": null, 
                "E17312D8DE93": "83.6 at 2.8 y", 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": "82.6 at 2.8 y", 
                "E82A9CE41292": "68 at 3 y", 
                "E8EE12049B2E": "13 (2.3)", 
                "EB421A7B8403": "6 (1)", 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "249 (44)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "158 (28)", 
                "F665784BFCA0": null, 
                "F91E38093E93": "Enzalutamide", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "NSAA+ADT", 
                "FBB1E4A88EE8": "80 at 3 y", 
                "FC992E7A5D74": "254 (45)", 
                "FD62EFD5662E": "E+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "31329516": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "11 (1.9)", 
                "011F14149E53": "86 (15.0)", 
                "0348CAC2849A": "32 (5.6)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "341 (59.4)", 
                "085A7C4CBF5E": "0 (0)", 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": "147 (83.1)", 
                "0E9353A1D622": 39.0, 
                "116B243F7C0C": "4 (0.5)", 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "ARCHES", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "402 (70)", 
                "17B78092E8E1": "354 (61.7)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "373 (64.8)", 
                "1C1F3983C02E": "12 (2.1)", 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": "448 (78)", 
                "25835DAF88D0": 70, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": "0 (0)", 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 1150, 
                "2FB5E711ED4D": "83 (14.5)", 
                "30367DD2D73C": "443 (76.9)", 
                "355467E6F99D": "386 (67.2)", 
                "35991F54AD8A": "42 (23.1)", 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": "72 (12.5)", 
                "4801CB01C83D": "116 (63.6)", 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 576.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": "7 (4.0)", 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": "203 (35.2)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "187 (32.5)", 
                "5E38B4BCDEBD": "rPFS", 
                "60C7E1905D85": null, 
                "638859C30428": "26 (4.3)", 
                "66260E0A7574": 70.0, 
                "6740730B2D70": "~52 (9.1)", 
                "684320C8F19F": null, 
                "6858E301D236": "~52 (9.1)", 
                "6EDA470D3DED": "344 (59.7)", 
                "6FCD847B7D4E": "486 (84.4)", 
                "7149F82D389F": "80 (13.9)", 
                "7651C7D79AA4": null, 
                "794014C65160": "9 (4.9)", 
                "7A300805A69F": "Enzalutamide 160mg OD; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": "133 (23.1)", 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": "89 (15.5)", 
                "8685EAA9D758": "0 (0)", 
                "86DFC7127724": "Time to PSA progression; PSA response; Radiographic response; OS", 
                "870828CC9464": "86 (14.9)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "365 (63.4)", 
                "8E23DACFB0A8": "~57 (9.9)", 
                "92BE5A7F545E": "147 (25.6)", 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": "75 (13.1)", 
                "9BCB3087C50B": "171 (29.8)", 
                "9C83E46F40DD": "Original", 
                "9E2C8F8E78F1": "10 (1.7)", 
                "9F13EA930D6F": "17 (9.6)", 
                "A008BC5C9F85": "461 (79.9)", 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT02677896", 
                "AB1128C53AB2": 31329516, 
                "AC649E8D1F86": "30 (5.2)", 
                "AF79B7633616": "24 (4.0)", 
                "AFAD2155AD67": "467 (81.2)", 
                "B23B0A65994F": 12.8, 
                "B3DA3CABD8E6": "373 (64.8)", 
                "B457B682A558": "73 (12.7)", 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": 14.4, 
                "B8FE4F52434E": "139 (24.3)", 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "220 (38.3)", 
                "CB8A3369E369": "485 (84.5)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": "72 (12.5)", 
                "CECABA14750C": 574, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": "3 (0.3)", 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": "43 (23.6)", 
                "DAB86546C4F7": 45.0, 
                "DAB906673934": "8 (1.4)", 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "77 (13.4)", 
                "E0B67B296150": null, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": "65 (36.7)", 
                "E30780128AA5": 11.6, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": "14 (2.4)", 
                "EBC598BE38BB": "~57 (9.9)", 
                "EBEC64CC1B96": "102 (17.7)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "125 (21.8)", 
                "F665784BFCA0": 19.0, 
                "F91E38093E93": "Enzalutamide", 
                "F9640855F41B": "8 (1.4)", 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": "103 (17.9)", 
                "FD62EFD5662E": "E+ADT", 
                "FDCFCF44082C": "0 (0)"
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "31447077": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "414 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 135.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "STAMPEDE", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": null, 
                "17B78092E8E1": "256 (56.6)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "342 (75)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": "47 (10.5)", 
                "22286C840BFC": "44.5 at 3.5 y", 
                "25183756ACC6": "335 (74)", 
                "25835DAF88D0": 66, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 901, 
                "2FB5E711ED4D": null, 
                "30367DD2D73C": "337 (74)", 
                "355467E6F99D": "345 (76)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "55 (12)", 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 452.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": "206 (45.9)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "110 (24)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 67.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": null, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "452 (100)", 
                "6FCD847B7D4E": "294 (65)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": "60.5 at 3.5 y", 
                "794014C65160": null, 
                "7A300805A69F": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": "115 (25)", 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "FFS", 
                "870828CC9464": null, 
                "8A4762F6156F": "55.5 at 3.5 y", 
                "8C9D45766DFA": null, 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "104 (23)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT00268476", 
                "AB1128C53AB2": 31447077, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": "243 (54.1)", 
                "B457B682A558": null, 
                "B525BFD9A067": "69.6 at 3.5 y", 
                "B66DC32F5166": "81.1 at 3.5 y", 
                "B79629FB310C": 42, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "196 (43.3)", 
                "CB8A3369E369": "296 (66.8)", 
                "CB90E5B8EF95": "No", 
                "CE95DBF09499": null, 
                "CECABA14750C": 414, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 195.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": null, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": "73.0 at 3.5 y", 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "0 (0)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "114 (25)", 
                "F665784BFCA0": null, 
                "F91E38093E93": "Abiraterone acetate", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": "593 (100)", 
                "FD62EFD5662E": "AAP+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "31560068": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "362 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": "15 (2)", 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 225.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "STAMPEDE", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "345 (95)", 
                "17B78092E8E1": "148 (41)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "Chemo-doublet", 
                "1A752545DC79": "480 (66)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": "221 (31)", 
                "22286C840BFC": "24.1  at 5 y", 
                "25183756ACC6": "270 (75)", 
                "25835DAF88D0": 65, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "37 at 5 y", 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 1086, 
                "2FB5E711ED4D": "17 (5)", 
                "30367DD2D73C": "521 (72)", 
                "355467E6F99D": "253 (70)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "102 (28)", 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 724.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": "238 (34)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": 76.7, 
                "5C07F729B9AA": "158 (22)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": "13 (4)", 
                "638859C30428": null, 
                "66260E0A7574": 65.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": null, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "724 (100)", 
                "6FCD847B7D4E": "634 (88)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": "33.8 at 5 y", 
                "794014C65160": null, 
                "7A300805A69F": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
                "7AB539ED4DCA": "Chemotherapy", 
                "7B0EFF1CA297": "203 (28)", 
                "7CC71BD77655": null, 
                "80892D26074F": 93.2, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "FFS, PFS, mPFS, PCSS", 
                "870828CC9464": "54 (5)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "688 (95)", 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": 59.1, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "65 (18)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT00268476", 
                "AB1128C53AB2": 31560068, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": "320 (44)", 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": "71.8  at 5 y", 
                "B79629FB310C": 78.2, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": "25 at 5 y", 
                "C7D275071E5D": "124 (34)", 
                "CB8A3369E369": "307 (85)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 362, 
                "D497B247EF62": "Chemotherapy", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": "33 (5)", 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 494.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": 43.1, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": "57.1 at 5 y", 
                "E82A9CE41292": "37 at 5 y", 
                "E8EE12049B2E": "6 (2)", 
                "EB421A7B8403": null, 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "0(0)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "92 (25)", 
                "F665784BFCA0": null, 
                "F91E38093E93": "Docetaxel", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": "49 at 5 y", 
                "FC992E7A5D74": "362 (100)", 
                "FD62EFD5662E": "D+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "31578173": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": null, 
                "011F14149E53": null, 
                "0348CAC2849A": null, 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": null, 
                "085A7C4CBF5E": "13 (2.5)", 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": null, 
                "116B243F7C0C": "22 (4.2)", 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "TITAN", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": null, 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "358 (67.9)", 
                "1C1F3983C02E": null, 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": "328 (62.5)", 
                "25835DAF88D0": null, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": null, 
                "2F4A705D3F9D": 1052, 
                "2FB5E711ED4D": null, 
                "30367DD2D73C": "348 (66)", 
                "355467E6F99D": "351 (66.9)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": null, 
                "4C28828475CE": null, 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "500 (94.9)", 
                "5E38B4BCDEBD": null, 
                "60C7E1905D85": null, 
                "638859C30428": "8 (1.5)", 
                "66260E0A7574": null, 
                "6740730B2D70": null, 
                "684320C8F19F": null, 
                "6858E301D236": null, 
                "6EDA470D3DED": null, 
                "6FCD847B7D4E": null, 
                "7149F82D389F": "110 (20.9)", 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Apalutamide 240 OD; standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": "179 (34.0)", 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": "6 (1.1)", 
                "86DFC7127724": null, 
                "870828CC9464": null, 
                "8A4762F6156F": null, 
                "8C9D45766DFA": null, 
                "8E23DACFB0A8": null, 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": "119 (22.7)", 
                "9BCB3087C50B": "174 (33.1)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": "365 (69.3)", 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": "Yes", 
                "AAA2600F90CA": "NCT02489318", 
                "AB1128C53AB2": 31578173, 
                "AC649E8D1F86": null, 
                "AF79B7633616": "11 (2.1)", 
                "AFAD2155AD67": "354 (67.4)", 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": "~20", 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": null, 
                "CE95DBF09499": null, 
                "CECABA14750C": 525, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": null, 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": "24 (4.6)", 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": null, 
                "DAB906673934": "10 (1.9)", 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": null, 
                "E0B67B296150": null, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": null, 
                "EBEC64CC1B96": null, 
                "F0D411DE4F55": "FACT-P, EQ-5D-5L, BPI-SF, BFI", 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "197 (37.5)", 
                "F665784BFCA0": null, 
                "F91E38093E93": "Apalutamide", 
                "F9640855F41B": "9 (1.7)", 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": null, 
                "FD62EFD5662E": "APA+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "32336645": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": null, 
                "011F14149E53": null, 
                "0348CAC2849A": null, 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": null, 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": null, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "ARCHES", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": null, 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": null, 
                "1C1F3983C02E": null, 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": null, 
                "25835DAF88D0": null, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": null, 
                "2F4A705D3F9D": 1150, 
                "2FB5E711ED4D": null, 
                "30367DD2D73C": null, 
                "355467E6F99D": null, 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 576.0, 
                "4C28828475CE": null, 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": null, 
                "5E38B4BCDEBD": null, 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": null, 
                "6740730B2D70": null, 
                "684320C8F19F": null, 
                "6858E301D236": null, 
                "6EDA470D3DED": null, 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Enzalutamide 160mg OD; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": null, 
                "870828CC9464": null, 
                "8A4762F6156F": null, 
                "8C9D45766DFA": null, 
                "8E23DACFB0A8": null, 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": null, 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": "Yes", 
                "AAA2600F90CA": "NCT02677896", 
                "AB1128C53AB2": 32336645, 
                "AC649E8D1F86": null, 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": null, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": null, 
                "CE95DBF09499": null, 
                "CECABA14750C": 574, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": null, 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": null, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": null, 
                "E0B67B296150": null, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": null, 
                "EBEC64CC1B96": null, 
                "F0D411DE4F55": "FACT-P, EQ-5D-5 L, BPI-SF, QLQ-PR25", 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": null, 
                "F665784BFCA0": null, 
                "F91E38093E93": "Enzalutamide", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": null, 
                "FD62EFD5662E": "E+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "34757812": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "Rx1: 173 (100); Rx2: 342 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": "2 (1)", 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": null, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "STAMPEDE", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": null, 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "Chemo-doublet", 
                "1A752545DC79": "253 (74)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": "Rx1: 137 (79); Rx2: 277(81)", 
                "25835DAF88D0": "Rx: 66; Rx2:66", 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": null, 
                "2F4A705D3F9D": 858, 
                "2FB5E711ED4D": null, 
                "30367DD2D73C": "273 (80)", 
                "355467E6F99D": "Rx1: 140 (81); Rx2: 252 (74)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 343.0, 
                "4C28828475CE": null, 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "82 (24)", 
                "5E38B4BCDEBD": "Difference in global-QLQ-C30 Q29 scores", 
                "60C7E1905D85": "Rx1: 4 (2);Rx2: 11 (3)", 
                "638859C30428": null, 
                "66260E0A7574": 66.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": null, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "343 (100)", 
                "6FCD847B7D4E": "190 (55)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Rx1: Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation; Rx2:Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
                "7AB539ED4DCA": "Chemotherapy", 
                "7B0EFF1CA297": "70 (20)", 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": null, 
                "870828CC9464": null, 
                "8A4762F6156F": null, 
                "8C9D45766DFA": null, 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "Rx1: 32 (18); Rx2: 83 (24)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": "Yes", 
                "AAA2600F90CA": "NCT00268476", 
                "AB1128C53AB2": 34757812, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": "Rx: NA; Rx2:23.2", 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": null, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": "Rx1: 87 (50);Rx2: 177 (52)", 
                "CB90E5B8EF95": null, 
                "CE95DBF09499": null, 
                "CECABA14750C": "Rx1: 173; Rx2: 342", 
                "D497B247EF62": "Chemotherapy", 
                "D5E5F6396AFF": null, 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": "11 (3)", 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": null, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": null, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": "Rx1: 0 (0);Rx2: 4 (1)", 
                "EB421A7B8403": null, 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "0 (0)", 
                "F0D411DE4F55": "EORTC QLQ-C 30, PR25", 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "Rx1: 36 (21); Rx2: 65(19)", 
                "F665784BFCA0": null, 
                "F91E38093E93": "Docetaxel", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": "Rx1: 173 (100); Rx2: 0(0)", 
                "FD62EFD5662E": "Rx1: D+ADT; Rx2:AAP+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "35179323": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "125 (19.2)", 
                "0348CAC2849A": "~99 (7.59)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "~99 (7.59)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 229.0, 
                "116B243F7C0C": "2 (0.3)", 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "ARASENS", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "558 (85.7)", 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "Triplet", 
                "1A752545DC79": "516 (78.9)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": "466 (71.6)", 
                "25835DAF88D0": 67, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "50.4 at 4 y", 
                "2D4C089B0DFA": "No", 
                "2F4A705D3F9D": 1306, 
                "2FB5E711ED4D": "86 (13.2)", 
                "30367DD2D73C": "462 (70.6)", 
                "355467E6F99D": "505 (77.6)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 654.0, 
                "4C28828475CE": "No", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "138 (21.1)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": null, 
                "638859C30428": "46 (7.0)", 
                "66260E0A7574": 67.0, 
                "6740730B2D70": "~214 (16.4)", 
                "684320C8F19F": null, 
                "6858E301D236": "~115 (17.7)", 
                "6EDA470D3DED": "~97 (6.97)", 
                "6FCD847B7D4E": null, 
                "7149F82D389F": "245 (37.3)", 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Darolutamide 600mg BID; Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI; Chemotherapy", 
                "7B0EFF1CA297": "190 (29.1)", 
                "7CC71BD77655": "63.4 at 4 y", 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "Time to CRPC; Time to pain progression; SSE-free survival; Time to first SSE; Time to subsequent systemic anti-neoplastic therapy; Time to worsening of disease related physical symptoms; Time to initiation of opioid use\nfor \u22657 consecutive days; Time to initiation of opioid use; Safety", 
                "870828CC9464": "82 (12.5)", 
                "8A4762F6156F": "52.1 at 4 y", 
                "8C9D45766DFA": "566 (86.5)", 
                "8E23DACFB0A8": "~219 (16.4)", 
                "92BE5A7F545E": "439 (67.5)", 
                "95066A6595E3": 43.7, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": "230 (35.3)", 
                "9BCB3087C50B": "110 (22.4)", 
                "9C83E46F40DD": "Original", 
                "9E2C8F8E78F1": "27 (4.0)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": "333 (50.9)", 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT02799602", 
                "AB1128C53AB2": 35179323, 
                "AC649E8D1F86": "~97 (6.97)", 
                "AF79B7633616": "43 (6.6)", 
                "AFAD2155AD67": "345 (53.0)", 
                "B23B0A65994F": 41, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": "63.1 at 4 y", 
                "B66DC32F5166": null, 
                "B79629FB310C": "43.7; 42.4", 
                "B8FE4F52434E": "458 (70.2)", 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 651, 
                "D497B247EF62": "ARPI; Chemotherapy", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": "7 (1.1)", 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 304.0, 
                "DAB906673934": "26 (4.0)", 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "119 (18.2)", 
                "E0B67B296150": 42.4, 
                "E17312D8DE93": "74.4 at 4 y", 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": 16.7, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": "28 (4.1)", 
                "EBC598BE38BB": "~122 (18.7)", 
                "EBEC64CC1B96": "654 (100)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "185 (28.4)", 
                "F665784BFCA0": 49.9, 
                "F91E38093E93": "Darolutamide + Docetaxel", 
                "F9640855F41B": "28 (4.3)", 
                "FAD89E87B16E": "D+ADT", 
                "FBB1E4A88EE8": "62.7 at 4 y", 
                "FC992E7A5D74": "651 (100)", 
                "FD62EFD5662E": "DARO+D+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "35405085": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "583 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 228.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "PEACE-1", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "583 (100)", 
                "17B78092E8E1": "331 (57)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "Triplet", 
                "1A752545DC79": "441 (77)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": "52 (9)", 
                "22286C840BFC": "48.3 at 4.4 y", 
                "25183756ACC6": "412 (71)", 
                "25835DAF88D0": 67, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "57.5 at 3.5 y", 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 1172, 
                "2FB5E711ED4D": "0 (0)", 
                "30367DD2D73C": "412 (70)", 
                "355467E6F99D": "429 (75)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "47 (8)", 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": 54.0, 
                "4BCC29FD82C5": 589.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": 42.0, 
                "567F7C6DB3C0": "253 (43)", 
                "5A1430A37320": 49.2, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "132 (23)", 
                "5E38B4BCDEBD": "OS, rPFS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 66.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": 61.2, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "589 (100)", 
                "6FCD847B7D4E": "475 (81)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": "58.9 at 4.4 y", 
                "794014C65160": null, 
                "7A300805A69F": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI; Chemotherapy", 
                "7B0EFF1CA297": "177 (30)", 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "Castration resistant free survival; Serious genitourinary event free survival; Prostate CSS; Time to next skeletal related event; PSA response; PSA at 8 months after initiation of SOC, Time to pain progression, Time to chemotherapy for CRPC; QoL; Safety; Change in BMD; Biomarkers; Outcomes for patients with NE differentiation.", 
                "870828CC9464": "0 (0)", 
                "8A4762F6156F": "57.5 at 4.4 y", 
                "8C9D45766DFA": "589 (100)", 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": "181 (52)", 
                "95066A6595E3": 68.4, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "145 (25)", 
                "9C83E46F40DD": "Original", 
                "9E2C8F8E78F1": "3 (1)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": 32.4, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT01957436", 
                "AB1128C53AB2": 35405085, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": "336 (57)", 
                "B457B682A558": null, 
                "B525BFD9A067": "65.9 at 4.4 y", 
                "B66DC32F5166": "77.7 at 4.4 y", 
                "B79629FB310C": 42, 
                "B8FE4F52434E": "217 (63)", 
                "BB93BE8888AA": "40.2 at 3.5 y", 
                "C7D275071E5D": "252 (43)", 
                "CB8A3369E369": "472 (81)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 583, 
                "D497B247EF62": "ARPI; Chemotherapy", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 268.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": 19.2, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": 56.4, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": "74.8 at 4.4 y", 
                "E82A9CE41292": "61.0 at 3.5 y", 
                "E8EE12049B2E": null, 
                "EB421A7B8403": "7(2)", 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "355 (60)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "171 (29)", 
                "F665784BFCA0": 26.4, 
                "F91E38093E93": "Abiraterone acetate + Docetaxel", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "D+ADT", 
                "FBB1E4A88EE8": "65.9 at 3.5 y", 
                "FC992E7A5D74": "355 (61)", 
                "FD62EFD5662E": "AAP+D+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "35411939": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "501 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": "8 (2)", 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 244.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "STAMPEDE", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "466 (93)", 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": null, 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": null, 
                "25835DAF88D0": 67, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 1003, 
                "2FB5E711ED4D": "35 (7)", 
                "30367DD2D73C": null, 
                "355467E6F99D": null, 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 502.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": null, 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": "21 (4)", 
                "638859C30428": null, 
                "66260E0A7574": 67.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": null, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "502 (100)", 
                "6FCD847B7D4E": "448 (89)", 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": null, 
                "870828CC9464": "27 (5)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "475 (95)", 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": 79.0, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": null, 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT00268476", 
                "AB1128C53AB2": 35411939, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": 29, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": 73.3, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": "434 (87)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 501, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": "21 (4)", 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 329.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": 46.0, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": "7 (1)", 
                "EB421A7B8403": null, 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": null, 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": null, 
                "F665784BFCA0": null, 
                "F91E38093E93": "Abiraterone acetate", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": null, 
                "FD62EFD5662E": "AAP+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "35420921": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "11 (1.9)", 
                "011F14149E53": "86 (15.0)", 
                "0348CAC2849A": "32 (5.6)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "341 (59.4)", 
                "085A7C4CBF5E": "0 (0)", 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 154.0, 
                "116B243F7C0C": "3 (0.5)", 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "ARCHES", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "402 (70)", 
                "17B78092E8E1": "354 (61.7)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "373 (64.8)", 
                "1C1F3983C02E": "12 (2.1)", 
                "1F2FA6ACB251": "80 (13.9)", 
                "22286C840BFC": "58.2 at 3.7 y", 
                "25183756ACC6": "448 (78)", 
                "25835DAF88D0": 70, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": "0 (0)", 
                "2AD2CF2D71DF": "64.9 at 4 y", 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 1150, 
                "2FB5E711ED4D": "83 (14.5)", 
                "30367DD2D73C": "443 (76.9)", 
                "355467E6F99D": "386 (67.2)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "74 (12.9)", 
                "3E1E7201B7D5": "72 (12.5)", 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": 49.8, 
                "4BCC29FD82C5": 576.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": 45.9, 
                "567F7C6DB3C0": "203 (35.2)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "187 (32.5)", 
                "5E38B4BCDEBD": null, 
                "60C7E1905D85": null, 
                "638859C30428": "25 (4.3)", 
                "66260E0A7574": 70.0, 
                "6740730B2D70": "~52 (9.1)", 
                "684320C8F19F": null, 
                "6858E301D236": "~52 (9.1)", 
                "6EDA470D3DED": "344 (59.7)", 
                "6FCD847B7D4E": "245 (42.5)", 
                "7149F82D389F": "80 (13.9)", 
                "7651C7D79AA4": "66.4 at 3.7 y", 
                "794014C65160": null, 
                "7A300805A69F": "Enzalutamide 160mg OD; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": "133 (23.1)", 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": "89 (15.5)", 
                "8685EAA9D758": "0 (0)", 
                "86DFC7127724": "OS", 
                "870828CC9464": "86 (14.9)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "365 (63.4)", 
                "8E23DACFB0A8": "~57 (9.9)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": "160 (27.9)", 
                "9B6D54D3076F": "75 (13.1)", 
                "9BCB3087C50B": "171 (29.8)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": "12 (2.1)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": "460 (79.9)", 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT02677896", 
                "AB1128C53AB2": 35420921, 
                "AC649E8D1F86": "30 (5.2)", 
                "AF79B7633616": "23 (4.0)", 
                "AFAD2155AD67": "466 (81.2)", 
                "B23B0A65994F": 40.2, 
                "B3DA3CABD8E6": "373 (64.8)", 
                "B457B682A558": "73 (12.7)", 
                "B525BFD9A067": null, 
                "B66DC32F5166": "84.1 at 3.7 y", 
                "B79629FB310C": 44.6, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "220 (38.3)", 
                "CB8A3369E369": "268 (46.7)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": "72 (12.5)", 
                "CECABA14750C": 574, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": "2 (0.3)", 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 202.0, 
                "DAB906673934": "8 (1.4)", 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "77 (13.4)", 
                "E0B67B296150": null, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": 16.8, 
                "E27A08B27405": null, 
                "E30780128AA5": 13.8, 
                "E7260BA72D00": "77.3 at 3.7 y", 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": "30 (5.2)", 
                "EBC598BE38BB": "~57 (9.9)", 
                "EBEC64CC1B96": "102 (17.7)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": "224 (39.2)", 
                "F596E2C6ED57": "125 (21.8)", 
                "F665784BFCA0": 38.9, 
                "F91E38093E93": "Enzalutamide", 
                "F9640855F41B": "8 (1.4)", 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": "73.2 at 4 y", 
                "FC992E7A5D74": "103 (17.9)", 
                "FD62EFD5662E": "E+ADT", 
                "FDCFCF44082C": "0 (0)"
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "35446628": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "638 (100)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "583 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 251.0, 
                "116B243F7C0C": "32 (4.9)", 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "SWOG1216", 
                "1622BC83AB7E": "5 (0.4)", 
                "16CE6FB34321": null, 
                "17B78092E8E1": null, 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "382 (59.8)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": null, 
                "25835DAF88D0": 67.6, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "57.9 at 5y", 
                "2D4C089B0DFA": "No", 
                "2F4A705D3F9D": 1279, 
                "2FB5E711ED4D": null, 
                "30367DD2D73C": null, 
                "355467E6F99D": "372 (58.3)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": 47.6, 
                "4BCC29FD82C5": 641.0, 
                "4C28828475CE": "No", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": null, 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "207 (32.3)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 68.1, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": null, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "589 (100)", 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "TAK 300 mg BD; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": null, 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "PFS; PSA at 7 mo; AE profile", 
                "870828CC9464": null, 
                "8A4762F6156F": null, 
                "8C9D45766DFA": null, 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": 81.1, 
                "9698F4F8CA22": "70 (11.1)", 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "211 (32.9)", 
                "9C83E46F40DD": "Original", 
                "9E2C8F8E78F1": "4 (0.6)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": "538 (83.9)", 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT01809691", 
                "AB1128C53AB2": 35446628, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": "539 (83.5)", 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": null, 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": 58.8, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": null, 
                "CB8A3369E369": "952 (74.4)", 
                "CB90E5B8EF95": "No", 
                "CE95DBF09499": "315 (24.6)", 
                "CECABA14750C": 638, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "No", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": "35 (5.5)", 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 274.0, 
                "DAB906673934": "64 (10.0)", 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "641 (100)", 
                "E0B67B296150": 70.2, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": "30 (2.4)", 
                "EB421A7B8403": "2 (0.3)", 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": null, 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": "273 (43.5)", 
                "F596E2C6ED57": null, 
                "F665784BFCA0": 23.0, 
                "F91E38093E93": "TAK", 
                "F9640855F41B": "71 (11.1)", 
                "FAD89E87B16E": "NSAA+ADT", 
                "FBB1E4A88EE8": "59.7 at 5y", 
                "FC992E7A5D74": null, 
                "FD62EFD5662E": "TAK+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "36795843": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": null, 
                "011F14149E53": null, 
                "0348CAC2849A": null, 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": null, 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 229.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "ARASENS", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "558 (85.7)", 
                "17B78092E8E1": "497 (76.3)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "Triplet", 
                "1A752545DC79": "516 (78.9)", 
                "1C1F3983C02E": null, 
                "1F2FA6ACB251": null, 
                "22286C840BFC": "47.2 at 4 y", 
                "25183756ACC6": "466 (71.6)", 
                "25835DAF88D0": 67, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "50.4 at 4 y", 
                "2D4C089B0DFA": "No", 
                "2F4A705D3F9D": 1306, 
                "2FB5E711ED4D": "86 (13.2)", 
                "30367DD2D73C": "462 (70.6)", 
                "355467E6F99D": "505 (77.6)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 654.0, 
                "4C28828475CE": "No", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": 42.4, 
                "567F7C6DB3C0": "146 (22.3)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "138 (21.1)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 67.0, 
                "6740730B2D70": null, 
                "684320C8F19F": null, 
                "6858E301D236": null, 
                "6EDA470D3DED": null, 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": "59.1 at 4 y", 
                "794014C65160": null, 
                "7A300805A69F": "Darolutamide 600mg BID; Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI; Chemotherapy", 
                "7B0EFF1CA297": "190 (29.1)", 
                "7CC71BD77655": "63.4 at 4 y", 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "Time to CRPC; Time to pain progression; SSE-free survival; Time to first SSE; Time to subsequent systemic anti-neoplastic therapy; Time to worsening of disease related physical symptoms; Time to initiation of opioid use\nfor \u22657 consecutive days; Time to initiation of opioid use; Safety", 
                "870828CC9464": "82 (12.5)", 
                "8A4762F6156F": "52.1 at 4 y", 
                "8C9D45766DFA": "566 (86.5)", 
                "8E23DACFB0A8": null, 
                "92BE5A7F545E": "439 (67.5)", 
                "95066A6595E3": 43.7, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "110 (22.4)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": "27 (4.0)", 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT02799602", 
                "AB1128C53AB2": 36795843, 
                "AC649E8D1F86": null, 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": 41, 
                "B3DA3CABD8E6": "508 (77.6)", 
                "B457B682A558": null, 
                "B525BFD9A067": "63.1 at 4 y", 
                "B66DC32F5166": "83.1 at 4 y", 
                "B79629FB310C": "43.7; 42.4", 
                "B8FE4F52434E": "458 (70.2)", 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "154 (23.6)", 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 651, 
                "D497B247EF62": "ARPI; Chemotherapy", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 304.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": null, 
                "E0B67B296150": 42.4, 
                "E17312D8DE93": "74.4 at 4 y", 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": 16.7, 
                "E7260BA72D00": "75.3 at 4 y", 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": "28 (4.1)", 
                "EBC598BE38BB": null, 
                "EBEC64CC1B96": "654 (100)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "185 (28.4)", 
                "F665784BFCA0": 49.9, 
                "F91E38093E93": "Darolutamide + Docetaxel", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "D+ADT", 
                "FBB1E4A88EE8": "62.7 at 4 y", 
                "FC992E7A5D74": "651 (100)", 
                "FD62EFD5662E": "DARO+D+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "36990608": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "117 (20.8)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": "8 (1)", 
                "0741F8ABDAF7": "102 (18.1)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": "11 (2)", 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": 208.0, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "ENZAMET", 
                "1622BC83AB7E": "5 (1)", 
                "16CE6FB34321": "335 (59.5)", 
                "17B78092E8E1": "301 (53.5)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "320 (57)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": "259 (46.1)", 
                "22286C840BFC": "49 at 5 y", 
                "25183756ACC6": "404 (71.9)", 
                "25835DAF88D0": 68.9, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": "57 at 5y", 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 1125, 
                "2FB5E711ED4D": "228 (40.4)", 
                "30367DD2D73C": "405 (72.1)", 
                "355467E6F99D": "335 (59.5)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "268 (47.6)", 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": 81.0, 
                "4BCC29FD82C5": 562.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": null, 
                "567F7C6DB3C0": "261 (46.4)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "164 (29.2)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": "55 (9.8)", 
                "638859C30428": null, 
                "66260E0A7574": 68.8, 
                "6740730B2D70": "344 (61.1)", 
                "684320C8F19F": null, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "93 (16.5)", 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": "55 at 5 y", 
                "794014C65160": null, 
                "7A300805A69F": "Enzalutamide 160mg OD; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": "157 (28)", 
                "7CC71BD77655": "60.2 at 5 y", 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": "Time to PSA progression; rPFS", 
                "870828CC9464": "228 (38.1)", 
                "8A4762F6156F": "47.4 at 5 y", 
                "8C9D45766DFA": "348 (61.9)", 
                "8E23DACFB0A8": "340 (60.5)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "152 (27)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT02446405", 
                "AB1128C53AB2": 36990608, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": "301 (53.5)", 
                "B457B682A558": null, 
                "B525BFD9A067": "58.2 at 5 y", 
                "B66DC32F5166": "80 at 5 y", 
                "B79629FB310C": 68, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "262 (46.5)", 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 563, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": "48 (8.5)", 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": 268.0, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "129 (22.9)", 
                "E0B67B296150": null, 
                "E17312D8DE93": "70.1 at 5 y", 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": "66 at 5 y", 
                "E82A9CE41292": null, 
                "E8EE12049B2E": "13 (2.3)", 
                "EB421A7B8403": null, 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "249 (44)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "158 (28)", 
                "F665784BFCA0": 25.0, 
                "F91E38093E93": "Enzalutamide", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "NSAA+ADT", 
                "FBB1E4A88EE8": "67 at 5 y", 
                "FC992E7A5D74": "254 (45)", 
                "FD62EFD5662E": "E+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "37142371": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": "0 (0)", 
                "011F14149E53": "0 (0)", 
                "0348CAC2849A": "0 (0)", 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": "462 (100)", 
                "085A7C4CBF5E": null, 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": null, 
                "116B243F7C0C": null, 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "STAMPEDE", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": null, 
                "17B78092E8E1": "196 (42)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "Triplet", 
                "1A752545DC79": "345 (75.9)", 
                "1C1F3983C02E": "0 (0)", 
                "1F2FA6ACB251": "278 (61)", 
                "22286C840BFC": "27 at ~5 y", 
                "25183756ACC6": "325 (70)", 
                "25835DAF88D0": 68, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 916, 
                "2FB5E711ED4D": null, 
                "30367DD2D73C": "315 (69)", 
                "355467E6F99D": "369 (79.8)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": "278 (60)", 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 454.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": 38.0, 
                "567F7C6DB3C0": "162 (36)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": 64.0, 
                "5C07F729B9AA": "92 (20)", 
                "5E38B4BCDEBD": "OS", 
                "60C7E1905D85": null, 
                "638859C30428": null, 
                "66260E0A7574": 68.0, 
                "6740730B2D70": "0 (0)", 
                "684320C8F19F": 54.0, 
                "6858E301D236": "0 (0)", 
                "6EDA470D3DED": "454 (100)", 
                "6FCD847B7D4E": null, 
                "7149F82D389F": null, 
                "7651C7D79AA4": "41 at ~5 y", 
                "794014C65160": null, 
                "7A300805A69F": "Enzalutamide 160mg OD; Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": "139 (31)", 
                "7CC71BD77655": null, 
                "80892D26074F": 80.0, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": null, 
                "86DFC7127724": null, 
                "870828CC9464": null, 
                "8A4762F6156F": null, 
                "8C9D45766DFA": null, 
                "8E23DACFB0A8": "0 (0)", 
                "92BE5A7F545E": null, 
                "95066A6595E3": 73.1, 
                "9698F4F8CA22": "204 (45)", 
                "9B6D54D3076F": null, 
                "9BCB3087C50B": "79 (17)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": null, 
                "A0BBF4C1BEF0": null, 
                "A599F8FF4C17": null, 
                "AAA2600F90CA": "NCT00268476", 
                "AB1128C53AB2": 37142371, 
                "AC649E8D1F86": "0 (0)", 
                "AF79B7633616": null, 
                "AFAD2155AD67": null, 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": "209 (46)", 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": "59 at ~5 y", 
                "B79629FB310C": 72, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "195 (42)", 
                "CB8A3369E369": null, 
                "CB90E5B8EF95": "No", 
                "CE95DBF09499": null, 
                "CECABA14750C": 462, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "No", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": null, 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": null, 
                "DAB906673934": null, 
                "DC9FF76C0D07": null, 
                "DF0ADDCB046E": "0 (0)", 
                "E0B67B296150": 51.8, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": "43 at ~5 y", 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": "0 (0)", 
                "EBEC64CC1B96": "39 (9)", 
                "F0D411DE4F55": null, 
                "F1C4BA3F6E42": "302 (68)", 
                "F596E2C6ED57": "137 (30)", 
                "F665784BFCA0": null, 
                "F91E38093E93": "Abiraterone acetate", 
                "F9640855F41B": null, 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": "41 (9)", 
                "FD62EFD5662E": "E+AAP+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }, 
        "37708629": {
          "attrs": {
            "main": {
              "g0": {
                "00DDD4AC47EA": null, 
                "011F14149E53": null, 
                "0348CAC2849A": null, 
                "050FC810D9C0": null, 
                "0741F8ABDAF7": null, 
                "085A7C4CBF5E": "13 (2.5)", 
                "0A5524EC1CBC": null, 
                "0D73E76FDCDE": null, 
                "0E9353A1D622": null, 
                "116B243F7C0C": "22 (4.2)", 
                "122FD2B80D7B": 2, 
                "14D7327C64F9": "TITAN", 
                "1622BC83AB7E": null, 
                "16CE6FB34321": "411 (78.3)", 
                "17B78092E8E1": "325 (61.9)", 
                "18921A8A3057": null, 
                "1957FE4BDCED": "ARPI-doublet", 
                "1A752545DC79": "358 (67.9)", 
                "1C1F3983C02E": null, 
                "1F2FA6ACB251": null, 
                "22286C840BFC": null, 
                "25183756ACC6": "181 (99)", 
                "25835DAF88D0": 69, 
                "2600019AA423": "Full Pub", 
                "2947655B99EA": null, 
                "2AD2CF2D71DF": null, 
                "2D4C089B0DFA": "Yes", 
                "2F4A705D3F9D": 1052, 
                "2FB5E711ED4D": "85 (16.2)", 
                "30367DD2D73C": "176 (96)", 
                "355467E6F99D": "351 (66.9)", 
                "35991F54AD8A": null, 
                "3C86DE29FB08": null, 
                "3E1E7201B7D5": null, 
                "4801CB01C83D": null, 
                "4B3CEEDEC0A3": null, 
                "4BCC29FD82C5": 527.0, 
                "4C28828475CE": "Yes", 
                "4CF32CD4D2E1": null, 
                "4D0F8908760E": 3, 
                "4FC461B9D53B": 38.7, 
                "567F7C6DB3C0": "192 (36.4)", 
                "5A1430A37320": null, 
                "5AC0C7E0125F": null, 
                "5C07F729B9AA": "169 (32)", 
                "5E38B4BCDEBD": "OS, rPFS", 
                "60C7E1905D85": null, 
                "638859C30428": "8 (1.5)", 
                "66260E0A7574": 68.0, 
                "6740730B2D70": null, 
                "684320C8F19F": null, 
                "6858E301D236": null, 
                "6EDA470D3DED": null, 
                "6FCD847B7D4E": "269 (51.0)", 
                "7149F82D389F": "110 (20.9)", 
                "7651C7D79AA4": null, 
                "794014C65160": null, 
                "7A300805A69F": "Apalutamide 240 OD; standard androgen deprivation", 
                "7AB539ED4DCA": "ARPI", 
                "7B0EFF1CA297": "179 (34.0)", 
                "7CC71BD77655": null, 
                "80892D26074F": null, 
                "8161C3F1D5BD": null, 
                "8685EAA9D758": "6 (1.1)", 
                "86DFC7127724": "Time to cytotoxic chemotherapy; Time to pain progression", 
                "870828CC9464": "59 (11.2)", 
                "8A4762F6156F": null, 
                "8C9D45766DFA": "441 (83.7)", 
                "8E23DACFB0A8": null, 
                "92BE5A7F545E": null, 
                "95066A6595E3": null, 
                "9698F4F8CA22": null, 
                "9B6D54D3076F": "119 (22.7)", 
                "9BCB3087C50B": "174 (33.1)", 
                "9C83E46F40DD": "Follow up", 
                "9E2C8F8E78F1": null, 
                "9F13EA930D6F": null, 
                "A008BC5C9F85": "365 (69.3)", 
                "A0BBF4C1BEF0": 30.5, 
                "A599F8FF4C17": "Yes", 
                "AAA2600F90CA": "NCT02489318", 
                "AB1128C53AB2": 37708629, 
                "AC649E8D1F86": null, 
                "AF79B7633616": "11 (2.1)", 
                "AFAD2155AD67": "354 (67.4)", 
                "B23B0A65994F": null, 
                "B3DA3CABD8E6": "335 (63.6)", 
                "B457B682A558": null, 
                "B525BFD9A067": null, 
                "B66DC32F5166": null, 
                "B79629FB310C": null, 
                "B8FE4F52434E": null, 
                "BB93BE8888AA": null, 
                "C7D275071E5D": "200 (38.1)", 
                "CB8A3369E369": "289 (55.1)", 
                "CB90E5B8EF95": "Yes", 
                "CE95DBF09499": null, 
                "CECABA14750C": 525, 
                "D497B247EF62": "ARPI", 
                "D5E5F6396AFF": "Yes", 
                "D60101026CD6": null, 
                "D6CBA5AC8DB2": "24 (4.6)", 
                "D8CBA39A83E1": null, 
                "D98F9A584E0E": null, 
                "DAB86546C4F7": null, 
                "DAB906673934": "10 (1.9)", 
                "DC9FF76C0D07": 14.9, 
                "DF0ADDCB046E": null, 
                "E0B67B296150": null, 
                "E17312D8DE93": null, 
                "E2018F9EC89C": null, 
                "E27A08B27405": null, 
                "E30780128AA5": null, 
                "E7260BA72D00": null, 
                "E82A9CE41292": null, 
                "E8EE12049B2E": null, 
                "EB421A7B8403": null, 
                "EBC598BE38BB": null, 
                "EBEC64CC1B96": "55 (10.4)", 
                "F0D411DE4F55": "BPI-SF", 
                "F1C4BA3F6E42": null, 
                "F596E2C6ED57": "197 (37.5)", 
                "F665784BFCA0": null, 
                "F91E38093E93": "Apalutamide", 
                "F9640855F41B": "9 (1.7)", 
                "FAD89E87B16E": "ADT", 
                "FBB1E4A88EE8": null, 
                "FC992E7A5D74": "58 (11)", 
                "FD62EFD5662E": "APA+ADT", 
                "FDCFCF44082C": null
              }
            }, 
            "other": []
          }, 
          "is_checked": true, 
          "is_selected": true, 
          "n_arms": 2
        }
      }, 
      "data_type": "raw", 
      "date_created": "2022-05-17 22:28:03", 
      "date_updated": "2024-04-16 18:01:48", 
      "extract_id": "9d2ad2e8-d630-11ec-b67e-000d3a9afec0", 
      "has_internal_val": true, 
      "internal_val": null, 
      "meta": {
        "abbr": "SN8GKJCT", 
        "cate_attrs": [
          {
            "abbr": "2C8469308B0F", 
            "attrs": [
              {
                "abbr": "14D7327C64F9", 
                "name": "Trial_Name", 
                "subs": []
              }, 
              {
                "abbr": "2600019AA423", 
                "name": "Full Pub or Abstract", 
                "subs": []
              }, 
              {
                "abbr": "4D0F8908760E", 
                "name": "Phase", 
                "subs": []
              }, 
              {
                "abbr": "9C83E46F40DD", 
                "name": "Original/Follow Up", 
                "subs": []
              }, 
              {
                "abbr": "122FD2B80D7B", 
                "name": "Number of Arms Included", 
                "subs": []
              }, 
              {
                "abbr": "FD62EFD5662E", 
                "name": "Treatment_Arms", 
                "subs": []
              }, 
              {
                "abbr": "FAD89E87B16E", 
                "name": "Control_Arm", 
                "subs": []
              }, 
              {
                "abbr": "D497B247EF62", 
                "name": "Class_of_Agent_in_Treatment_Arm_1", 
                "subs": []
              }, 
              {
                "abbr": "7A300805A69F", 
                "name": "Treatment Arm 1 Regimen", 
                "subs": []
              }, 
              {
                "abbr": "2F4A705D3F9D", 
                "name": "Total Participants - N", 
                "subs": []
              }, 
              {
                "abbr": "CECABA14750C", 
                "name": "Treatment Arm - N", 
                "subs": []
              }, 
              {
                "abbr": "4BCC29FD82C5", 
                "name": "Control_Arm - N", 
                "subs": []
              }, 
              {
                "abbr": "B79629FB310C", 
                "name": "Median Follow-Up Duration (mo)", 
                "subs": []
              }, 
              {
                "abbr": "A25D1A5BFC42", 
                "name": "Median On-Treatment Duration (mo)", 
                "subs": [
                  {
                    "abbr": "B23B0A65994F", 
                    "name": "Treatment", 
                    "sub_categories": []
                  }, 
                  {
                    "abbr": "E30780128AA5", 
                    "name": "Control", 
                    "sub_categories": []
                  }
                ]
              }, 
              {
                "abbr": "A599F8FF4C17", 
                "name": "Quality of Life reported", 
                "subs": []
              }, 
              {
                "abbr": "F0D411DE4F55", 
                "name": "Quality of Life Scale", 
                "subs": []
              }, 
              {
                "abbr": "A233AF7E0C0C", 
                "name": "Reporting by prognostic groups - Y/N", 
                "subs": [
                  {
                    "abbr": "D5E5F6396AFF", 
                    "name": "Synchronous", 
                    "sub_categories": []
                  }, 
                  {
                    "abbr": "CB90E5B8EF95", 
                    "name": "Metachronous", 
                    "sub_categories": []
                  }, 
                  {
                    "abbr": "4C28828475CE", 
                    "name": "High volume", 
                    "sub_categories": []
                  }, 
                  {
                    "abbr": "2D4C089B0DFA", 
                    "name": "Low volume", 
                    "sub_categories": []
                  }
                ]
              }
            ], 
            "name": "TRIAL CHARACTERISTICS"
          }, 
          {
            "abbr": "84ADBC858A72", 
            "attrs": [
              {
                "abbr": "7D5F8AFCDD7E", 
                "name": "Mode of metastases - N (%)", 
                "subs": [
                  {
                    "abbr": "DDEAB0A88EB4", 
                    "name": "Synchronous", 
                    "sub_categories": [
                      {
                        "abbr": "16CE6FB34321", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "8C9D45766DFA", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "53A5491FF4A7", 
                    "name": "Metachronous", 
                    "sub_categories": [
                      {
                        "abbr": "2FB5E711ED4D", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "870828CC9464", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "F648A045200B", 
                "name": "Volume of disease - N (%)", 
                "subs": [
                  {
                    "abbr": "0481753992BE", 
                    "name": "High", 
                    "sub_categories": [
                      {
                        "abbr": "17B78092E8E1", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "B3DA3CABD8E6", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "BF293BCFBB31", 
                    "name": "Low", 
                    "sub_categories": [
                      {
                        "abbr": "C7D275071E5D", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "567F7C6DB3C0", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "65F911331A0F", 
                "name": "Docetaxel administration - N (%)", 
                "subs": [
                  {
                    "abbr": "FC992E7A5D74", 
                    "name": "Treatment", 
                    "sub_categories": []
                  }, 
                  {
                    "abbr": "EBEC64CC1B96", 
                    "name": "Control", 
                    "sub_categories": []
                  }
                ]
              }, 
              {
                "abbr": "F658A1BFEA0E", 
                "name": "Median Age (years)", 
                "subs": [
                  {
                    "abbr": "25835DAF88D0", 
                    "name": "Treatment", 
                    "sub_categories": []
                  }, 
                  {
                    "abbr": "66260E0A7574", 
                    "name": "Control", 
                    "sub_categories": []
                  }
                ]
              }, 
              {
                "abbr": "AC1E093AF770", 
                "name": "Race - N (%)", 
                "subs": [
                  {
                    "abbr": "D662314A8036", 
                    "name": "White", 
                    "sub_categories": [
                      {
                        "abbr": "AFAD2155AD67", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "A008BC5C9F85", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "9DD9787BC58C", 
                    "name": "Black or African American", 
                    "sub_categories": [
                      {
                        "abbr": "DAB906673934", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "F9640855F41B", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "A661B06C2A97", 
                    "name": "Asian", 
                    "sub_categories": [
                      {
                        "abbr": "9B6D54D3076F", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "7149F82D389F", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "433BA677D996", 
                    "name": "Nat. Hawaiian or Pac. Islander", 
                    "sub_categories": [
                      {
                        "abbr": "FDCFCF44082C", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "2947655B99EA", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "0BB441F04D92", 
                    "name": "Amer. Indian or Alaska Nat.", 
                    "sub_categories": [
                      {
                        "abbr": "8685EAA9D758", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "085A7C4CBF5E", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "162885A3E3D5", 
                    "name": "Other", 
                    "sub_categories": [
                      {
                        "abbr": "D6CBA5AC8DB2", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "116B243F7C0C", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "74DB87C1E6BF", 
                    "name": "Unknown", 
                    "sub_categories": [
                      {
                        "abbr": "AF79B7633616", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "638859C30428", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "3D7D1040B256", 
                "name": "Region - N (%)", 
                "subs": [
                  {
                    "abbr": "B60A61D96A3B", 
                    "name": "North America", 
                    "sub_categories": [
                      {
                        "abbr": "011F14149E53", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "DF0ADDCB046E", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "435A98274D90", 
                    "name": "South America", 
                    "sub_categories": [
                      {
                        "abbr": "0348CAC2849A", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "AC649E8D1F86", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "37D516F044E3", 
                    "name": "Europe", 
                    "sub_categories": [
                      {
                        "abbr": "0741F8ABDAF7", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "6EDA470D3DED", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "820CC338237D", 
                    "name": "Africa", 
                    "sub_categories": [
                      {
                        "abbr": "00DDD4AC47EA", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "1C1F3983C02E", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "F8AF2D01930C", 
                    "name": "Asia", 
                    "sub_categories": [
                      {
                        "abbr": "6858E301D236", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "EBC598BE38BB", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "BDF8075B3F5D", 
                    "name": "Oceania", 
                    "sub_categories": [
                      {
                        "abbr": "6740730B2D70", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "8E23DACFB0A8", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "5CC326ED6A7C", 
                "name": "PS - N (%)", 
                "subs": [
                  {
                    "abbr": "E9D87DBB746E", 
                    "name": "0", 
                    "sub_categories": [
                      {
                        "abbr": "25183756ACC6", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "30367DD2D73C", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "CE3CAC0BB17B", 
                    "name": "1-2", 
                    "sub_categories": [
                      {
                        "abbr": "F596E2C6ED57", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "7B0EFF1CA297", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "071E48B21AC8", 
                "name": "Gleason score - N (%)", 
                "subs": [
                  {
                    "abbr": "D8B5F6033599", 
                    "name": "\u2264 7", 
                    "sub_categories": [
                      {
                        "abbr": "9BCB3087C50B", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "5C07F729B9AA", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "A1A562144C83", 
                    "name": "\u2265 8", 
                    "sub_categories": [
                      {
                        "abbr": "355467E6F99D", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "1A752545DC79", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "9FE9BB663559", 
                "name": "Metastases - N (%)", 
                "subs": [
                  {
                    "abbr": "65D37BAC7C5A", 
                    "name": "Liver", 
                    "sub_categories": [
                      {
                        "abbr": "E8EE12049B2E", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "0A5524EC1CBC", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "89B5012F6912", 
                    "name": "Lungs", 
                    "sub_categories": [
                      {
                        "abbr": "60C7E1905D85", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "D8CBA39A83E1", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "94CC60BDEFC7", 
                    "name": "Bone", 
                    "sub_categories": [
                      {
                        "abbr": "CB8A3369E369", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "6FCD847B7D4E", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "09E60DF47100", 
                    "name": "Nodal", 
                    "sub_categories": [
                      {
                        "abbr": "3C86DE29FB08", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "1F2FA6ACB251", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "51238A93C6B0", 
                "name": "Previous local therapy - N (%)", 
                "subs": [
                  {
                    "abbr": "18FB3FBE76C6", 
                    "name": "Prostatectomy", 
                    "sub_categories": [
                      {
                        "abbr": "CE95DBF09499", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "8161C3F1D5BD", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "B47DE26754A4", 
                    "name": "Orchiectomy", 
                    "sub_categories": [
                      {
                        "abbr": "1622BC83AB7E", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "050FC810D9C0", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "1D7B4E605430", 
                    "name": "Radiotherapy", 
                    "sub_categories": [
                      {
                        "abbr": "B457B682A558", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "3E1E7201B7D5", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }
            ], 
            "name": "POPULATION CHARACTERISTICS"
          }, 
          {
            "abbr": "BE1E047373EC", 
            "attrs": [
              {
                "abbr": "5E38B4BCDEBD", 
                "name": "Primary Endpoint(s)", 
                "subs": []
              }, 
              {
                "abbr": "86DFC7127724", 
                "name": "Secondary Endpoint(s)", 
                "subs": []
              }, 
              {
                "abbr": "D402202C00BD", 
                "name": "ORR - N (%)", 
                "subs": [
                  {
                    "abbr": "8F90A813AA13", 
                    "name": "Treatment", 
                    "sub_categories": [
                      {
                        "abbr": "0D73E76FDCDE", 
                        "name": "Overall"
                      }, 
                      {
                        "abbr": "E27A08B27405", 
                        "name": "CR"
                      }, 
                      {
                        "abbr": "9F13EA930D6F", 
                        "name": "SD"
                      }, 
                      {
                        "abbr": "4CF32CD4D2E1", 
                        "name": "PD"
                      }
                    ]
                  }, 
                  {
                    "abbr": "BF6B496E5981", 
                    "name": "Control", 
                    "sub_categories": [
                      {
                        "abbr": "4801CB01C83D", 
                        "name": "Overall"
                      }, 
                      {
                        "abbr": "35991F54AD8A", 
                        "name": "CR"
                      }, 
                      {
                        "abbr": "D98F9A584E0E", 
                        "name": "SD"
                      }, 
                      {
                        "abbr": "794014C65160", 
                        "name": "PD"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "C25CA364463A", 
                "name": "Adverse Events - N (%)", 
                "subs": [
                  {
                    "abbr": "C5B2639DC5A9", 
                    "name": "All-Cause Grade 3 or Higher", 
                    "sub_categories": [
                      {
                        "abbr": "B8FE4F52434E", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "92BE5A7F545E", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "15908294B245", 
                    "name": "Treatment-related Grade 3 or Higher", 
                    "sub_categories": [
                      {
                        "abbr": "F1C4BA3F6E42", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "9698F4F8CA22", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "3FE8CF351AAE", 
                    "name": "Treatment-related Grade 5", 
                    "sub_categories": [
                      {
                        "abbr": "EB421A7B8403", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "9E2C8F8E78F1", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "627A646011DD", 
                "name": "No. of Deaths - N", 
                "subs": [
                  {
                    "abbr": "0E9353A1D622", 
                    "name": "Treatment", 
                    "sub_categories": []
                  }, 
                  {
                    "abbr": "DAB86546C4F7", 
                    "name": "Control", 
                    "sub_categories": []
                  }
                ]
              }, 
              {
                "abbr": "38340C0241D7", 
                "name": "TTPSA (mo)", 
                "subs": [
                  {
                    "abbr": "D60101026CD6", 
                    "name": "Treatment", 
                    "sub_categories": []
                  }, 
                  {
                    "abbr": "E2018F9EC89C", 
                    "name": "Control", 
                    "sub_categories": []
                  }
                ]
              }, 
              {
                "abbr": "12FFCCD1583B", 
                "name": "OS Rate (%)", 
                "subs": [
                  {
                    "abbr": "30236649F1DB", 
                    "name": "Overall", 
                    "sub_categories": [
                      {
                        "abbr": "FBB1E4A88EE8", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "2AD2CF2D71DF", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "BE7D2697E83A", 
                "name": "Median OS (mo)", 
                "subs": [
                  {
                    "abbr": "375EF19DCF76", 
                    "name": "Overall", 
                    "sub_categories": [
                      {
                        "abbr": "95066A6595E3", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "E0B67B296150", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "657F5544C65F", 
                "name": "PFS Rate (%)", 
                "subs": [
                  {
                    "abbr": "83C5FBB6B4F7", 
                    "name": "Overall", 
                    "sub_categories": [
                      {
                        "abbr": "E82A9CE41292", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "BB93BE8888AA", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "443ADC37EBAC", 
                "name": "Median PFS (mo)", 
                "subs": [
                  {
                    "abbr": "90DCFDBF818F", 
                    "name": "Overall", 
                    "sub_categories": [
                      {
                        "abbr": "4B3CEEDEC0A3", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "F665784BFCA0", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }
            ], 
            "name": "RESULTS FOR OVERALL POPULATION"
          }, 
          {
            "abbr": "0CAE27D4B6D2", 
            "attrs": [
              {
                "abbr": "F0A2C4144BD8", 
                "name": "OS Rate (%)", 
                "subs": [
                  {
                    "abbr": "5996425C92CC", 
                    "name": "Synchronous", 
                    "sub_categories": [
                      {
                        "abbr": "B525BFD9A067", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "8A4762F6156F", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "77DD75E17878", 
                    "name": "Metachronous", 
                    "sub_categories": [
                      {
                        "abbr": "E17312D8DE93", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "7CC71BD77655", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "40B45484D6AD", 
                    "name": "High volume", 
                    "sub_categories": [
                      {
                        "abbr": "7651C7D79AA4", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "22286C840BFC", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "8CEA1807CF0E", 
                    "name": "Low volume", 
                    "sub_categories": [
                      {
                        "abbr": "B66DC32F5166", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "E7260BA72D00", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "0D4D99614E1D", 
                "name": "Median OS (mo)", 
                "subs": [
                  {
                    "abbr": "E1ABA59DAE21", 
                    "name": "High volume", 
                    "sub_categories": [
                      {
                        "abbr": "684320C8F19F", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "4FC461B9D53B", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "F0A8467C1064", 
                    "name": "Low volume", 
                    "sub_categories": [
                      {
                        "abbr": "80892D26074F", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "5AC0C7E0125F", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }, 
              {
                "abbr": "F1736EF0E5AB", 
                "name": "Median PFS (mo)", 
                "subs": [
                  {
                    "abbr": "3571255A9B0D", 
                    "name": "High volume", 
                    "sub_categories": [
                      {
                        "abbr": "5A1430A37320", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "DC9FF76C0D07", 
                        "name": "Control"
                      }
                    ]
                  }, 
                  {
                    "abbr": "7EC04D54D29D", 
                    "name": "Low volume", 
                    "sub_categories": [
                      {
                        "abbr": "18921A8A3057", 
                        "name": "Treatment"
                      }, 
                      {
                        "abbr": "A0BBF4C1BEF0", 
                        "name": "Control"
                      }
                    ]
                  }
                ]
              }
            ], 
            "name": "RESULTS BY PROGNOSTIC GROUPS"
          }, 
          {
            "abbr": "82624D63EE66", 
            "attrs": [
              {
                "abbr": "F91E38093E93", 
                "name": "Add-on Treatment", 
                "subs": []
              }, 
              {
                "abbr": "7AB539ED4DCA", 
                "name": "Treatment Class", 
                "subs": []
              }, 
              {
                "abbr": "1957FE4BDCED", 
                "name": "Type of Therapy", 
                "subs": []
              }
            ], 
            "name": "_SYS"
          }
        ], 
        "category": "default", 
        "certainty": {
          "cie": "4", 
          "importance": "1", 
          "imprecision": "1", 
          "inconsistency": "1", 
          "indirectness": "1", 
          "publication_bias": "0", 
          "risk_of_bias": "1"
        }, 
        "coe": {}, 
        "cq_abbr": "mcspc", 
        "default_attrs": [
          "Trial_Name", 
          "Treatment Arm 1", 
          "Control_Arm"
        ], 
        "filters": [
          {
            "attr": "Type of Therapy", 
            "display_name": "Type of Therapy", 
            "type": "radio", 
            "value": 0, 
            "values": [
              {
                "default": true, 
                "display_name": "All", 
                "sql_cond": "{$col} is not NULL", 
                "value": 0
              }, 
              {
                "default": false, 
                "display_name": "Triplet", 
                "sql_cond": "{$col} like '%Triplet%'", 
                "value": 1
              }, 
              {
                "default": false, 
                "display_name": "ARPI-doublet", 
                "sql_cond": "{$col} like '%ARPI-doublet%'", 
                "value": 2
              }, 
              {
                "default": false, 
                "display_name": "Chemo-doublet", 
                "sql_cond": "{$col} like '%Chemo-doublet%'", 
                "value": 3
              }
            ]
          }, 
          {
            "attr": "Add-on Treatment", 
            "display_name": "Add-on Treatment", 
            "type": "radio", 
            "value": 0, 
            "values": [
              {
                "default": true, 
                "display_name": "All", 
                "sql_cond": "{$col} is not NULL", 
                "value": 0
              }, 
              {
                "default": false, 
                "display_name": "Darolutamide + Docetaxel", 
                "sql_cond": "{$col} like '%Darolutamide + Docetaxel%'", 
                "value": 1
              }, 
              {
                "default": false, 
                "display_name": "Abiraterone acetate + Docetaxel", 
                "sql_cond": "{$col} like '%Abiraterone acetate + Docetaxel%'", 
                "value": 2
              }, 
              {
                "default": false, 
                "display_name": "Apalutamide", 
                "sql_cond": "{$col} like '%Apalutamide%'", 
                "value": 3
              }, 
              {
                "default": false, 
                "display_name": "Enzalutamide", 
                "sql_cond": "{$col} like '%Enzalutamide%'", 
                "value": 4
              }, 
              {
                "default": false, 
                "display_name": "Abiraterone acetate", 
                "sql_cond": "{$col} like '%Abiraterone acetate%'", 
                "value": 5
              }, 
              {
                "default": false, 
                "display_name": "Docetaxel", 
                "sql_cond": "{$col} like '%Docetaxel%'", 
                "value": 6
              }, 
              {
                "default": false, 
                "display_name": "TAK", 
                "sql_cond": "{$col} like '%TAK%'", 
                "value": 7
              }
            ]
          }, 
          {
            "attr": "Treatment Class", 
            "display_name": "Treatment Class", 
            "type": "radio", 
            "value": 0, 
            "values": [
              {
                "default": true, 
                "display_name": "All", 
                "sql_cond": "{$col} is not NULL", 
                "value": 0
              }, 
              {
                "default": false, 
                "display_name": "ARPI", 
                "sql_cond": "{$col} like '%ARPI%'", 
                "value": 1
              }, 
              {
                "default": false, 
                "display_name": "Chemotherapy", 
                "sql_cond": "{$col} like '%Chemotherapy%'", 
                "value": 2
              }
            ]
          }, 
          {
            "attr": "Original/Follow Up", 
            "display_name": "Trial Version", 
            "type": "radio", 
            "value": 0, 
            "values": [
              {
                "default": true, 
                "display_name": "All", 
                "sql_cond": "{$col} is not NULL", 
                "value": 0
              }, 
              {
                "default": false, 
                "display_name": "Original", 
                "sql_cond": "{$col} like '%Original%'", 
                "value": 1
              }, 
              {
                "default": false, 
                "display_name": "Follow up", 
                "sql_cond": "{$col} like '%Follow up%'", 
                "value": 2
              }
            ]
          }
        ], 
        "full_name": "Interactive Table", 
        "group": "itable", 
        "input_format": "custom", 
        "is_subg_analysis": "no", 
        "oc_type": "itable", 
        "sub_groups": [
          "A"
        ]
      }, 
      "n_selected": 32, 
      "oc_type": "itable", 
      "project_id": "05f09190-d449-11eb-b67e-000d3a9afec0", 
      "survival_in_control": 0
    }, 
    "latest": {
      "last_created": "2024-04-15", 
      "last_queried": "2024-04-18 16:29:10", 
      "last_updated": "2024-04-16"
    }, 
    "paper_dict": {
      "10.1016/j.annonc.2020.08.871": {
        "is_pmid": false, 
        "journal": "Annals of Oncology; vol. 31", 
        "pid": "10.1016/j.annonc.2020.08.871", 
        "pid_type": "DOI", 
        "pub_date": "2020", 
        "rct_id": "NCT00268476", 
        "short_name": "James, N. et al 2020", 
        "study_type": "followup", 
        "title": "611O Abiraterone acetate plus prednisolone for hormone-na\u00efve prostate cancer (PCa): Long-term results from metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476)", 
        "year": "2020"
      }, 
      "10.1093/annonc/mdz394.046": {
        "is_pmid": false, 
        "journal": "Annals of Oncology; p. v886-v887; vol. 30", 
        "pid": "10.1093/annonc/mdz394.046", 
        "pid_type": "DOI", 
        "pub_date": "2019", 
        "rct_id": "NCT02446405", 
        "short_name": "Stockler, M. R. et al 2019", 
        "study_type": "original", 
        "title": "Health-related quality of life (HRQL) in a randomized phase III trial of enzalutamide with standard first-line therapy for metastatic, hormone-sensitive prostate cancer (mHSPC): ENZAMET (ANZUP 1304), an ANZUP-led, international, co-operative group trial", 
        "year": "2019"
      }, 
      "10.1200/jco.2020.38.6_suppl.87": {
        "is_pmid": false, 
        "journal": "Journal of Clinical Oncology; p. 87-87; vol. 38; (6_suppl)", 
        "pid": "10.1200/jco.2020.38.6_suppl.87", 
        "pid_type": "DOI", 
        "pub_date": "2020", 
        "rct_id": "NCT02489318", 
        "short_name": "Ozguroglu, Mustafa et al 2020", 
        "study_type": "followup", 
        "title": "Apalutamide (APA) for metastatic castration-sensitive prostate cancer (mCSPC) in TITAN: Outcomes in patients (pts) with low- and high-risk disease", 
        "year": "2020"
      }, 
      "10.1200/jco.2021.39.6_suppl.11": {
        "is_pmid": false, 
        "journal": "Journal of Clinical Oncology; p. 11-11; vol. 39; (6_suppl)", 
        "pid": "10.1200/jco.2021.39.6_suppl.11", 
        "pid_type": "DOI", 
        "pub_date": "2021", 
        "rct_id": "NCT02489318", 
        "short_name": "Chi, Kim N. et al 2021", 
        "study_type": "followup", 
        "title": "Final analysis results from TITAN: A phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT)", 
        "year": "2021"
      }, 
      "23306100": {
        "is_pmid": true, 
        "journal": "Lancet Oncology; Lancet Oncology; p. 149-58; vol. 14; (2)", 
        "pid": "23306100", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2013 Feb", 
        "rct_id": "NCT00104715", 
        "short_name": "Gravis, Gwenaelle et al 2013", 
        "study_type": "original", 
        "title": "Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial", 
        "year": "2013"
      }, 
      "26244877": {
        "is_pmid": true, 
        "journal": "New England Journal of Medicine; p. 737-46; vol. 373; (8)", 
        "pid": "26244877", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2015 Aug 20", 
        "rct_id": "NCT00309985", 
        "short_name": "Sweeney et al 2015", 
        "study_type": "original", 
        "title": "Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer", 
        "year": "2015"
      }, 
      "26610858": {
        "is_pmid": true, 
        "journal": "European Urology; p. 256-62; vol. 70; (2)", 
        "pid": "26610858", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2016 08", 
        "rct_id": "NCT00104715", 
        "short_name": "Gravis, Gwenaelle et al 2016", 
        "study_type": "followup", 
        "title": "Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial", 
        "year": "2016"
      }, 
      "26719232": {
        "is_pmid": true, 
        "journal": "Lancet; Lancet; p. 1163-77; vol. 387; (10024)", 
        "pid": "26719232", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2016 Mar 19", 
        "rct_id": "NCT00268476", 
        "short_name": "James, Nicholas D. et al 2016", 
        "study_type": "followup", 
        "title": "Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial", 
        "year": "2016"
      }, 
      "28578607": {
        "is_pmid": true, 
        "journal": "New England Journal of Medicine; p. 352-360; vol. 377; (4)", 
        "pid": "28578607", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2017 07 27", 
        "rct_id": "NCT01715285", 
        "short_name": "Fizazi, Karim et al 2017", 
        "study_type": "original", 
        "title": "Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer", 
        "year": "2017"
      }, 
      "28578639": {
        "is_pmid": true, 
        "journal": "New England Journal of Medicine; p. 338-351; vol. 377; (4)", 
        "pid": "28578639", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2017 07 27", 
        "rct_id": "NCT00268476", 
        "short_name": "James, Nicholas D. et al 2017", 
        "study_type": "followup", 
        "title": "Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy", 
        "year": "2017"
      }, 
      "29326030": {
        "is_pmid": true, 
        "journal": "Lancet Oncology; Lancet Oncology; p. 194-206; vol. 19; (2)", 
        "pid": "29326030", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2018 02", 
        "rct_id": "NCT01715285", 
        "short_name": "Chi, Kim N. et al 2018", 
        "study_type": "followup", 
        "title": "Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial", 
        "year": "2018"
      }, 
      "29384722": {
        "is_pmid": true, 
        "journal": "Journal of Clinical Oncology; p. 1080-1087; vol. 36; (11)", 
        "pid": "29384722", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2018 04 10", 
        "rct_id": "NCT00309985", 
        "short_name": "Kyriakopoulos et al 2018", 
        "study_type": "followup", 
        "title": "Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial", 
        "year": "2018"
      }, 
      "29522362": {
        "is_pmid": true, 
        "journal": "Journal of Clinical Oncology; p. 1088-1095; vol. 36; (11)", 
        "pid": "29522362", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2018 04 10", 
        "rct_id": "NCT00309985", 
        "short_name": "Morgans, Alicia K. et al 2018", 
        "study_type": "followup", 
        "title": "Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer", 
        "year": "2018"
      }, 
      "29529169": {
        "is_pmid": true, 
        "journal": "Ann Oncol", 
        "pid": "29529169", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2018-05-01", 
        "rct_id": "NCT00268476", 
        "short_name": "M R Sydes et al 2018", 
        "study_type": "followup", 
        "title": "Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.", 
        "year": "2018"
      }, 
      "30987939": {
        "is_pmid": true, 
        "journal": "Lancet Oncology; Lancet Oncology; p. 686-700; vol. 20; (5)", 
        "pid": "30987939", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2019 05", 
        "rct_id": "NCT01715285", 
        "short_name": "Fizazi, Karim et al 2019", 
        "study_type": "followup", 
        "title": "Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial", 
        "year": "2019"
      }, 
      "31150574": {
        "is_pmid": true, 
        "journal": "New England Journal of Medicine; p. 13-24; vol. 381; (1)", 
        "pid": "31150574", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2019 07 04", 
        "rct_id": "NCT02489318", 
        "short_name": "Chi, Kim N. et al 2019", 
        "study_type": "followup", 
        "title": "Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer", 
        "year": "2019"
      }, 
      "31157964": {
        "is_pmid": true, 
        "journal": "New England Journal of Medicine; p. 121-131; vol. 381; (2)", 
        "pid": "31157964", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2019 07 11", 
        "rct_id": "NCT02446405", 
        "short_name": "Davis, Ian D. et al 2019", 
        "study_type": "followup", 
        "title": "Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer", 
        "year": "2019"
      }, 
      "31329516": {
        "is_pmid": true, 
        "journal": "J Clin Oncol", 
        "pid": "31329516", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2019-07-22", 
        "rct_id": "NCT02677896", 
        "short_name": "Andrew J Armstrong et al 2019", 
        "study_type": "original", 
        "title": "ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer.", 
        "year": "2019"
      }, 
      "31447077": {
        "is_pmid": true, 
        "journal": "Eur Urol", 
        "pid": "31447077", 
        "pid_type": "PMID", 
        "pub_date": "2019-08-23", 
        "rct_id": "NCT00268476", 
        "short_name": "Alex P Hoyle et al 2019", 
        "study_type": "followup", 
        "title": "Abiraterone in \"High-\" and \"Low-risk\" Metastatic Hormone-sensitive Prostate Cancer.", 
        "year": "2019"
      }, 
      "31560068": {
        "is_pmid": true, 
        "journal": "Annals of Oncology; p. 1992-2003; vol. 30; (12)", 
        "pid": "31560068", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2019 12 01", 
        "rct_id": "NCT00268476", 
        "short_name": "Clarke, N. W. et al 2019", 
        "study_type": "followup", 
        "title": "Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial", 
        "year": "2019"
      }, 
      "31578173": {
        "is_pmid": true, 
        "journal": "Lancet Oncology; Lancet Oncology; p. 1518-1530; vol. 20; (11)", 
        "pid": "31578173", 
        "pid_type": "MEDLINE and Epub Ahead of Print,", 
        "pub_date": "2019 11", 
        "rct_id": "NCT02489318", 
        "short_name": "Agarwal, Neeraj et al 2019", 
        "study_type": "original", 
        "title": "Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study", 
        "year": "2019"
      }, 
      "32336645": {
        "is_pmid": true, 
        "journal": "European Urology. 78(4):603-614, 2020 10.", 
        "pid": "32336645", 
        "pid_type": "MEDLINE", 
        "pub_date": "2020", 
        "rct_id": "NCT02677896", 
        "short_name": "Stenzl A et al 2020", 
        "study_type": "followup", 
        "title": "Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study.", 
        "year": "2020"
      }, 
      "34757812": {
        "is_pmid": true, 
        "journal": "J Clin Oncol", 
        "pid": "34757812", 
        "pid_type": "PMID", 
        "pub_date": "2021-11-10", 
        "rct_id": "NCT00268476", 
        "short_name": "Hannah L Rush et al 2021", 
        "study_type": "followup", 
        "title": "Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial.", 
        "year": "2021"
      }, 
      "35179323": {
        "is_pmid": true, 
        "journal": "N Engl J Med", 
        "pid": "35179323", 
        "pid_type": "PMID", 
        "pub_date": "2022-02-17", 
        "rct_id": "NCT02799602", 
        "short_name": "Matthew R Smith et al 2022", 
        "study_type": "followup", 
        "title": "Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.", 
        "year": "2022"
      }, 
      "35405085": {
        "is_pmid": true, 
        "journal": "Lancet", 
        "pid": "35405085", 
        "pid_type": "PMID", 
        "pub_date": "2022-04-08", 
        "rct_id": "NCT01957436", 
        "short_name": "Karim Fizazi et al 2022", 
        "study_type": "followup", 
        "title": "Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2\u2009\u00d7\u20092 factorial design.", 
        "year": "2022"
      }, 
      "35411939": {
        "is_pmid": true, 
        "journal": "Int J Cancer", 
        "pid": "35411939", 
        "pid_type": "PMID", 
        "pub_date": "2022-05-16", 
        "rct_id": "NCT00268476", 
        "short_name": "Nicholas D James et al 2022", 
        "study_type": "followup", 
        "title": "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).", 
        "year": "2022"
      }, 
      "35420921": {
        "is_pmid": true, 
        "journal": "J Clin Oncol", 
        "pid": "35420921", 
        "pid_type": "PMID", 
        "pub_date": "2022-04-14", 
        "rct_id": "NCT02677896", 
        "short_name": "Andrew J Armstrong et al 2022", 
        "study_type": "followup", 
        "title": "Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer.", 
        "year": "2022"
      }, 
      "35446628": {
        "is_pmid": true, 
        "journal": "J Clin Oncol", 
        "pid": "35446628", 
        "pid_type": "PMID", 
        "pub_date": "2022-04-21", 
        "rct_id": "NCT01809691", 
        "short_name": "Neeraj Agarwal et al 2022", 
        "study_type": "followup", 
        "title": "Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).", 
        "year": "2022"
      }, 
      "36795843": {
        "is_pmid": true, 
        "journal": "J Clin Oncol", 
        "pid": "36795843", 
        "pid_type": "PMID", 
        "pub_date": "2023-02-16", 
        "rct_id": "NCT02799602", 
        "short_name": "Maha Hussain et al 2023", 
        "study_type": "followup", 
        "title": "Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial.", 
        "year": "2023"
      }, 
      "36990608": {
        "is_pmid": true, 
        "journal": "Lancet Oncology. 24(4):323-334, 2023 Apr.", 
        "pid": "36990608", 
        "pid_type": "MEDLINE", 
        "pub_date": "2023", 
        "rct_id": "NCT02446405", 
        "short_name": "Sweeney CJ et al 2023", 
        "study_type": "followup", 
        "title": "Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.", 
        "year": "2023"
      }, 
      "37142371": {
        "is_pmid": true, 
        "journal": "Lancet Oncol", 
        "pid": "37142371", 
        "pid_type": "PMID", 
        "pub_date": "2023-May", 
        "rct_id": "NCT00268476", 
        "short_name": "Gerhardt Attard et al 2023", 
        "study_type": "followup", 
        "title": "Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.", 
        "year": "2023"
      }, 
      "37708629": {
        "is_pmid": true, 
        "journal": "European Journal of Cancer", 
        "pid": "37708629", 
        "pid_type": "PMID", 
        "pub_date": "2023-11", 
        "rct_id": "NCT02489318", 
        "short_name": "Axel S. Merseburger et al 2023", 
        "study_type": "followup", 
        "title": "Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study", 
        "year": "2023"
      }
    }, 
    "rs": [
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": "34 (18.3)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": "179 (91.5)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "0 (0)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "4 (2.1)", 
        " Gleason score - N (%) | \u2264 7 | Control": "78 (41)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "84 (45)", 
        " Gleason score - N (%) | \u2265 8 | Control": "113 (59)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "103 (55)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 54.2, 
        " Median OS (mo) | Overall | Treatment": 58.9, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 12.9, 
        " Median PFS (mo) | Overall | Treatment": 22.9, 
        " Metastases - N (%) | Bone | Control": "156 (81)", 
        " Metastases - N (%) | Bone | Treatment": "155 (81)", 
        " Metastases - N (%) | Liver | Control": "3 (2)", 
        " Metastases - N (%) | Liver | Treatment": "9 (5)", 
        " Metastases - N (%) | Lungs | Control": "22 (11)", 
        " Metastases - N (%) | Lungs | Treatment": "22 (11)", 
        " Metastases - N (%) | Nodal | Control": "108 (56)", 
        " Metastases - N (%) | Nodal | Treatment": "100 (52)", 
        " Mode of metastases - N (%) | Metachronous | Control": "46 (24)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "62 (32)", 
        " Mode of metastases - N (%) | Synchronous | Control": "144 (75)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "128 (67)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": "62.9 at 3 y", 
        " OS Rate (%) | Overall | Treatment": "64.2 at 3 y", 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "193 (100)", 
        " Region - N (%) | Europe | Treatment": "192 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Gravis, Gwenaelle et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "Chemotherapy", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 193.0, 
        "Docetaxel administration - N (%) | Control": "0 (0)", 
        "Docetaxel administration - N (%) | Treatment": "192 (100)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "no", 
        "Median Age (years) | Control": 64.0, 
        "Median Age (years) | Treatment": 63, 
        "Median Follow-Up Duration (mo)": 50, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 15.4, 
        "Median On-Treatment Duration (mo) | Treatment": 20, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00104715", 
        "No. of Deaths - N | Control": 88.0, 
        "No. of Deaths - N | Treatment": 88.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Original", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "23306100", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": "EORTC QLQ-C 30", 
        "Quality of Life reported": "Yes", 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "No", 
        "Reporting by prognostic groups - Y/N | Low volume": "No", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "cPFS; bPFS", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 385, 
        "Treatment Arm - N": 192, 
        "Treatment Arm 1 Regimen": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
        "Treatment_Arms": "D+ADT", 
        "Treatment Class": "Chemotherapy", 
        "Trial_Name": "GETUG-AFU15", 
        "Type of Therapy": "Chemo-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2013", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "0 (0)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "1 (1)", 
        " Gleason score - N (%) | \u2264 7 | Control": "104 (26)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "117 (30)", 
        " Gleason score - N (%) | \u2265 8 | Control": "243 (61.8)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "241 (60.7)", 
        " Median OS (mo) | High volume | Control": 32.2, 
        " Median OS (mo) | High volume | Treatment": 49.2, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 44.0, 
        " Median OS (mo) | Overall | Treatment": 57.6, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 19.8, 
        " Median PFS (mo) | Overall | Treatment": 33.0, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": "106 (27.0)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "108 (27.2)", 
        " Mode of metastases - N (%) | Synchronous | Control": "286 (72.8)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "289 (72.8)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "272 (69.2)", 
        " PS - N (%) | 0 | Treatment": "277 (69.8)", 
        " PS - N (%) | 1-2 | Control": "121 (30.8)", 
        " PS - N (%) | 1-2 | Treatment": "120 (30.2)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": "73 (18.6)", 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": "81 (20.4)", 
        " Previous local therapy - N (%) | Radiotherapy | Control": "33 (8.4)", 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": "27 (6.8)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": "37 (9.4)", 
        " Race - N (%) | Asian | Treatment": "39 (9.8)", 
        " Race - N (%) | Black or African American | Control": "330 (84.0)", 
        " Race - N (%) | Black or African American | Treatment": "344 (86.6)", 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": "6 (1.5)", 
        " Race - N (%) | Other | Treatment": "4 (1.0)", 
        " Race - N (%) | Unknown | Control": "20 (5.1)", 
        " Race - N (%) | Unknown | Treatment": "10 (2.5)", 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "0 (0)", 
        " Region - N (%) | Europe | Treatment": "0 (0)", 
        " Region - N (%) | North America | Control": "393 (100)", 
        " Region - N (%) | North America | Treatment": "397 (100)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": "250 (63.6)", 
        " Volume of disease - N (%) | High | Treatment": "263 (66.2)", 
        " Volume of disease - N (%) | Low | Control": "143 (36.4)", 
        " Volume of disease - N (%) | Low | Treatment": "134 (33.8)", 
        "Add-on Treatment": "Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Sweeney et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "Chemotherapy", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 393.0, 
        "Docetaxel administration - N (%) | Control": "0 (0)", 
        "Docetaxel administration - N (%) | Treatment": "397 (100)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "no", 
        "Median Age (years) | Control": 63.0, 
        "Median Age (years) | Treatment": 64, 
        "Median Follow-Up Duration (mo)": 28.9, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00309985", 
        "No. of Deaths - N | Control": 136.0, 
        "No. of Deaths - N | Treatment": 101.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Original", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "26244877", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "PSA level; Time to castration-resistant prostate cancer; Time to clinical progression", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 790, 
        "Treatment Arm - N": 397, 
        "Treatment Arm 1 Regimen": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
        "Treatment_Arms": "D+ADT", 
        "Treatment Class": "Chemotherapy", 
        "Trial_Name": "CHAARTED", 
        "Type of Therapy": "Chemo-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2015", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": "78 (41)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "84 (45)", 
        " Gleason score - N (%) | \u2265 8 | Control": "113 (59)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "103 (55)", 
        " Median OS (mo) | High volume | Control": 35.1, 
        " Median OS (mo) | High volume | Treatment": 39.8, 
        " Median OS (mo) | Low volume | Control": 83.4, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 48.6, 
        " Median OS (mo) | Overall | Treatment": 62.1, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 12.9, 
        " Median PFS (mo) | Overall | Treatment": 22.9, 
        " Metastases - N (%) | Bone | Control": "95 (49)", 
        " Metastases - N (%) | Bone | Treatment": "82 (43)", 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": "46 (24)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "62 (32)", 
        " Mode of metastases - N (%) | Synchronous | Control": "144 (75)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "128 (67)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "176 (96)", 
        " PS - N (%) | 0 | Treatment": "181 (99)", 
        " PS - N (%) | 1-2 | Control": "7(4)", 
        " PS - N (%) | 1-2 | Treatment": "2(1)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "193 (100)", 
        " Region - N (%) | Europe | Treatment": "192 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": "91 (47)", 
        " Volume of disease - N (%) | High | Treatment": "92 (48)", 
        " Volume of disease - N (%) | Low | Control": "102 (53)", 
        " Volume of disease - N (%) | Low | Treatment": "100 (52)", 
        "Add-on Treatment": "Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Gravis, Gwenaelle et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "Chemotherapy", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 193.0, 
        "Docetaxel administration - N (%) | Control": "0 (0)", 
        "Docetaxel administration - N (%) | Treatment": "192 (100)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 64.0, 
        "Median Age (years) | Treatment": 63, 
        "Median Follow-Up Duration (mo)": 83.9, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 48.6, 
        "Median On-Treatment Duration (mo) | Treatment": 62.1, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00104715", 
        "No. of Deaths - N | Control": 127.0, 
        "No. of Deaths - N | Treatment": 115.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "26610858", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "bPFS ; rPFS", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 385, 
        "Treatment Arm - N": 192, 
        "Treatment Arm 1 Regimen": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
        "Treatment_Arms": "D+ADT", 
        "Treatment Class": "Chemotherapy", 
        "Trial_Name": "GETUG-AFU15", 
        "Type of Therapy": "Chemo-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2016", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": "399 (32)", 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": "288 (52)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "4(0.7)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "5(0.4)", 
        " Gleason score - N (%) | \u2264 7 | Control": "282 (24)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "110 (19)", 
        " Gleason score - N (%) | \u2265 8 | Control": "810 (68)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "436 (74)", 
        " Median OS (mo) | High volume | Control": 33.3, 
        " Median OS (mo) | High volume | Treatment": 49.7, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 71.0, 
        " Median OS (mo) | Overall | Treatment": 81.0, 
        " Median PFS (mo) | High volume | Control": 14.7, 
        " Median PFS (mo) | High volume | Treatment": 33.1, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": "634 (54)", 
        " Metastases - N (%) | Bone | Treatment": "307 (52)", 
        " Metastases - N (%) | Liver | Control": "15 (1)", 
        " Metastases - N (%) | Liver | Treatment": "6 (1)", 
        " Metastases - N (%) | Lungs | Control": "33 (3)", 
        " Metastases - N (%) | Lungs | Treatment": "13 (2)", 
        " Metastases - N (%) | Nodal | Control": "220 (19)", 
        " Metastases - N (%) | Nodal | Treatment": "102 (17)", 
        " Mode of metastases - N (%) | Metachronous | Control": "230 (39)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "227 (38)", 
        " Mode of metastases - N (%) | Synchronous | Control": "362 (61)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "366 (62)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": "2 (0)", 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": "5 (0)", 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": "844 (71)", 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": "424 (72)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "1184 (100)", 
        " Region - N (%) | Europe | Treatment": "592 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "James, Nicholas D. et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "Chemotherapy", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 1184.0, 
        "Docetaxel administration - N (%) | Control": "0 (0)", 
        "Docetaxel administration - N (%) | Treatment": "593 (100)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 65.0, 
        "Median Age (years) | Treatment": 65, 
        "Median Follow-Up Duration (mo)": 43, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 24, 
        "Median On-Treatment Duration (mo) | Treatment": 11, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00268476", 
        "No. of Deaths - N | Control": 415.0, 
        "No. of Deaths - N | Treatment": 175.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Original", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "26719232", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS, FFS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "No", 
        "Reporting by prognostic groups - Y/N | Low volume": "No", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": null, 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 2962, 
        "Treatment Arm - N": 592, 
        "Treatment Arm 1 Regimen": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
        "Treatment_Arms": "D+ADT", 
        "Treatment Class": "Chemotherapy", 
        "Trial_Name": "STAMPEDE", 
        "Type of Therapy": "Chemo-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2016", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": "287 (48)", 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": "374(63)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "24 (4)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "28 (5)", 
        " Gleason score - N (%) | \u2264 7 | Control": "1 (0.2)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "4 (0.7)", 
        " Gleason score - N (%) | \u2265 8 | Control": "586 (97)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "584 (98)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 34.7, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 14.8, 
        " Median PFS (mo) | Overall | Treatment": 33.0, 
        " Metastases - N (%) | Bone | Control": "585 (98)", 
        " Metastases - N (%) | Bone | Treatment": "580 (97)", 
        " Metastases - N (%) | Liver | Control": "30 (5)", 
        " Metastases - N (%) | Liver | Treatment": "32 (5)", 
        " Metastases - N (%) | Lungs | Control": "72 (12)", 
        " Metastases - N (%) | Lungs | Treatment": "73 (12)", 
        " Metastases - N (%) | Nodal | Control": "287 (48)", 
        " Metastases - N (%) | Nodal | Treatment": "283 (47)", 
        " Mode of metastases - N (%) | Metachronous | Control": "0 (0)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "0 (0)", 
        " Mode of metastases - N (%) | Synchronous | Control": "602 (100)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "597 (100)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": "49 at 3 y", 
        " OS Rate (%) | Overall | Treatment": "66 at 3 y", 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": "71 (12)", 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": "73 (12)", 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": "26 (4)", 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": "19 (3)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": null, 
        " Region - N (%) | Africa | Treatment": null, 
        " Region - N (%) | Asia | Control": null, 
        " Region - N (%) | Asia | Treatment": null, 
        " Region - N (%) | Europe | Control": null, 
        " Region - N (%) | Europe | Treatment": null, 
        " Region - N (%) | North America | Control": null, 
        " Region - N (%) | North America | Treatment": null, 
        " Region - N (%) | Oceania | Control": null, 
        " Region - N (%) | Oceania | Treatment": null, 
        " Region - N (%) | South America | Control": null, 
        " Region - N (%) | South America | Treatment": null, 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Abiraterone acetate", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Fizazi, Karim et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 602.0, 
        "Docetaxel administration - N (%) | Control": "187 (40)", 
        "Docetaxel administration - N (%) | Treatment": "106 (34)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 67.0, 
        "Median Age (years) | Treatment": 68, 
        "Median Follow-Up Duration (mo)": 30.4, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 14, 
        "Median On-Treatment Duration (mo) | Treatment": 24, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT01715285", 
        "No. of Deaths - N | Control": 237.0, 
        "No. of Deaths - N | Treatment": 169.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Original", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "28578607", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS, rPFS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "No", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to pain progression; Time to initiation of chemotherapy; Subsequent therapy for prostate cancer;  PSA progression; Symptomatic skeletal-related events", 
        "TTPSA (mo) | Control": 7.4, 
        "TTPSA (mo) | Treatment": 33.2, 
        "Total Participants - N": 1199, 
        "Treatment Arm - N": 597, 
        "Treatment Arm 1 Regimen": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
        "Treatment_Arms": "AAP+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "LATITUDE", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2017", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": "315 (33)", 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": "443 (47)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "3 (0.3)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "9 (0.9)", 
        " Gleason score - N (%) | \u2264 7 | Control": "223 (23)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "221 (23)", 
        " Gleason score - N (%) | \u2265 8 | Control": "721 (75)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "715 (74)", 
        " Median OS (mo) | High volume | Control": 33.3, 
        " Median OS (mo) | High volume | Treatment": 49.7, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": 14.7, 
        " Median PFS (mo) | High volume | Treatment": 33.1, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": "434 (45)", 
        " Metastases - N (%) | Bone | Treatment": "448 (47)", 
        " Metastases - N (%) | Liver | Control": "8 (1)", 
        " Metastases - N (%) | Liver | Treatment": "7 (1)", 
        " Metastases - N (%) | Lungs | Control": "21 (2)", 
        " Metastases - N (%) | Lungs | Treatment": "21 (2)", 
        " Metastases - N (%) | Nodal | Control": "150 (16)", 
        " Metastases - N (%) | Nodal | Treatment": "142 (15)", 
        " Mode of metastases - N (%) | Metachronous | Control": "455 (47.5)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "460 (47.9)", 
        " Mode of metastases - N (%) | Synchronous | Control": "502 (52.5)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "500 (52.1)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": "90.3 at 3 y", 
        " OS Rate (%) | Metachronous | Treatment": "92.6 at 3 y", 
        " OS Rate (%) | Overall | Control": "76 at 3 y", 
        " OS Rate (%) | Overall | Treatment": "83 at 3 y", 
        " OS Rate (%) | Synchronous | Control": "56.6 at 3 y", 
        " OS Rate (%) | Synchronous | Treatment": "70.0 at 3 y", 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "744 (78)", 
        " PS - N (%) | 0 | Treatment": "745 (78)", 
        " PS - N (%) | 1-2 | Control": "213 (22)", 
        " PS - N (%) | 1-2 | Treatment": "215 (22)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": "5 (1)", 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": "3 (<1)", 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "957 (100)", 
        " Region - N (%) | Europe | Treatment": "960 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Abiraterone acetate", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "James, Nicholas D. et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 957.0, 
        "Docetaxel administration - N (%) | Control": null, 
        "Docetaxel administration - N (%) | Treatment": null, 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 67.0, 
        "Median Age (years) | Treatment": 67, 
        "Median Follow-Up Duration (mo)": 40, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": 33.2, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00268476", 
        "No. of Deaths - N | Control": 262.0, 
        "No. of Deaths - N | Treatment": 184.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Original", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "28578639", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "No", 
        "Reporting by prognostic groups - Y/N | Low volume": "No", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "FFS", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1917, 
        "Treatment Arm - N": 960, 
        "Treatment Arm 1 Regimen": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
        "Treatment_Arms": "AAP+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "STAMPEDE", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2017", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": null, 
        " Gleason score - N (%) | \u2264 7 | Treatment": null, 
        " Gleason score - N (%) | \u2265 8 | Control": null, 
        " Gleason score - N (%) | \u2265 8 | Treatment": null, 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": null, 
        " Mode of metastases - N (%) | Metachronous | Treatment": null, 
        " Mode of metastases - N (%) | Synchronous | Control": null, 
        " Mode of metastases - N (%) | Synchronous | Treatment": null, 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": null, 
        " Region - N (%) | Africa | Treatment": null, 
        " Region - N (%) | Asia | Control": null, 
        " Region - N (%) | Asia | Treatment": null, 
        " Region - N (%) | Europe | Control": null, 
        " Region - N (%) | Europe | Treatment": null, 
        " Region - N (%) | North America | Control": null, 
        " Region - N (%) | North America | Treatment": null, 
        " Region - N (%) | Oceania | Control": null, 
        " Region - N (%) | Oceania | Treatment": null, 
        " Region - N (%) | South America | Control": null, 
        " Region - N (%) | South America | Treatment": null, 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Abiraterone acetate", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Chi, Kim N. et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 602.0, 
        "Docetaxel administration - N (%) | Control": null, 
        "Docetaxel administration - N (%) | Treatment": null, 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "no", 
        "Median Age (years) | Control": null, 
        "Median Age (years) | Treatment": null, 
        "Median Follow-Up Duration (mo)": "~30", 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT01715285", 
        "No. of Deaths - N | Control": null, 
        "No. of Deaths - N | Treatment": null, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "29326030", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS, rPFS", 
        "Quality of Life Scale": "FACT-P, EORTC QLQ-C 30, BPI-SF, BFI", 
        "Quality of Life reported": "Yes", 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": null, 
        "Reporting by prognostic groups - Y/N | Low volume": null, 
        "Reporting by prognostic groups - Y/N | Metachronous": null, 
        "Reporting by prognostic groups - Y/N | Synchronous": null, 
        "Secondary Endpoint(s)": null, 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1199, 
        "Treatment Arm - N": 597, 
        "Treatment Arm 1 Regimen": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
        "Treatment_Arms": "AAP+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "LATITUDE", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2018", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": "104 (26)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "117 (30)", 
        " Gleason score - N (%) | \u2265 8 | Control": "243 (61.8)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "241 (60.7)", 
        " Median OS (mo) | High volume | Control": 34.4, 
        " Median OS (mo) | High volume | Treatment": 51.2, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": 63.5, 
        " Median OS (mo) | Overall | Control": 47.2, 
        " Median OS (mo) | Overall | Treatment": 57.6, 
        " Median PFS (mo) | High volume | Control": 13.0, 
        " Median PFS (mo) | High volume | Treatment": 27.3, 
        " Median PFS (mo) | Low volume | Control": 44.3, 
        " Median PFS (mo) | Low volume | Treatment": 42.5, 
        " Median PFS (mo) | Overall | Control": 19.8, 
        " Median PFS (mo) | Overall | Treatment": 30.3, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": "106 (27.0)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "108 (27.2)", 
        " Mode of metastases - N (%) | Synchronous | Control": "286 (72.8)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "289 (72.8)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": 35.2, 
        " OS Rate (%) | High volume | Treatment": 47.9, 
        " OS Rate (%) | Low volume | Control": 65.7, 
        " OS Rate (%) | Low volume | Treatment": 61.9, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "272 (69.2)", 
        " PS - N (%) | 0 | Treatment": "277 (69.8)", 
        " PS - N (%) | 1-2 | Control": "121 (30.8)", 
        " PS - N (%) | 1-2 | Treatment": "120 (30.2)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "0 (0)", 
        " Region - N (%) | Europe | Treatment": "0 (0)", 
        " Region - N (%) | North America | Control": "393 (100)", 
        " Region - N (%) | North America | Treatment": "397 (100)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": "250 (63.6)", 
        " Volume of disease - N (%) | High | Treatment": "263 (66.2)", 
        " Volume of disease - N (%) | Low | Control": "143 (36.4)", 
        " Volume of disease - N (%) | Low | Treatment": "134 (33.8)", 
        "Add-on Treatment": "Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Kyriakopoulos et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "Chemotherapy", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 393.0, 
        "Docetaxel administration - N (%) | Control": "0 (0)", 
        "Docetaxel administration - N (%) | Treatment": "397 (100)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 63.0, 
        "Median Age (years) | Treatment": 64, 
        "Median Follow-Up Duration (mo)": 53.7, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00309985", 
        "No. of Deaths - N | Control": 211.0, 
        "No. of Deaths - N | Treatment": 188.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "29384722", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to CRPC", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 790, 
        "Treatment Arm - N": 397, 
        "Treatment Arm 1 Regimen": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
        "Treatment_Arms": "D+ADT", 
        "Treatment Class": "Chemotherapy", 
        "Trial_Name": "CHAARTED", 
        "Type of Therapy": "Chemo-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2018", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": null, 
        " Gleason score - N (%) | \u2264 7 | Treatment": null, 
        " Gleason score - N (%) | \u2265 8 | Control": null, 
        " Gleason score - N (%) | \u2265 8 | Treatment": null, 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": null, 
        " Mode of metastases - N (%) | Metachronous | Treatment": null, 
        " Mode of metastases - N (%) | Synchronous | Control": null, 
        " Mode of metastases - N (%) | Synchronous | Treatment": null, 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "272 (69.2)", 
        " PS - N (%) | 0 | Treatment": "277 (69.8)", 
        " PS - N (%) | 1-2 | Control": "120 (30.6)", 
        " PS - N (%) | 1-2 | Treatment": "120 (30.2)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": "73 (18.6)", 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": "81 (20.4)", 
        " Previous local therapy - N (%) | Radiotherapy | Control": "33 (8.4)", 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": "27 (6.8)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "0 (0)", 
        " Region - N (%) | Europe | Treatment": "0 (0)", 
        " Region - N (%) | North America | Control": "393 (100)", 
        " Region - N (%) | North America | Treatment": "397 (100)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": "249 (63.5)", 
        " Volume of disease - N (%) | High | Treatment": "263 (66.2)", 
        " Volume of disease - N (%) | Low | Control": "143 (36.5)", 
        " Volume of disease - N (%) | Low | Treatment": "134 (33.8)", 
        "Add-on Treatment": "Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Morgans, Alicia K. et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "Chemotherapy", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 393.0, 
        "Docetaxel administration - N (%) | Control": "0 (0)", 
        "Docetaxel administration - N (%) | Treatment": "397 (100)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "no", 
        "Median Age (years) | Control": 63.0, 
        "Median Age (years) | Treatment": 64, 
        "Median Follow-Up Duration (mo)": null, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00309985", 
        "No. of Deaths - N | Control": null, 
        "No. of Deaths - N | Treatment": null, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "29522362", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "FACT-P", 
        "Quality of Life Scale": "FACT-P, FACT-Taxane, FACIT-Fatigue", 
        "Quality of Life reported": "Yes", 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": null, 
        "Reporting by prognostic groups - Y/N | Low volume": null, 
        "Reporting by prognostic groups - Y/N | Metachronous": null, 
        "Reporting by prognostic groups - Y/N | Synchronous": null, 
        "Secondary Endpoint(s)": null, 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 790, 
        "Treatment Arm - N": 397, 
        "Treatment Arm 1 Regimen": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
        "Treatment_Arms": "D+ADT", 
        "Treatment Class": "Chemotherapy", 
        "Trial_Name": "CHAARTED", 
        "Type of Therapy": "Chemo-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2018", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": "86 (50)", 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": "180 (48)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": "35 (19)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "91 (25)", 
        " Gleason score - N (%) | \u2265 8 | Control": "153 (81)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "276 (75)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": "74 (39)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "150 (40)", 
        " Mode of metastases - N (%) | Synchronous | Control": "115 (61)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "227 (60)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": "91.9 at 4 y", 
        " OS Rate (%) | Metachronous | Treatment": "89.3 at 4 y", 
        " OS Rate (%) | Overall | Control": "76.7 at 4 y", 
        " OS Rate (%) | Overall | Treatment": "72 at 4 y", 
        " OS Rate (%) | Synchronous | Control": "67.0 at 4 y", 
        " OS Rate (%) | Synchronous | Treatment": "60.8 at 4 y", 
        " PFS Rate (%) | Overall | Control": "61.9 at 4 y", 
        " PFS Rate (%) | Overall | Treatment": "72.6 at 4 y", 
        " PS - N (%) | 0 | Control": "149 (79)", 
        " PS - N (%) | 0 | Treatment": "300 (80)", 
        " PS - N (%) | 1-2 | Control": "40 (21)", 
        " PS - N (%) | 1-2 | Treatment": "77 (20)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "189 (100)", 
        " Region - N (%) | Europe | Treatment": "377 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "M R Sydes et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "D+ADT", 
        "Control_Arm - N": 189.0, 
        "Docetaxel administration - N (%) | Control": "189 (100)", 
        "Docetaxel administration - N (%) | Treatment": "0 (0)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 65.0, 
        "Median Age (years) | Treatment": 65, 
        "Median Follow-Up Duration (mo)": 48, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 78.2, 
        "Median On-Treatment Duration (mo) | Treatment": 78.2, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00268476", 
        "No. of Deaths - N | Control": 44.0, 
        "No. of Deaths - N | Treatment": 105.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "29529169", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "No", 
        "Reporting by prognostic groups - Y/N | Low volume": "No", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "FFS", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 566, 
        "Treatment Arm - N": 377, 
        "Treatment Arm 1 Regimen": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
        "Treatment_Arms": "AAP+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "STAMPEDE", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2018", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": "309 (51)", 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": "411 (69)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": "11(2)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": "24(4)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "3 (<1)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "3 (0.5)", 
        " Gleason score - N (%) | \u2264 7 | Control": "16 (3)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "13 (3)", 
        " Gleason score - N (%) | \u2265 8 | Control": "586 (97)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "584 (98)", 
        " Median OS (mo) | High volume | Control": 33.3, 
        " Median OS (mo) | High volume | Treatment": 49.7, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 36.5, 
        " Median OS (mo) | Overall | Treatment": 53.3, 
        " Median PFS (mo) | High volume | Control": 14.7, 
        " Median PFS (mo) | High volume | Treatment": 33.1, 
        " Median PFS (mo) | Low volume | Control": 22.4, 
        " Median PFS (mo) | Low volume | Treatment": 49.8, 
        " Median PFS (mo) | Overall | Control": 30.1, 
        " Median PFS (mo) | Overall | Treatment": 53.3, 
        " Metastases - N (%) | Bone | Control": "585 (98)", 
        " Metastases - N (%) | Bone | Treatment": "580 (97)", 
        " Metastases - N (%) | Liver | Control": "30 (5)", 
        " Metastases - N (%) | Liver | Treatment": "32 (5)", 
        " Metastases - N (%) | Lungs | Control": "72 (12)", 
        " Metastases - N (%) | Lungs | Treatment": "73 (12)", 
        " Metastases - N (%) | Nodal | Control": "287 (48)", 
        " Metastases - N (%) | Nodal | Treatment": "283 (47)", 
        " Mode of metastases - N (%) | Metachronous | Control": "0 (0)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "0 (0)", 
        " Mode of metastases - N (%) | Synchronous | Control": "602 (100)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "597 (100)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": "38.2  at 4.3 y", 
        " OS Rate (%) | High volume | Treatment": "50.5 at 4.3 y", 
        " OS Rate (%) | Low volume | Control": "59.4 at 4.3 y", 
        " OS Rate (%) | Low volume | Treatment": "69.1 at 4.3 y", 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": "43.0 at 4.3 y", 
        " OS Rate (%) | Synchronous | Treatment": "53.9 at 4.3 y", 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": "71 (12)", 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": "73 (12)", 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": "26 (4)", 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": "19 (3)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": null, 
        " Region - N (%) | Africa | Treatment": null, 
        " Region - N (%) | Asia | Control": null, 
        " Region - N (%) | Asia | Treatment": null, 
        " Region - N (%) | Europe | Control": null, 
        " Region - N (%) | Europe | Treatment": null, 
        " Region - N (%) | North America | Control": null, 
        " Region - N (%) | North America | Treatment": null, 
        " Region - N (%) | Oceania | Control": null, 
        " Region - N (%) | Oceania | Treatment": null, 
        " Region - N (%) | South America | Control": null, 
        " Region - N (%) | South America | Treatment": null, 
        " Volume of disease - N (%) | High | Control": "468 (77.7)", 
        " Volume of disease - N (%) | High | Treatment": "487 (81.6)", 
        " Volume of disease - N (%) | Low | Control": "133 (22.1)", 
        " Volume of disease - N (%) | Low | Treatment": "110 (18.4)", 
        "Add-on Treatment": "Abiraterone acetate", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Fizazi, Karim et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 602.0, 
        "Docetaxel administration - N (%) | Control": "212 (35)", 
        "Docetaxel administration - N (%) | Treatment": "144 (24)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 66.8, 
        "Median Age (years) | Treatment": 67.3, 
        "Median Follow-Up Duration (mo)": 51.8, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 14.4, 
        "Median On-Treatment Duration (mo) | Treatment": 25.8, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT01715285", 
        "No. of Deaths - N | Control": 343.0, 
        "No. of Deaths - N | Treatment": 275.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "30987939", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS, rPFS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to pain progression; Time to initiation of chemotherapy; Subsequent therapy for prostate cancer;  PSA progression; Symptomatic skeletal-related events", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1199, 
        "Treatment Arm - N": 597, 
        "Treatment Arm 1 Regimen": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
        "Treatment_Arms": "AAP+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "LATITUDE", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2019", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": "215 (40.8)", 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": "221 (42.2)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "16 (3.0)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "10 (1.9)", 
        " Gleason score - N (%) | \u2264 7 | Control": "169 (32)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "174 (33.1)", 
        " Gleason score - N (%) | \u2265 8 | Control": "358 (67.9)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "351 (66.9)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 52.2, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": 14.9, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": 30.5, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 22.1, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": "59 (11.2)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "85 (16.2)", 
        " Mode of metastases - N (%) | Synchronous | Control": "441 (83.7)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "411 (78.3)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": "71.0 at 1.9 y", 
        " OS Rate (%) | High volume | Treatment": "78.8 at 1.9 y", 
        " OS Rate (%) | Low volume | Control": "89.6 at 1.9 y", 
        " OS Rate (%) | Low volume | Treatment": "93.0 at 1.9 y", 
        " OS Rate (%) | Metachronous | Control": "81.4 at 1.9 y", 
        " OS Rate (%) | Metachronous | Treatment": "91.8 at 1.9 y", 
        " OS Rate (%) | Overall | Control": "73.5 at 2 y", 
        " OS Rate (%) | Overall | Treatment": "82.4 at 2 y", 
        " OS Rate (%) | Synchronous | Control": "77.1 at 1.9 y", 
        " OS Rate (%) | Synchronous | Treatment": "82.7 at 1.9 y", 
        " PFS Rate (%) | Overall | Control": "47.5 at 2 y", 
        " PFS Rate (%) | Overall | Treatment": "68.2 at 2 y", 
        " PS - N (%) | 0 | Control": "348 (66)", 
        " PS - N (%) | 0 | Treatment": "328 (62.5)", 
        " PS - N (%) | 1-2 | Control": "179 (34.0)", 
        " PS - N (%) | 1-2 | Treatment": "197 (37.5)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": "40 (7.6)", 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": "33 (6.3)", 
        " Previous local therapy - N (%) | Prostatectomy | Control": "40 (7.6)", 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": "47 (9)", 
        " Previous local therapy - N (%) | Radiotherapy | Control": "52 (9.9)", 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": "68 (13)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": null, 
        " Region - N (%) | Africa | Treatment": null, 
        " Region - N (%) | Asia | Control": null, 
        " Region - N (%) | Asia | Treatment": null, 
        " Region - N (%) | Europe | Control": "~87 (16.5)", 
        " Region - N (%) | Europe | Treatment": "~87 (16.6)", 
        " Region - N (%) | North America | Control": "~87 (16.5)", 
        " Region - N (%) | North America | Treatment": "~87 (16.6)", 
        " Region - N (%) | Oceania | Control": null, 
        " Region - N (%) | Oceania | Treatment": null, 
        " Region - N (%) | South America | Control": null, 
        " Region - N (%) | South America | Treatment": null, 
        " Volume of disease - N (%) | High | Control": "335 (63.6)", 
        " Volume of disease - N (%) | High | Treatment": "325 (61.9)", 
        " Volume of disease - N (%) | Low | Control": "192 (36.4)", 
        " Volume of disease - N (%) | Low | Treatment": "200 (38.1)", 
        "Add-on Treatment": "Apalutamide", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Chi, Kim N. et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 527.0, 
        "Docetaxel administration - N (%) | Control": "55 (10.4)", 
        "Docetaxel administration - N (%) | Treatment": "58 (11)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 68.0, 
        "Median Age (years) | Treatment": 69, 
        "Median Follow-Up Duration (mo)": 22.7, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 18.3, 
        "Median On-Treatment Duration (mo) | Treatment": 20.5, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02489318", 
        "No. of Deaths - N | Control": 117.0, 
        "No. of Deaths - N | Treatment": 83.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Original", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "31150574", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS, rPFS", 
        "Quality of Life Scale": "FACT-P", 
        "Quality of Life reported": "Yes", 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to cytotoxic chemotherapy; Time to pain progression", 
        "TTPSA (mo) | Control": 12.9, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1052, 
        "Treatment Arm - N": 525, 
        "Treatment Arm 1 Regimen": "Apalutamide 240 OD; standard androgen deprivation", 
        "Treatment_Arms": "APA+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "TITAN", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2019", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": "241 (43)", 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": "321 (57)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "7 (1)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "6 (1)", 
        " Gleason score - N (%) | \u2264 7 | Control": "164 (29.2)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "152 (27)", 
        " Gleason score - N (%) | \u2265 8 | Control": "320 (57)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "335 (59.5)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": "11 (2)", 
        " Metastases - N (%) | Liver | Treatment": "13 (2.3)", 
        " Metastases - N (%) | Lungs | Control": "48 (8.5)", 
        " Metastases - N (%) | Lungs | Treatment": "55 (9.8)", 
        " Metastases - N (%) | Nodal | Control": "259 (46.1)", 
        " Metastases - N (%) | Nodal | Treatment": "268 (47.6)", 
        " Mode of metastases - N (%) | Metachronous | Control": "235 (41.8)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "238 (42.3)", 
        " Mode of metastases - N (%) | Synchronous | Control": "327 (58.2)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "325 (57.7)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": "67.3 at 2.8 y", 
        " OS Rate (%) | High volume | Treatment": "72.5 at 2.8 y", 
        " OS Rate (%) | Low volume | Control": "82.6 at 2.8 y", 
        " OS Rate (%) | Low volume | Treatment": "91.9 at 2.8 y", 
        " OS Rate (%) | Metachronous | Control": "79.1 at 2.8 y", 
        " OS Rate (%) | Metachronous | Treatment": "83.6 at 2.8 y", 
        " OS Rate (%) | Overall | Control": "72 at 3 y", 
        " OS Rate (%) | Overall | Treatment": "80 at 3 y", 
        " OS Rate (%) | Synchronous | Control": "71.3 at 2.8 y", 
        " OS Rate (%) | Synchronous | Treatment": "80.6 at 2.8 y", 
        " PFS Rate (%) | Overall | Control": "41 at 3 y", 
        " PFS Rate (%) | Overall | Treatment": "68 at 3 y", 
        " PS - N (%) | 0 | Control": "405 (72.1)", 
        " PS - N (%) | 0 | Treatment": "405 (71.9)", 
        " PS - N (%) | 1-2 | Control": "157 (28)", 
        " PS - N (%) | 1-2 | Treatment": "158 (28)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": "8 (1)", 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": "5 (1)", 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "93 (16.5)", 
        " Region - N (%) | Europe | Treatment": "102 (18.1)", 
        " Region - N (%) | North America | Control": "129 (22.9)", 
        " Region - N (%) | North America | Treatment": "117 (20.8)", 
        " Region - N (%) | Oceania | Control": "340 (60.5)", 
        " Region - N (%) | Oceania | Treatment": "344 (61.1)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": "297 (53)", 
        " Volume of disease - N (%) | High | Treatment": "291 (52)", 
        " Volume of disease - N (%) | Low | Control": "265 (47)", 
        " Volume of disease - N (%) | Low | Treatment": "272 (48)", 
        "Add-on Treatment": "Enzalutamide", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Davis, Ian D. et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "NSAA+ADT", 
        "Control_Arm - N": 562.0, 
        "Docetaxel administration - N (%) | Control": "249 (44)", 
        "Docetaxel administration - N (%) | Treatment": "254 (45)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 68.8, 
        "Median Age (years) | Treatment": 68.9, 
        "Median Follow-Up Duration (mo)": 34, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02446405", 
        "No. of Deaths - N | Control": 143.0, 
        "No. of Deaths - N | Treatment": 102.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Original", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "31157964", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to PSA progression; rPFS", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1125, 
        "Treatment Arm - N": 563, 
        "Treatment Arm 1 Regimen": "Enzalutamide 160mg OD; Standard androgen deprivation", 
        "Treatment_Arms": "E+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "ENZAMET", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2019", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": "147 (25.6)", 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": "139 (24.3)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "10 (1.7)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "14 (2.4)", 
        " Gleason score - N (%) | \u2264 7 | Control": "187 (32.5)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "171 (29.8)", 
        " Gleason score - N (%) | \u2265 8 | Control": "373 (64.8)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "386 (67.2)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 19.0, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": "486 (84.4)", 
        " Metastases - N (%) | Bone | Treatment": "485 (84.5)", 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": "86 (14.9)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "83 (14.5)", 
        " Mode of metastases - N (%) | Synchronous | Control": "365 (63.4)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "402 (70)", 
        " ORR - N (%) | Control | CR": "42 (23.1)", 
        " ORR - N (%) | Control | Overall": "116 (63.6)", 
        " ORR - N (%) | Control | PD": "9 (4.9)", 
        " ORR - N (%) | Control | SD": "43 (23.6)", 
        " ORR - N (%) | Treatment | CR": "65 (36.7)", 
        " ORR - N (%) | Treatment | Overall": "147 (83.1)", 
        " ORR - N (%) | Treatment | PD": "7 (4.0)", 
        " ORR - N (%) | Treatment | SD": "17 (9.6)", 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "443 (76.9)", 
        " PS - N (%) | 0 | Treatment": "448 (78)", 
        " PS - N (%) | 1-2 | Control": "133 (23.1)", 
        " PS - N (%) | 1-2 | Treatment": "125 (21.8)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": "89 (15.5)", 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": "72 (12.5)", 
        " Previous local therapy - N (%) | Radiotherapy | Control": "72 (12.5)", 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": "73 (12.7)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": "0 (0)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": "0 (0)", 
        " Race - N (%) | Asian | Control": "80 (13.9)", 
        " Race - N (%) | Asian | Treatment": "75 (13.1)", 
        " Race - N (%) | Black or African American | Control": "8 (1.4)", 
        " Race - N (%) | Black or African American | Treatment": "8 (1.4)", 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": "0 (0)", 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": "0 (0)", 
        " Race - N (%) | Other | Control": "4 (0.5)", 
        " Race - N (%) | Other | Treatment": "3 (0.3)", 
        " Race - N (%) | Unknown | Control": "26 (4.3)", 
        " Race - N (%) | Unknown | Treatment": "24 (4.0)", 
        " Race - N (%) | White | Control": "461 (79.9)", 
        " Race - N (%) | White | Treatment": "467 (81.2)", 
        " Region - N (%) | Africa | Control": "12 (2.1)", 
        " Region - N (%) | Africa | Treatment": "11 (1.9)", 
        " Region - N (%) | Asia | Control": "~57 (9.9)", 
        " Region - N (%) | Asia | Treatment": "~52 (9.1)", 
        " Region - N (%) | Europe | Control": "344 (59.7)", 
        " Region - N (%) | Europe | Treatment": "341 (59.4)", 
        " Region - N (%) | North America | Control": "77 (13.4)", 
        " Region - N (%) | North America | Treatment": "86 (15.0)", 
        " Region - N (%) | Oceania | Control": "~57 (9.9)", 
        " Region - N (%) | Oceania | Treatment": "~52 (9.1)", 
        " Region - N (%) | South America | Control": "30 (5.2)", 
        " Region - N (%) | South America | Treatment": "32 (5.6)", 
        " Volume of disease - N (%) | High | Control": "373 (64.8)", 
        " Volume of disease - N (%) | High | Treatment": "354 (61.7)", 
        " Volume of disease - N (%) | Low | Control": "203 (35.2)", 
        " Volume of disease - N (%) | Low | Treatment": "220 (38.3)", 
        "Add-on Treatment": "Enzalutamide", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Andrew J Armstrong et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 576.0, 
        "Docetaxel administration - N (%) | Control": "102 (17.7)", 
        "Docetaxel administration - N (%) | Treatment": "103 (17.9)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 70.0, 
        "Median Age (years) | Treatment": 70, 
        "Median Follow-Up Duration (mo)": 14.4, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 11.6, 
        "Median On-Treatment Duration (mo) | Treatment": 12.8, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02677896", 
        "No. of Deaths - N | Control": 45.0, 
        "No. of Deaths - N | Treatment": 39.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Original", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "31329516", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "rPFS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to PSA progression; PSA response; Radiographic response; OS", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1150, 
        "Treatment Arm - N": 574, 
        "Treatment Arm 1 Regimen": "Enzalutamide 160mg OD; Standard androgen deprivation", 
        "Treatment_Arms": "E+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "ARCHES", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2019", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": "110 (24)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "104 (23)", 
        " Gleason score - N (%) | \u2265 8 | Control": "342 (75)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "345 (76)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": "294 (65)", 
        " Metastases - N (%) | Bone | Treatment": "296 (66.8)", 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": "47 (10.5)", 
        " Metastases - N (%) | Nodal | Treatment": "55 (12)", 
        " Mode of metastases - N (%) | Metachronous | Control": null, 
        " Mode of metastases - N (%) | Metachronous | Treatment": null, 
        " Mode of metastases - N (%) | Synchronous | Control": null, 
        " Mode of metastases - N (%) | Synchronous | Treatment": null, 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": "44.5 at 3.5 y", 
        " OS Rate (%) | High volume | Treatment": "60.5 at 3.5 y", 
        " OS Rate (%) | Low volume | Control": "73.0 at 3.5 y", 
        " OS Rate (%) | Low volume | Treatment": "81.1 at 3.5 y", 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": "55.5 at 3.5 y", 
        " OS Rate (%) | Synchronous | Treatment": "69.6 at 3.5 y", 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "337 (74)", 
        " PS - N (%) | 0 | Treatment": "335 (74)", 
        " PS - N (%) | 1-2 | Control": "115 (25)", 
        " PS - N (%) | 1-2 | Treatment": "114 (25)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "452 (100)", 
        " Region - N (%) | Europe | Treatment": "414 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": "243 (54.1)", 
        " Volume of disease - N (%) | High | Treatment": "256 (56.6)", 
        " Volume of disease - N (%) | Low | Control": "206 (45.9)", 
        " Volume of disease - N (%) | Low | Treatment": "196 (43.3)", 
        "Add-on Treatment": "Abiraterone acetate", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Alex P Hoyle et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 452.0, 
        "Docetaxel administration - N (%) | Control": "0 (0)", 
        "Docetaxel administration - N (%) | Treatment": "593 (100)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 67.0, 
        "Median Age (years) | Treatment": 66, 
        "Median Follow-Up Duration (mo)": 42, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00268476", 
        "No. of Deaths - N | Control": 195.0, 
        "No. of Deaths - N | Treatment": 135.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "31447077", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "No", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "FFS", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 901, 
        "Treatment Arm - N": 414, 
        "Treatment Arm 1 Regimen": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
        "Treatment_Arms": "AAP+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "STAMPEDE", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2019", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": "158 (22)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "65 (18)", 
        " Gleason score - N (%) | \u2265 8 | Control": "480 (66)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "253 (70)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": 76.7, 
        " Median OS (mo) | Low volume | Treatment": 93.2, 
        " Median OS (mo) | Overall | Control": 43.1, 
        " Median OS (mo) | Overall | Treatment": 59.1, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": "634 (88)", 
        " Metastases - N (%) | Bone | Treatment": "307 (85)", 
        " Metastases - N (%) | Liver | Control": "15 (2)", 
        " Metastases - N (%) | Liver | Treatment": "6 (2)", 
        " Metastases - N (%) | Lungs | Control": "33 (5)", 
        " Metastases - N (%) | Lungs | Treatment": "13 (4)", 
        " Metastases - N (%) | Nodal | Control": "221 (31)", 
        " Metastases - N (%) | Nodal | Treatment": "102 (28)", 
        " Mode of metastases - N (%) | Metachronous | Control": "54 (5)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "17 (5)", 
        " Mode of metastases - N (%) | Synchronous | Control": "688 (95)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "345 (95)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": "24.1  at 5 y", 
        " OS Rate (%) | High volume | Treatment": "33.8 at 5 y", 
        " OS Rate (%) | Low volume | Control": "57.1 at 5 y", 
        " OS Rate (%) | Low volume | Treatment": "71.8  at 5 y", 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": "37 at 5 y", 
        " OS Rate (%) | Overall | Treatment": "49 at 5 y", 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": "25 at 5 y", 
        " PFS Rate (%) | Overall | Treatment": "37 at 5 y", 
        " PS - N (%) | 0 | Control": "521 (72)", 
        " PS - N (%) | 0 | Treatment": "270 (75)", 
        " PS - N (%) | 1-2 | Control": "203 (28)", 
        " PS - N (%) | 1-2 | Treatment": "92 (25)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "724 (100)", 
        " Region - N (%) | Europe | Treatment": "362 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": "320 (44)", 
        " Volume of disease - N (%) | High | Treatment": "148 (41)", 
        " Volume of disease - N (%) | Low | Control": "238 (34)", 
        " Volume of disease - N (%) | Low | Treatment": "124 (34)", 
        "Add-on Treatment": "Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Clarke, N. W. et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "Chemotherapy", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 724.0, 
        "Docetaxel administration - N (%) | Control": "0(0)", 
        "Docetaxel administration - N (%) | Treatment": "362 (100)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 65.0, 
        "Median Age (years) | Treatment": 65, 
        "Median Follow-Up Duration (mo)": 78.2, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00268476", 
        "No. of Deaths - N | Control": 494.0, 
        "No. of Deaths - N | Treatment": 225.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "31560068", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "FFS, PFS, mPFS, PCSS", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1086, 
        "Treatment Arm - N": 362, 
        "Treatment Arm 1 Regimen": "Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
        "Treatment_Arms": "D+ADT", 
        "Treatment Class": "Chemotherapy", 
        "Trial_Name": "STAMPEDE", 
        "Type of Therapy": "Chemo-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2019", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": "500 (94.9)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "174 (33.1)", 
        " Gleason score - N (%) | \u2265 8 | Control": "358 (67.9)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "351 (66.9)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": null, 
        " Mode of metastases - N (%) | Metachronous | Treatment": null, 
        " Mode of metastases - N (%) | Synchronous | Control": null, 
        " Mode of metastases - N (%) | Synchronous | Treatment": null, 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "348 (66)", 
        " PS - N (%) | 0 | Treatment": "328 (62.5)", 
        " PS - N (%) | 1-2 | Control": "179 (34.0)", 
        " PS - N (%) | 1-2 | Treatment": "197 (37.5)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": "13 (2.5)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": "6 (1.1)", 
        " Race - N (%) | Asian | Control": "110 (20.9)", 
        " Race - N (%) | Asian | Treatment": "119 (22.7)", 
        " Race - N (%) | Black or African American | Control": "9 (1.7)", 
        " Race - N (%) | Black or African American | Treatment": "10 (1.9)", 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": "22 (4.2)", 
        " Race - N (%) | Other | Treatment": "24 (4.6)", 
        " Race - N (%) | Unknown | Control": "8 (1.5)", 
        " Race - N (%) | Unknown | Treatment": "11 (2.1)", 
        " Race - N (%) | White | Control": "365 (69.3)", 
        " Race - N (%) | White | Treatment": "354 (67.4)", 
        " Region - N (%) | Africa | Control": null, 
        " Region - N (%) | Africa | Treatment": null, 
        " Region - N (%) | Asia | Control": null, 
        " Region - N (%) | Asia | Treatment": null, 
        " Region - N (%) | Europe | Control": null, 
        " Region - N (%) | Europe | Treatment": null, 
        " Region - N (%) | North America | Control": null, 
        " Region - N (%) | North America | Treatment": null, 
        " Region - N (%) | Oceania | Control": null, 
        " Region - N (%) | Oceania | Treatment": null, 
        " Region - N (%) | South America | Control": null, 
        " Region - N (%) | South America | Treatment": null, 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Apalutamide", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Agarwal, Neeraj et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": null, 
        "Docetaxel administration - N (%) | Control": null, 
        "Docetaxel administration - N (%) | Treatment": null, 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "no", 
        "Median Age (years) | Control": null, 
        "Median Age (years) | Treatment": null, 
        "Median Follow-Up Duration (mo)": "~20", 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02489318", 
        "No. of Deaths - N | Control": null, 
        "No. of Deaths - N | Treatment": null, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "31578173", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": null, 
        "Quality of Life Scale": "FACT-P, EQ-5D-5L, BPI-SF, BFI", 
        "Quality of Life reported": "Yes", 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": null, 
        "Reporting by prognostic groups - Y/N | Low volume": null, 
        "Reporting by prognostic groups - Y/N | Metachronous": null, 
        "Reporting by prognostic groups - Y/N | Synchronous": null, 
        "Secondary Endpoint(s)": null, 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1052, 
        "Treatment Arm - N": 525, 
        "Treatment Arm 1 Regimen": "Apalutamide 240 OD; standard androgen deprivation", 
        "Treatment_Arms": "APA+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "TITAN", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2019", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": null, 
        " Gleason score - N (%) | \u2264 7 | Treatment": null, 
        " Gleason score - N (%) | \u2265 8 | Control": null, 
        " Gleason score - N (%) | \u2265 8 | Treatment": null, 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": null, 
        " Mode of metastases - N (%) | Metachronous | Treatment": null, 
        " Mode of metastases - N (%) | Synchronous | Control": null, 
        " Mode of metastases - N (%) | Synchronous | Treatment": null, 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": null, 
        " Region - N (%) | Africa | Treatment": null, 
        " Region - N (%) | Asia | Control": null, 
        " Region - N (%) | Asia | Treatment": null, 
        " Region - N (%) | Europe | Control": null, 
        " Region - N (%) | Europe | Treatment": null, 
        " Region - N (%) | North America | Control": null, 
        " Region - N (%) | North America | Treatment": null, 
        " Region - N (%) | Oceania | Control": null, 
        " Region - N (%) | Oceania | Treatment": null, 
        " Region - N (%) | South America | Control": null, 
        " Region - N (%) | South America | Treatment": null, 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Enzalutamide", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Stenzl A et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 576.0, 
        "Docetaxel administration - N (%) | Control": null, 
        "Docetaxel administration - N (%) | Treatment": null, 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "no", 
        "Median Age (years) | Control": null, 
        "Median Age (years) | Treatment": null, 
        "Median Follow-Up Duration (mo)": null, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02677896", 
        "No. of Deaths - N | Control": null, 
        "No. of Deaths - N | Treatment": null, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "32336645", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": null, 
        "Quality of Life Scale": "FACT-P, EQ-5D-5 L, BPI-SF, QLQ-PR25", 
        "Quality of Life reported": "Yes", 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": null, 
        "Reporting by prognostic groups - Y/N | Low volume": null, 
        "Reporting by prognostic groups - Y/N | Metachronous": null, 
        "Reporting by prognostic groups - Y/N | Synchronous": null, 
        "Secondary Endpoint(s)": null, 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1150, 
        "Treatment Arm - N": 574, 
        "Treatment Arm 1 Regimen": "Enzalutamide 160mg OD; Standard androgen deprivation", 
        "Treatment_Arms": "E+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "ARCHES", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2020", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": "82 (24)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "Rx1: 32 (18); Rx2: 83 (24)", 
        " Gleason score - N (%) | \u2265 8 | Control": "253 (74)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "Rx1: 140 (81); Rx2: 252 (74)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": "190 (55)", 
        " Metastases - N (%) | Bone | Treatment": "Rx1: 87 (50);Rx2: 177 (52)", 
        " Metastases - N (%) | Liver | Control": "2 (1)", 
        " Metastases - N (%) | Liver | Treatment": "Rx1: 0 (0);Rx2: 4 (1)", 
        " Metastases - N (%) | Lungs | Control": "11 (3)", 
        " Metastases - N (%) | Lungs | Treatment": "Rx1: 4 (2);Rx2: 11 (3)", 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": null, 
        " Mode of metastases - N (%) | Metachronous | Treatment": null, 
        " Mode of metastases - N (%) | Synchronous | Control": null, 
        " Mode of metastases - N (%) | Synchronous | Treatment": null, 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "273 (80)", 
        " PS - N (%) | 0 | Treatment": "Rx1: 137 (79); Rx2: 277(81)", 
        " PS - N (%) | 1-2 | Control": "70 (20)", 
        " PS - N (%) | 1-2 | Treatment": "Rx1: 36 (21); Rx2: 65(19)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "343 (100)", 
        " Region - N (%) | Europe | Treatment": "Rx1: 173 (100); Rx2: 342 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Hannah L Rush et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "Chemotherapy", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 343.0, 
        "Docetaxel administration - N (%) | Control": "0 (0)", 
        "Docetaxel administration - N (%) | Treatment": "Rx1: 173 (100); Rx2: 0(0)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "no", 
        "Median Age (years) | Control": 66.0, 
        "Median Age (years) | Treatment": "Rx: 66; Rx2:66", 
        "Median Follow-Up Duration (mo)": null, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": "Rx: NA; Rx2:23.2", 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00268476", 
        "No. of Deaths - N | Control": null, 
        "No. of Deaths - N | Treatment": null, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "34757812", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "Difference in global-QLQ-C30 Q29 scores", 
        "Quality of Life Scale": "EORTC QLQ-C 30, PR25", 
        "Quality of Life reported": "Yes", 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": null, 
        "Reporting by prognostic groups - Y/N | Low volume": null, 
        "Reporting by prognostic groups - Y/N | Metachronous": null, 
        "Reporting by prognostic groups - Y/N | Synchronous": null, 
        "Secondary Endpoint(s)": null, 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 858, 
        "Treatment Arm - N": "Rx1: 173; Rx2: 342", 
        "Treatment Arm 1 Regimen": "Rx1: Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation; Rx2:Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
        "Treatment_Arms": "Rx1: D+ADT; Rx2:AAP+ADT", 
        "Treatment Class": "Chemotherapy", 
        "Trial_Name": "STAMPEDE", 
        "Type of Therapy": "Chemo-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2021", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": "439 (67.5)", 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": "458 (70.2)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "27 (4.0)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "28 (4.1)", 
        " Gleason score - N (%) | \u2264 7 | Control": "138 (21.1)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "110 (22.4)", 
        " Gleason score - N (%) | \u2265 8 | Control": "516 (78.9)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "505 (77.6)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 42.4, 
        " Median OS (mo) | Overall | Treatment": 43.7, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 49.9, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": "82 (12.5)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "86 (13.2)", 
        " Mode of metastases - N (%) | Synchronous | Control": "566 (86.5)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "558 (85.7)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": "63.4 at 4 y", 
        " OS Rate (%) | Metachronous | Treatment": "74.4 at 4 y", 
        " OS Rate (%) | Overall | Control": "50.4 at 4 y", 
        " OS Rate (%) | Overall | Treatment": "62.7 at 4 y", 
        " OS Rate (%) | Synchronous | Control": "52.1 at 4 y", 
        " OS Rate (%) | Synchronous | Treatment": "63.1 at 4 y", 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "462 (70.6)", 
        " PS - N (%) | 0 | Treatment": "466 (71.6)", 
        " PS - N (%) | 1-2 | Control": "190 (29.1)", 
        " PS - N (%) | 1-2 | Treatment": "185 (28.4)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": "245 (37.3)", 
        " Race - N (%) | Asian | Treatment": "230 (35.3)", 
        " Race - N (%) | Black or African American | Control": "28 (4.3)", 
        " Race - N (%) | Black or African American | Treatment": "26 (4.0)", 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": "2 (0.3)", 
        " Race - N (%) | Other | Treatment": "7 (1.1)", 
        " Race - N (%) | Unknown | Control": "46 (7.0)", 
        " Race - N (%) | Unknown | Treatment": "43 (6.6)", 
        " Race - N (%) | White | Control": "333 (50.9)", 
        " Race - N (%) | White | Treatment": "345 (53.0)", 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "~122 (18.7)", 
        " Region - N (%) | Asia | Treatment": "~115 (17.7)", 
        " Region - N (%) | Europe | Control": "~97 (6.97)", 
        " Region - N (%) | Europe | Treatment": "~99 (7.59)", 
        " Region - N (%) | North America | Control": "119 (18.2)", 
        " Region - N (%) | North America | Treatment": "125 (19.2)", 
        " Region - N (%) | Oceania | Control": "~219 (16.4)", 
        " Region - N (%) | Oceania | Treatment": "~214 (16.4)", 
        " Region - N (%) | South America | Control": "~97 (6.97)", 
        " Region - N (%) | South America | Treatment": "~99 (7.59)", 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Darolutamide + Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Matthew R Smith et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI; Chemotherapy", 
        "Control_Arm": "D+ADT", 
        "Control_Arm - N": 654.0, 
        "Docetaxel administration - N (%) | Control": "654 (100)", 
        "Docetaxel administration - N (%) | Treatment": "651 (100)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 67.0, 
        "Median Age (years) | Treatment": 67, 
        "Median Follow-Up Duration (mo)": "43.7; 42.4", 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 16.7, 
        "Median On-Treatment Duration (mo) | Treatment": 41, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02799602", 
        "No. of Deaths - N | Control": 304.0, 
        "No. of Deaths - N | Treatment": 229.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Original", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "35179323", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "No", 
        "Reporting by prognostic groups - Y/N | Low volume": "No", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to CRPC; Time to pain progression; SSE-free survival; Time to first SSE; Time to subsequent systemic anti-neoplastic therapy; Time to worsening of disease related physical symptoms; Time to initiation of opioid use\nfor \u22657 consecutive days; Time to initiation of opioid use; Safety", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1306, 
        "Treatment Arm - N": 651, 
        "Treatment Arm 1 Regimen": "Darolutamide 600mg BID; Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
        "Treatment_Arms": "DARO+D+ADT", 
        "Treatment Class": "ARPI; Chemotherapy", 
        "Trial_Name": "ARASENS", 
        "Type of Therapy": "Triplet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2022", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": "181 (52)", 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": "217 (63)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "3 (1)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "7(2)", 
        " Gleason score - N (%) | \u2264 7 | Control": "132 (23)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "145 (25)", 
        " Gleason score - N (%) | \u2265 8 | Control": "441 (77)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "429 (75)", 
        " Median OS (mo) | High volume | Control": 42.0, 
        " Median OS (mo) | High volume | Treatment": 61.2, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 56.4, 
        " Median OS (mo) | Overall | Treatment": 68.4, 
        " Median PFS (mo) | High volume | Control": 19.2, 
        " Median PFS (mo) | High volume | Treatment": 49.2, 
        " Median PFS (mo) | Low volume | Control": 32.4, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 26.4, 
        " Median PFS (mo) | Overall | Treatment": 54.0, 
        " Metastases - N (%) | Bone | Control": "475 (81)", 
        " Metastases - N (%) | Bone | Treatment": "472 (81)", 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": "52 (9)", 
        " Metastases - N (%) | Nodal | Treatment": "47 (8)", 
        " Mode of metastases - N (%) | Metachronous | Control": "0 (0)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "0 (0)", 
        " Mode of metastases - N (%) | Synchronous | Control": "589 (100)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "583 (100)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": "48.3 at 4.4 y", 
        " OS Rate (%) | High volume | Treatment": "58.9 at 4.4 y", 
        " OS Rate (%) | Low volume | Control": "74.8 at 4.4 y", 
        " OS Rate (%) | Low volume | Treatment": "77.7 at 4.4 y", 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": "57.5 at 3.5 y", 
        " OS Rate (%) | Overall | Treatment": "65.9 at 3.5 y", 
        " OS Rate (%) | Synchronous | Control": "57.5 at 4.4 y", 
        " OS Rate (%) | Synchronous | Treatment": "65.9 at 4.4 y", 
        " PFS Rate (%) | Overall | Control": "40.2 at 3.5 y", 
        " PFS Rate (%) | Overall | Treatment": "61.0 at 3.5 y", 
        " PS - N (%) | 0 | Control": "412 (70)", 
        " PS - N (%) | 0 | Treatment": "412 (71)", 
        " PS - N (%) | 1-2 | Control": "177 (30)", 
        " PS - N (%) | 1-2 | Treatment": "171 (29)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "589 (100)", 
        " Region - N (%) | Europe | Treatment": "583 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": "336 (57)", 
        " Volume of disease - N (%) | High | Treatment": "331 (57)", 
        " Volume of disease - N (%) | Low | Control": "253 (43)", 
        " Volume of disease - N (%) | Low | Treatment": "252 (43)", 
        "Add-on Treatment": "Abiraterone acetate + Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Karim Fizazi et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI; Chemotherapy", 
        "Control_Arm": "D+ADT", 
        "Control_Arm - N": 589.0, 
        "Docetaxel administration - N (%) | Control": "355 (60)", 
        "Docetaxel administration - N (%) | Treatment": "355 (61)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 66.0, 
        "Median Age (years) | Treatment": 67, 
        "Median Follow-Up Duration (mo)": 42, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT01957436", 
        "No. of Deaths - N | Control": 268.0, 
        "No. of Deaths - N | Treatment": 228.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Original", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "35405085", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS, rPFS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Castration resistant free survival; Serious genitourinary event free survival; Prostate CSS; Time to next skeletal related event; PSA response; PSA at 8 months after initiation of SOC, Time to pain progression, Time to chemotherapy for CRPC; QoL; Safety; Change in BMD; Biomarkers; Outcomes for patients with NE differentiation.", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1172, 
        "Treatment Arm - N": 583, 
        "Treatment Arm 1 Regimen": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
        "Treatment_Arms": "AAP+D+ADT", 
        "Treatment Class": "ARPI; Chemotherapy", 
        "Trial_Name": "PEACE-1", 
        "Type of Therapy": "Triplet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2022", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": null, 
        " Gleason score - N (%) | \u2264 7 | Treatment": null, 
        " Gleason score - N (%) | \u2265 8 | Control": null, 
        " Gleason score - N (%) | \u2265 8 | Treatment": null, 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 46.0, 
        " Median OS (mo) | Overall | Treatment": 79.0, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": "448 (89)", 
        " Metastases - N (%) | Bone | Treatment": "434 (87)", 
        " Metastases - N (%) | Liver | Control": "8 (2)", 
        " Metastases - N (%) | Liver | Treatment": "7 (1)", 
        " Metastases - N (%) | Lungs | Control": "21 (4)", 
        " Metastases - N (%) | Lungs | Treatment": "21 (4)", 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": "27 (5)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "35 (7)", 
        " Mode of metastases - N (%) | Synchronous | Control": "475 (95)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "466 (93)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "502 (100)", 
        " Region - N (%) | Europe | Treatment": "501 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Abiraterone acetate", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Nicholas D James et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 502.0, 
        "Docetaxel administration - N (%) | Control": null, 
        "Docetaxel administration - N (%) | Treatment": null, 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 67.0, 
        "Median Age (years) | Treatment": 67, 
        "Median Follow-Up Duration (mo)": 73.3, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": 29, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00268476", 
        "No. of Deaths - N | Control": 329.0, 
        "No. of Deaths - N | Treatment": 244.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "35411939", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": null, 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1003, 
        "Treatment Arm - N": 501, 
        "Treatment Arm 1 Regimen": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
        "Treatment_Arms": "AAP+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "STAMPEDE", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2022", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": "160 (27.9)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": "224 (39.2)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "12 (2.1)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "30 (5.2)", 
        " Gleason score - N (%) | \u2264 7 | Control": "187 (32.5)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "171 (29.8)", 
        " Gleason score - N (%) | \u2265 8 | Control": "373 (64.8)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "386 (67.2)", 
        " Median OS (mo) | High volume | Control": 45.9, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 38.9, 
        " Median PFS (mo) | Overall | Treatment": 49.8, 
        " Metastases - N (%) | Bone | Control": "245 (42.5)", 
        " Metastases - N (%) | Bone | Treatment": "268 (46.7)", 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": "80 (13.9)", 
        " Metastases - N (%) | Nodal | Treatment": "74 (12.9)", 
        " Mode of metastases - N (%) | Metachronous | Control": "86 (14.9)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "83 (14.5)", 
        " Mode of metastases - N (%) | Synchronous | Control": "365 (63.4)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "402 (70)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": "58.2 at 3.7 y", 
        " OS Rate (%) | High volume | Treatment": "66.4 at 3.7 y", 
        " OS Rate (%) | Low volume | Control": "77.3 at 3.7 y", 
        " OS Rate (%) | Low volume | Treatment": "84.1 at 3.7 y", 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": "64.9 at 4 y", 
        " OS Rate (%) | Overall | Treatment": "73.2 at 4 y", 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "443 (76.9)", 
        " PS - N (%) | 0 | Treatment": "448 (78)", 
        " PS - N (%) | 1-2 | Control": "133 (23.1)", 
        " PS - N (%) | 1-2 | Treatment": "125 (21.8)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": "89 (15.5)", 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": "72 (12.5)", 
        " Previous local therapy - N (%) | Radiotherapy | Control": "72 (12.5)", 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": "73 (12.7)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": "0 (0)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": "0 (0)", 
        " Race - N (%) | Asian | Control": "80 (13.9)", 
        " Race - N (%) | Asian | Treatment": "75 (13.1)", 
        " Race - N (%) | Black or African American | Control": "8 (1.4)", 
        " Race - N (%) | Black or African American | Treatment": "8 (1.4)", 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": "0 (0)", 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": "0 (0)", 
        " Race - N (%) | Other | Control": "3 (0.5)", 
        " Race - N (%) | Other | Treatment": "2 (0.3)", 
        " Race - N (%) | Unknown | Control": "25 (4.3)", 
        " Race - N (%) | Unknown | Treatment": "23 (4.0)", 
        " Race - N (%) | White | Control": "460 (79.9)", 
        " Race - N (%) | White | Treatment": "466 (81.2)", 
        " Region - N (%) | Africa | Control": "12 (2.1)", 
        " Region - N (%) | Africa | Treatment": "11 (1.9)", 
        " Region - N (%) | Asia | Control": "~57 (9.9)", 
        " Region - N (%) | Asia | Treatment": "~52 (9.1)", 
        " Region - N (%) | Europe | Control": "344 (59.7)", 
        " Region - N (%) | Europe | Treatment": "341 (59.4)", 
        " Region - N (%) | North America | Control": "77 (13.4)", 
        " Region - N (%) | North America | Treatment": "86 (15.0)", 
        " Region - N (%) | Oceania | Control": "~57 (9.9)", 
        " Region - N (%) | Oceania | Treatment": "~52 (9.1)", 
        " Region - N (%) | South America | Control": "30 (5.2)", 
        " Region - N (%) | South America | Treatment": "32 (5.6)", 
        " Volume of disease - N (%) | High | Control": "373 (64.8)", 
        " Volume of disease - N (%) | High | Treatment": "354 (61.7)", 
        " Volume of disease - N (%) | Low | Control": "203 (35.2)", 
        " Volume of disease - N (%) | Low | Treatment": "220 (38.3)", 
        "Add-on Treatment": "Enzalutamide", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Andrew J Armstrong et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 576.0, 
        "Docetaxel administration - N (%) | Control": "102 (17.7)", 
        "Docetaxel administration - N (%) | Treatment": "103 (17.9)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 70.0, 
        "Median Age (years) | Treatment": 70, 
        "Median Follow-Up Duration (mo)": 44.6, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 13.8, 
        "Median On-Treatment Duration (mo) | Treatment": 40.2, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02677896", 
        "No. of Deaths - N | Control": 202.0, 
        "No. of Deaths - N | Treatment": 154.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "35420921", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": null, 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "OS", 
        "TTPSA (mo) | Control": 16.8, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1150, 
        "Treatment Arm - N": 574, 
        "Treatment Arm 1 Regimen": "Enzalutamide 160mg OD; Standard androgen deprivation", 
        "Treatment_Arms": "E+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "ARCHES", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2022", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": "70 (11.1)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": "273 (43.5)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "4 (0.6)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "2 (0.3)", 
        " Gleason score - N (%) | \u2264 7 | Control": "207 (32.3)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "211 (32.9)", 
        " Gleason score - N (%) | \u2265 8 | Control": "382 (59.8)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "372 (58.3)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 70.2, 
        " Median OS (mo) | Overall | Treatment": 81.1, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 23.0, 
        " Median PFS (mo) | Overall | Treatment": 47.6, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": "952 (74.4)", 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": "30 (2.4)", 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": null, 
        " Mode of metastases - N (%) | Metachronous | Treatment": null, 
        " Mode of metastases - N (%) | Synchronous | Control": null, 
        " Mode of metastases - N (%) | Synchronous | Treatment": null, 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": "57.9 at 5y", 
        " OS Rate (%) | Overall | Treatment": "59.7 at 5y", 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": "5 (0.4)", 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": "315 (24.6)", 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": "71 (11.1)", 
        " Race - N (%) | Black or African American | Treatment": "64 (10.0)", 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": "32 (4.9)", 
        " Race - N (%) | Other | Treatment": "35 (5.5)", 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": "538 (83.9)", 
        " Race - N (%) | White | Treatment": "539 (83.5)", 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "589 (100)", 
        " Region - N (%) | Europe | Treatment": "583 (100)", 
        " Region - N (%) | North America | Control": "641 (100)", 
        " Region - N (%) | North America | Treatment": "638 (100)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "TAK", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Neeraj Agarwal et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "NSAA+ADT", 
        "Control_Arm - N": 641.0, 
        "Docetaxel administration - N (%) | Control": null, 
        "Docetaxel administration - N (%) | Treatment": null, 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 68.1, 
        "Median Age (years) | Treatment": 67.6, 
        "Median Follow-Up Duration (mo)": 58.8, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT01809691", 
        "No. of Deaths - N | Control": 274.0, 
        "No. of Deaths - N | Treatment": 251.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Original", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "35446628", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "No", 
        "Reporting by prognostic groups - Y/N | Low volume": "No", 
        "Reporting by prognostic groups - Y/N | Metachronous": "No", 
        "Reporting by prognostic groups - Y/N | Synchronous": "No", 
        "Secondary Endpoint(s)": "PFS; PSA at 7 mo; AE profile", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1279, 
        "Treatment Arm - N": 638, 
        "Treatment Arm 1 Regimen": "TAK 300 mg BD; Standard androgen deprivation", 
        "Treatment_Arms": "TAK+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "SWOG1216", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2022", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": "439 (67.5)", 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": "458 (70.2)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": "27 (4.0)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": "28 (4.1)", 
        " Gleason score - N (%) | \u2264 7 | Control": "138 (21.1)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "110 (22.4)", 
        " Gleason score - N (%) | \u2265 8 | Control": "516 (78.9)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "505 (77.6)", 
        " Median OS (mo) | High volume | Control": 42.4, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 42.4, 
        " Median OS (mo) | Overall | Treatment": 43.7, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 49.9, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": "82 (12.5)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "86 (13.2)", 
        " Mode of metastases - N (%) | Synchronous | Control": "566 (86.5)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "558 (85.7)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": "47.2 at 4 y", 
        " OS Rate (%) | High volume | Treatment": "59.1 at 4 y", 
        " OS Rate (%) | Low volume | Control": "75.3 at 4 y", 
        " OS Rate (%) | Low volume | Treatment": "83.1 at 4 y", 
        " OS Rate (%) | Metachronous | Control": "63.4 at 4 y", 
        " OS Rate (%) | Metachronous | Treatment": "74.4 at 4 y", 
        " OS Rate (%) | Overall | Control": "50.4 at 4 y", 
        " OS Rate (%) | Overall | Treatment": "62.7 at 4 y", 
        " OS Rate (%) | Synchronous | Control": "52.1 at 4 y", 
        " OS Rate (%) | Synchronous | Treatment": "63.1 at 4 y", 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "462 (70.6)", 
        " PS - N (%) | 0 | Treatment": "466 (71.6)", 
        " PS - N (%) | 1-2 | Control": "190 (29.1)", 
        " PS - N (%) | 1-2 | Treatment": "185 (28.4)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": null, 
        " Region - N (%) | Africa | Treatment": null, 
        " Region - N (%) | Asia | Control": null, 
        " Region - N (%) | Asia | Treatment": null, 
        " Region - N (%) | Europe | Control": null, 
        " Region - N (%) | Europe | Treatment": null, 
        " Region - N (%) | North America | Control": null, 
        " Region - N (%) | North America | Treatment": null, 
        " Region - N (%) | Oceania | Control": null, 
        " Region - N (%) | Oceania | Treatment": null, 
        " Region - N (%) | South America | Control": null, 
        " Region - N (%) | South America | Treatment": null, 
        " Volume of disease - N (%) | High | Control": "508 (77.6)", 
        " Volume of disease - N (%) | High | Treatment": "497 (76.3)", 
        " Volume of disease - N (%) | Low | Control": "146 (22.3)", 
        " Volume of disease - N (%) | Low | Treatment": "154 (23.6)", 
        "Add-on Treatment": "Darolutamide + Docetaxel", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Maha Hussain et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI; Chemotherapy", 
        "Control_Arm": "D+ADT", 
        "Control_Arm - N": 654.0, 
        "Docetaxel administration - N (%) | Control": "654 (100)", 
        "Docetaxel administration - N (%) | Treatment": "651 (100)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 67.0, 
        "Median Age (years) | Treatment": 67, 
        "Median Follow-Up Duration (mo)": "43.7; 42.4", 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 16.7, 
        "Median On-Treatment Duration (mo) | Treatment": 41, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02799602", 
        "No. of Deaths - N | Control": 304.0, 
        "No. of Deaths - N | Treatment": 229.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "36795843", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "No", 
        "Reporting by prognostic groups - Y/N | Low volume": "No", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to CRPC; Time to pain progression; SSE-free survival; Time to first SSE; Time to subsequent systemic anti-neoplastic therapy; Time to worsening of disease related physical symptoms; Time to initiation of opioid use\nfor \u22657 consecutive days; Time to initiation of opioid use; Safety", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1306, 
        "Treatment Arm - N": 651, 
        "Treatment Arm 1 Regimen": "Darolutamide 600mg BID; Docetaxel 6 cycles at 75mg/m\u00b2/cycle, one cycle every 3 weeks; Standard androgen deprivation", 
        "Treatment_Arms": "DARO+D+ADT", 
        "Treatment Class": "ARPI; Chemotherapy", 
        "Trial_Name": "ARASENS", 
        "Type of Therapy": "Triplet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2023", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": "164 (29.2)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "152 (27)", 
        " Gleason score - N (%) | \u2265 8 | Control": "320 (57)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "335 (59.5)", 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 25.0, 
        " Median PFS (mo) | Overall | Treatment": 81.0, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": "11 (2)", 
        " Metastases - N (%) | Liver | Treatment": "13 (2.3)", 
        " Metastases - N (%) | Lungs | Control": "48 (8.5)", 
        " Metastases - N (%) | Lungs | Treatment": "55 (9.8)", 
        " Metastases - N (%) | Nodal | Control": "259 (46.1)", 
        " Metastases - N (%) | Nodal | Treatment": "268 (47.6)", 
        " Mode of metastases - N (%) | Metachronous | Control": "228 (38.1)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "228 (40.4)", 
        " Mode of metastases - N (%) | Synchronous | Control": "348 (61.9)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "335 (59.5)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": "49 at 5 y", 
        " OS Rate (%) | High volume | Treatment": "55 at 5 y", 
        " OS Rate (%) | Low volume | Control": "66 at 5 y", 
        " OS Rate (%) | Low volume | Treatment": "80 at 5 y", 
        " OS Rate (%) | Metachronous | Control": "60.2 at 5 y", 
        " OS Rate (%) | Metachronous | Treatment": "70.1 at 5 y", 
        " OS Rate (%) | Overall | Control": "57 at 5y", 
        " OS Rate (%) | Overall | Treatment": "67 at 5 y", 
        " OS Rate (%) | Synchronous | Control": "47.4 at 5 y", 
        " OS Rate (%) | Synchronous | Treatment": "58.2 at 5 y", 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "405 (72.1)", 
        " PS - N (%) | 0 | Treatment": "404 (71.9)", 
        " PS - N (%) | 1-2 | Control": "157 (28)", 
        " PS - N (%) | 1-2 | Treatment": "158 (28)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": "8 (1)", 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": "5 (1)", 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "93 (16.5)", 
        " Region - N (%) | Europe | Treatment": "102 (18.1)", 
        " Region - N (%) | North America | Control": "129 (22.9)", 
        " Region - N (%) | North America | Treatment": "117 (20.8)", 
        " Region - N (%) | Oceania | Control": "340 (60.5)", 
        " Region - N (%) | Oceania | Treatment": "344 (61.1)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": "301 (53.5)", 
        " Volume of disease - N (%) | High | Treatment": "301 (53.5)", 
        " Volume of disease - N (%) | Low | Control": "261 (46.4)", 
        " Volume of disease - N (%) | Low | Treatment": "262 (46.5)", 
        "Add-on Treatment": "Enzalutamide", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Sweeney CJ et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "NSAA+ADT", 
        "Control_Arm - N": 562.0, 
        "Docetaxel administration - N (%) | Control": "249 (44)", 
        "Docetaxel administration - N (%) | Treatment": "254 (45)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 68.8, 
        "Median Age (years) | Treatment": 68.9, 
        "Median Follow-Up Duration (mo)": 68, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02446405", 
        "No. of Deaths - N | Control": 268.0, 
        "No. of Deaths - N | Treatment": 208.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "36990608", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to PSA progression; rPFS", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1125, 
        "Treatment Arm - N": 563, 
        "Treatment Arm 1 Regimen": "Enzalutamide 160mg OD; Standard androgen deprivation", 
        "Treatment_Arms": "E+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "ENZAMET", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2023", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": "204 (45)", 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": "302 (68)", 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": "92 (20)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "79 (17)", 
        " Gleason score - N (%) | \u2265 8 | Control": "345 (75.9)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "369 (79.8)", 
        " Median OS (mo) | High volume | Control": 38.0, 
        " Median OS (mo) | High volume | Treatment": 54.0, 
        " Median OS (mo) | Low volume | Control": 64.0, 
        " Median OS (mo) | Low volume | Treatment": 80.0, 
        " Median OS (mo) | Overall | Control": 51.8, 
        " Median OS (mo) | Overall | Treatment": 73.1, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": "278 (61)", 
        " Metastases - N (%) | Nodal | Treatment": "278 (60)", 
        " Mode of metastases - N (%) | Metachronous | Control": null, 
        " Mode of metastases - N (%) | Metachronous | Treatment": null, 
        " Mode of metastases - N (%) | Synchronous | Control": null, 
        " Mode of metastases - N (%) | Synchronous | Treatment": null, 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": "27 at ~5 y", 
        " OS Rate (%) | High volume | Treatment": "41 at ~5 y", 
        " OS Rate (%) | Low volume | Control": "43 at ~5 y", 
        " OS Rate (%) | Low volume | Treatment": "59 at ~5 y", 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "315 (69)", 
        " PS - N (%) | 0 | Treatment": "325 (70)", 
        " PS - N (%) | 1-2 | Control": "139 (31)", 
        " PS - N (%) | 1-2 | Treatment": "137 (30)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "454 (100)", 
        " Region - N (%) | Europe | Treatment": "462 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": "209 (46)", 
        " Volume of disease - N (%) | High | Treatment": "196 (42)", 
        " Volume of disease - N (%) | Low | Control": "162 (36)", 
        " Volume of disease - N (%) | Low | Treatment": "195 (42)", 
        "Add-on Treatment": "Abiraterone acetate", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Gerhardt Attard et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 454.0, 
        "Docetaxel administration - N (%) | Control": "39 (9)", 
        "Docetaxel administration - N (%) | Treatment": "41 (9)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 68.0, 
        "Median Age (years) | Treatment": 68, 
        "Median Follow-Up Duration (mo)": 72, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00268476", 
        "No. of Deaths - N | Control": null, 
        "No. of Deaths - N | Treatment": null, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "37142371", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "No", 
        "Reporting by prognostic groups - Y/N | Synchronous": "No", 
        "Secondary Endpoint(s)": null, 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 916, 
        "Treatment Arm - N": 462, 
        "Treatment Arm 1 Regimen": "Enzalutamide 160mg OD; Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
        "Treatment_Arms": "E+AAP+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "STAMPEDE", 
        "Type of Therapy": "Triplet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2023", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": "169 (32)", 
        " Gleason score - N (%) | \u2264 7 | Treatment": "174 (33.1)", 
        " Gleason score - N (%) | \u2265 8 | Control": "358 (67.9)", 
        " Gleason score - N (%) | \u2265 8 | Treatment": "351 (66.9)", 
        " Median OS (mo) | High volume | Control": 38.7, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": 14.9, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": 30.5, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": "269 (51.0)", 
        " Metastases - N (%) | Bone | Treatment": "289 (55.1)", 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": "59 (11.2)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "85 (16.2)", 
        " Mode of metastases - N (%) | Synchronous | Control": "441 (83.7)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "411 (78.3)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": "176 (96)", 
        " PS - N (%) | 0 | Treatment": "181 (99)", 
        " PS - N (%) | 1-2 | Control": "179 (34.0)", 
        " PS - N (%) | 1-2 | Treatment": "197 (37.5)", 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": "13 (2.5)", 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": "6 (1.1)", 
        " Race - N (%) | Asian | Control": "110 (20.9)", 
        " Race - N (%) | Asian | Treatment": "119 (22.7)", 
        " Race - N (%) | Black or African American | Control": "9 (1.7)", 
        " Race - N (%) | Black or African American | Treatment": "10 (1.9)", 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": "22 (4.2)", 
        " Race - N (%) | Other | Treatment": "24 (4.6)", 
        " Race - N (%) | Unknown | Control": "8 (1.5)", 
        " Race - N (%) | Unknown | Treatment": "11 (2.1)", 
        " Race - N (%) | White | Control": "365 (69.3)", 
        " Race - N (%) | White | Treatment": "354 (67.4)", 
        " Region - N (%) | Africa | Control": null, 
        " Region - N (%) | Africa | Treatment": null, 
        " Region - N (%) | Asia | Control": null, 
        " Region - N (%) | Asia | Treatment": null, 
        " Region - N (%) | Europe | Control": null, 
        " Region - N (%) | Europe | Treatment": null, 
        " Region - N (%) | North America | Control": null, 
        " Region - N (%) | North America | Treatment": null, 
        " Region - N (%) | Oceania | Control": null, 
        " Region - N (%) | Oceania | Treatment": null, 
        " Region - N (%) | South America | Control": null, 
        " Region - N (%) | South America | Treatment": null, 
        " Volume of disease - N (%) | High | Control": "335 (63.6)", 
        " Volume of disease - N (%) | High | Treatment": "325 (61.9)", 
        " Volume of disease - N (%) | Low | Control": "192 (36.4)", 
        " Volume of disease - N (%) | Low | Treatment": "200 (38.1)", 
        "Add-on Treatment": "Apalutamide", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Axel S. Merseburger et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 527.0, 
        "Docetaxel administration - N (%) | Control": "55 (10.4)", 
        "Docetaxel administration - N (%) | Treatment": "58 (11)", 
        "Full Pub or Abstract": "Full Pub", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 68.0, 
        "Median Age (years) | Treatment": 69, 
        "Median Follow-Up Duration (mo)": null, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02489318", 
        "No. of Deaths - N | Control": null, 
        "No. of Deaths - N | Treatment": null, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "37708629", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS, rPFS", 
        "Quality of Life Scale": "BPI-SF", 
        "Quality of Life reported": "Yes", 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "Yes", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to cytotoxic chemotherapy; Time to pain progression", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1052, 
        "Treatment Arm - N": 525, 
        "Treatment Arm 1 Regimen": "Apalutamide 240 OD; standard androgen deprivation", 
        "Treatment_Arms": "APA+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "TITAN", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2023", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": null, 
        " Gleason score - N (%) | \u2264 7 | Treatment": null, 
        " Gleason score - N (%) | \u2265 8 | Control": null, 
        " Gleason score - N (%) | \u2265 8 | Treatment": null, 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": null, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": null, 
        " Mode of metastases - N (%) | Metachronous | Treatment": null, 
        " Mode of metastases - N (%) | Synchronous | Control": null, 
        " Mode of metastases - N (%) | Synchronous | Treatment": null, 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": null, 
        " Region - N (%) | Africa | Treatment": null, 
        " Region - N (%) | Asia | Control": null, 
        " Region - N (%) | Asia | Treatment": null, 
        " Region - N (%) | Europe | Control": null, 
        " Region - N (%) | Europe | Treatment": null, 
        " Region - N (%) | North America | Control": null, 
        " Region - N (%) | North America | Treatment": null, 
        " Region - N (%) | Oceania | Control": null, 
        " Region - N (%) | Oceania | Treatment": null, 
        " Region - N (%) | South America | Control": null, 
        " Region - N (%) | South America | Treatment": null, 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Enzalutamide", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Stockler, M. R. et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "NSAA+ADT", 
        "Control_Arm - N": 562.0, 
        "Docetaxel administration - N (%) | Control": null, 
        "Docetaxel administration - N (%) | Treatment": null, 
        "Full Pub or Abstract": "Abstract", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "no", 
        "Median Age (years) | Control": null, 
        "Median Age (years) | Treatment": null, 
        "Median Follow-Up Duration (mo)": null, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02446405", 
        "No. of Deaths - N | Control": null, 
        "No. of Deaths - N | Treatment": null, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "10.1093/annonc/mdz394.046", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": null, 
        "Quality of Life Scale": "EORTC QLQ-C 30, PR25", 
        "Quality of Life reported": "Yes", 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": null, 
        "Reporting by prognostic groups - Y/N | Low volume": null, 
        "Reporting by prognostic groups - Y/N | Metachronous": null, 
        "Reporting by prognostic groups - Y/N | Synchronous": null, 
        "Secondary Endpoint(s)": null, 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1125, 
        "Treatment Arm - N": 563, 
        "Treatment Arm 1 Regimen": "Enzalutamide 160mg OD; Standard androgen deprivation", 
        "Treatment_Arms": "E+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "ENZAMET", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2019", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": null, 
        " Gleason score - N (%) | \u2264 7 | Treatment": null, 
        " Gleason score - N (%) | \u2265 8 | Control": null, 
        " Gleason score - N (%) | \u2265 8 | Treatment": null, 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 45.6, 
        " Median OS (mo) | Overall | Treatment": 79.2, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": 40.8, 
        " Median PFS (mo) | Overall | Treatment": 70.8, 
        " Metastases - N (%) | Bone | Control": "448 (89)", 
        " Metastases - N (%) | Bone | Treatment": "434 (87)", 
        " Metastases - N (%) | Liver | Control": "8 (2)", 
        " Metastases - N (%) | Liver | Treatment": "7 (1)", 
        " Metastases - N (%) | Lungs | Control": "21 (4)", 
        " Metastases - N (%) | Lungs | Treatment": "21 (4)", 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": "0 (0)", 
        " Mode of metastases - N (%) | Metachronous | Treatment": "0 (0)", 
        " Mode of metastases - N (%) | Synchronous | Control": "502 (100)", 
        " Mode of metastases - N (%) | Synchronous | Treatment": "501 (100)", 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": null, 
        " OS Rate (%) | Overall | Treatment": null, 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": "0 (0)", 
        " Region - N (%) | Africa | Treatment": "0 (0)", 
        " Region - N (%) | Asia | Control": "0 (0)", 
        " Region - N (%) | Asia | Treatment": "0 (0)", 
        " Region - N (%) | Europe | Control": "502 (100)", 
        " Region - N (%) | Europe | Treatment": "501 (100)", 
        " Region - N (%) | North America | Control": "0 (0)", 
        " Region - N (%) | North America | Treatment": "0 (0)", 
        " Region - N (%) | Oceania | Control": "0 (0)", 
        " Region - N (%) | Oceania | Treatment": "0 (0)", 
        " Region - N (%) | South America | Control": "0 (0)", 
        " Region - N (%) | South America | Treatment": "0 (0)", 
        " Volume of disease - N (%) | High | Control": "256 (51)", 
        " Volume of disease - N (%) | High | Treatment": "243 (48.5)", 
        " Volume of disease - N (%) | Low | Control": "196 (39.0)", 
        " Volume of disease - N (%) | Low | Treatment": "206 (41.1)", 
        "Add-on Treatment": "Abiraterone acetate", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "James, N. et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 502.0, 
        "Docetaxel administration - N (%) | Control": null, 
        "Docetaxel administration - N (%) | Treatment": null, 
        "Full Pub or Abstract": "Abstract", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 67.0, 
        "Median Age (years) | Treatment": 67, 
        "Median Follow-Up Duration (mo)": 73.3, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": null, 
        "Median On-Treatment Duration (mo) | Treatment": null, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT00268476", 
        "No. of Deaths - N | Control": 329.0, 
        "No. of Deaths - N | Treatment": 244.0, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "10.1016/j.annonc.2020.08.871", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Low volume": "Yes", 
        "Reporting by prognostic groups - Y/N | Metachronous": "No", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": null, 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1003, 
        "Treatment Arm - N": 501, 
        "Treatment Arm 1 Regimen": "Abiraterone acetate 1000mg OD + Prednisolone 5mg BID; Standard androgen deprivation", 
        "Treatment_Arms": "AAP+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "STAMPEDE", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2020", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": null, 
        " Gleason score - N (%) | \u2264 7 | Treatment": null, 
        " Gleason score - N (%) | \u2265 8 | Control": null, 
        " Gleason score - N (%) | \u2265 8 | Treatment": null, 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 52.2, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": null, 
        " Mode of metastases - N (%) | Metachronous | Treatment": null, 
        " Mode of metastases - N (%) | Synchronous | Control": null, 
        " Mode of metastases - N (%) | Synchronous | Treatment": null, 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": "63 (high risk) and 85 (low risk) at 2 y", 
        " OS Rate (%) | Overall | Treatment": "76 (high risk) and 90 (low risk) at 2 y", 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": null, 
        " Region - N (%) | Africa | Treatment": null, 
        " Region - N (%) | Asia | Control": null, 
        " Region - N (%) | Asia | Treatment": null, 
        " Region - N (%) | Europe | Control": null, 
        " Region - N (%) | Europe | Treatment": null, 
        " Region - N (%) | North America | Control": null, 
        " Region - N (%) | North America | Treatment": null, 
        " Region - N (%) | Oceania | Control": null, 
        " Region - N (%) | Oceania | Treatment": null, 
        " Region - N (%) | South America | Control": null, 
        " Region - N (%) | South America | Treatment": null, 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Apalutamide", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Ozguroglu, Mustafa et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 527.0, 
        "Docetaxel administration - N (%) | Control": "55 (10.4)", 
        "Docetaxel administration - N (%) | Treatment": "58 (11)", 
        "Full Pub or Abstract": "Abstract", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "no", 
        "Median Age (years) | Control": 68.0, 
        "Median Age (years) | Treatment": 69, 
        "Median Follow-Up Duration (mo)": null, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": "20.3 (low risk); 14.7 (high risk)", 
        "Median On-Treatment Duration (mo) | Treatment": "21.8 (low risk); 19.5 (high risk)", 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02489318", 
        "No. of Deaths - N | Control": null, 
        "No. of Deaths - N | Treatment": null, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "10.1200/jco.2020.38.6_suppl.87", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS, rPFS", 
        "Quality of Life Scale": null, 
        "Quality of Life reported": null, 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "No", 
        "Reporting by prognostic groups - Y/N | Low volume": "No", 
        "Reporting by prognostic groups - Y/N | Metachronous": "No", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to cytotoxic chemotherapy; Time to pain progression", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1052, 
        "Treatment Arm - N": 525, 
        "Treatment Arm 1 Regimen": "Apalutamide 240 OD; standard androgen deprivation", 
        "Treatment_Arms": "APA+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "TITAN", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2020", 
        "_arm_idx": 0
      }, 
      {
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | All-Cause Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 3 or Higher | Treatment": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Control": null, 
        " Adverse Events - N (%) | Treatment-related Grade 5 | Treatment": null, 
        " Gleason score - N (%) | \u2264 7 | Control": null, 
        " Gleason score - N (%) | \u2264 7 | Treatment": null, 
        " Gleason score - N (%) | \u2265 8 | Control": null, 
        " Gleason score - N (%) | \u2265 8 | Treatment": null, 
        " Median OS (mo) | High volume | Control": null, 
        " Median OS (mo) | High volume | Treatment": null, 
        " Median OS (mo) | Low volume | Control": null, 
        " Median OS (mo) | Low volume | Treatment": null, 
        " Median OS (mo) | Overall | Control": 52.2, 
        " Median OS (mo) | Overall | Treatment": null, 
        " Median PFS (mo) | High volume | Control": null, 
        " Median PFS (mo) | High volume | Treatment": null, 
        " Median PFS (mo) | Low volume | Control": null, 
        " Median PFS (mo) | Low volume | Treatment": null, 
        " Median PFS (mo) | Overall | Control": null, 
        " Median PFS (mo) | Overall | Treatment": null, 
        " Metastases - N (%) | Bone | Control": null, 
        " Metastases - N (%) | Bone | Treatment": null, 
        " Metastases - N (%) | Liver | Control": null, 
        " Metastases - N (%) | Liver | Treatment": null, 
        " Metastases - N (%) | Lungs | Control": null, 
        " Metastases - N (%) | Lungs | Treatment": null, 
        " Metastases - N (%) | Nodal | Control": null, 
        " Metastases - N (%) | Nodal | Treatment": null, 
        " Mode of metastases - N (%) | Metachronous | Control": null, 
        " Mode of metastases - N (%) | Metachronous | Treatment": null, 
        " Mode of metastases - N (%) | Synchronous | Control": null, 
        " Mode of metastases - N (%) | Synchronous | Treatment": null, 
        " ORR - N (%) | Control | CR": null, 
        " ORR - N (%) | Control | Overall": null, 
        " ORR - N (%) | Control | PD": null, 
        " ORR - N (%) | Control | SD": null, 
        " ORR - N (%) | Treatment | CR": null, 
        " ORR - N (%) | Treatment | Overall": null, 
        " ORR - N (%) | Treatment | PD": null, 
        " ORR - N (%) | Treatment | SD": null, 
        " OS Rate (%) | High volume | Control": null, 
        " OS Rate (%) | High volume | Treatment": null, 
        " OS Rate (%) | Low volume | Control": null, 
        " OS Rate (%) | Low volume | Treatment": null, 
        " OS Rate (%) | Metachronous | Control": null, 
        " OS Rate (%) | Metachronous | Treatment": null, 
        " OS Rate (%) | Overall | Control": "52 at 4 y", 
        " OS Rate (%) | Overall | Treatment": "65 at 4 y", 
        " OS Rate (%) | Synchronous | Control": null, 
        " OS Rate (%) | Synchronous | Treatment": null, 
        " PFS Rate (%) | Overall | Control": null, 
        " PFS Rate (%) | Overall | Treatment": null, 
        " PS - N (%) | 0 | Control": null, 
        " PS - N (%) | 0 | Treatment": null, 
        " PS - N (%) | 1-2 | Control": null, 
        " PS - N (%) | 1-2 | Treatment": null, 
        " Previous local therapy - N (%) | Orchiectomy | Control": null, 
        " Previous local therapy - N (%) | Orchiectomy | Treatment": null, 
        " Previous local therapy - N (%) | Prostatectomy | Control": null, 
        " Previous local therapy - N (%) | Prostatectomy | Treatment": null, 
        " Previous local therapy - N (%) | Radiotherapy | Control": null, 
        " Previous local therapy - N (%) | Radiotherapy | Treatment": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Control": null, 
        " Race - N (%) | Amer. Indian or Alaska Nat. | Treatment": null, 
        " Race - N (%) | Asian | Control": null, 
        " Race - N (%) | Asian | Treatment": null, 
        " Race - N (%) | Black or African American | Control": null, 
        " Race - N (%) | Black or African American | Treatment": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Control": null, 
        " Race - N (%) | Nat. Hawaiian or Pac. Islander | Treatment": null, 
        " Race - N (%) | Other | Control": null, 
        " Race - N (%) | Other | Treatment": null, 
        " Race - N (%) | Unknown | Control": null, 
        " Race - N (%) | Unknown | Treatment": null, 
        " Race - N (%) | White | Control": null, 
        " Race - N (%) | White | Treatment": null, 
        " Region - N (%) | Africa | Control": null, 
        " Region - N (%) | Africa | Treatment": null, 
        " Region - N (%) | Asia | Control": null, 
        " Region - N (%) | Asia | Treatment": null, 
        " Region - N (%) | Europe | Control": "~87 (16.5)", 
        " Region - N (%) | Europe | Treatment": "~87 (16.6)", 
        " Region - N (%) | North America | Control": "~87 (16.5)", 
        " Region - N (%) | North America | Treatment": "~87 (16.6)", 
        " Region - N (%) | Oceania | Control": null, 
        " Region - N (%) | Oceania | Treatment": null, 
        " Region - N (%) | South America | Control": null, 
        " Region - N (%) | South America | Treatment": null, 
        " Volume of disease - N (%) | High | Control": null, 
        " Volume of disease - N (%) | High | Treatment": null, 
        " Volume of disease - N (%) | Low | Control": null, 
        " Volume of disease - N (%) | Low | Treatment": null, 
        "Add-on Treatment": "Apalutamide", 
        "Adverse Events - N (%) | All-Cause Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 3 or Higher": "", 
        "Adverse Events - N (%) | Treatment-related Grade 5": "", 
        "Authors": "Chi, Kim N. et al", 
        "Class_of_Agent_in_Treatment_Arm_1": "ARPI", 
        "Control_Arm": "ADT", 
        "Control_Arm - N": 527.0, 
        "Docetaxel administration - N (%) | Control": "55 (10.4)", 
        "Docetaxel administration - N (%) | Treatment": "58 (11)", 
        "Full Pub or Abstract": "Abstract", 
        "Gleason score - N (%) | \u2264 7": "", 
        "Gleason score - N (%) | \u2265 8": "", 
        "Included in MA": "yes", 
        "Median Age (years) | Control": 68.0, 
        "Median Age (years) | Treatment": 69, 
        "Median Follow-Up Duration (mo)": 44, 
        "Median OS (mo) | High volume": "", 
        "Median OS (mo) | Low volume": "", 
        "Median OS (mo) | Overall": "", 
        "Median On-Treatment Duration (mo) | Control": 20.2, 
        "Median On-Treatment Duration (mo) | Treatment": 39.3, 
        "Median PFS (mo) | High volume": "", 
        "Median PFS (mo) | Low volume": "", 
        "Median PFS (mo) | Overall": "", 
        "Metastases - N (%) | Bone": "", 
        "Metastases - N (%) | Liver": "", 
        "Metastases - N (%) | Lungs": "", 
        "Metastases - N (%) | Nodal": "", 
        "Mode of metastases - N (%) | Metachronous": "", 
        "Mode of metastases - N (%) | Synchronous": "", 
        "NCT": "NCT02489318", 
        "No. of Deaths - N | Control": null, 
        "No. of Deaths - N | Treatment": null, 
        "Number of Arms Included": 2, 
        "ORR - N (%) | Control": "", 
        "ORR - N (%) | Treatment": "", 
        "OS Rate (%) | High volume": "", 
        "OS Rate (%) | Low volume": "", 
        "OS Rate (%) | Metachronous": "", 
        "OS Rate (%) | Overall": "", 
        "OS Rate (%) | Synchronous": "", 
        "Original/Follow Up": "Follow up", 
        "PFS Rate (%) | Overall": "", 
        "PMID": "10.1200/jco.2021.39.6_suppl.11", 
        "PS - N (%) | 0": "", 
        "PS - N (%) | 1-2": "", 
        "Phase": 3, 
        "Previous local therapy - N (%) | Orchiectomy": "", 
        "Previous local therapy - N (%) | Prostatectomy": "", 
        "Previous local therapy - N (%) | Radiotherapy": "", 
        "Primary Endpoint(s)": "OS, rPFS", 
        "Quality of Life Scale": "FACT-P", 
        "Quality of Life reported": "Yes", 
        "Race - N (%) | Amer. Indian or Alaska Nat.": "", 
        "Race - N (%) | Asian": "", 
        "Race - N (%) | Black or African American": "", 
        "Race - N (%) | Nat. Hawaiian or Pac. Islander": "", 
        "Race - N (%) | Other": "", 
        "Race - N (%) | Unknown": "", 
        "Race - N (%) | White": "", 
        "Region - N (%) | Africa": "", 
        "Region - N (%) | Asia": "", 
        "Region - N (%) | Europe": "", 
        "Region - N (%) | North America": "", 
        "Region - N (%) | Oceania": "", 
        "Region - N (%) | South America": "", 
        "Reporting by prognostic groups - Y/N | High volume": "No", 
        "Reporting by prognostic groups - Y/N | Low volume": "No", 
        "Reporting by prognostic groups - Y/N | Metachronous": "No", 
        "Reporting by prognostic groups - Y/N | Synchronous": "Yes", 
        "Secondary Endpoint(s)": "Time to cytotoxic chemotherapy; Time to pain progression", 
        "TTPSA (mo) | Control": null, 
        "TTPSA (mo) | Treatment": null, 
        "Total Participants - N": 1052, 
        "Treatment Arm - N": 525, 
        "Treatment Arm 1 Regimen": "Apalutamide 240 OD; standard androgen deprivation", 
        "Treatment_Arms": "APA+ADT", 
        "Treatment Class": "ARPI", 
        "Trial_Name": "TITAN", 
        "Type of Therapy": "ARPI-doublet", 
        "Volume of disease - N (%) | High": "", 
        "Volume of disease - N (%) | Low": "", 
        "Year": "2021", 
        "_arm_idx": 0
      }
    ]
  }
  